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EPIGRAPH 
Questing 
1. The act or an instance of seeking or pursuing something - a search
2. A journey requiring great exertion, long travels and the overcoming of many
obstacles
3. An expedition undertaken in medieval romance by a knight in order to
perform a prescribed feat: e.g. the quest for the Holy Grail, the quest to destroy
the One Ring (Lord of the Rings).
4. Archaic: an inquest or a jury appointed to take part in an inquest
5. from Middle English “queste”, from Old French and ultimately from Latin
“quaesta” (feminine of quaestus, the past participle of quaerere, to seek)
6. Tick climbing up a blade of grass or other structure and then waiting with its
front legs outstretched to come into contact with a suitable host
The Quest 
The Impossible Dream 
Musical: Man of La Mancha – Don Quichote  
Composer: Mitch Leigh - Songwriter: Joe Darion - Song Version: Andy Williams 
To dream the impossible dream 
To fight the unbeatable foe 
To bear with unbearable sorrow 
To run where the brave dare not go 
To right the unrightable wrong 
To love pure and chaste from afar 
To try when your arms are too weary 
To reach the unreachable star 
This is my quest, to follow that star, 
No matter how hopeless, no matter how far 
To fight for the right without question or cause 
To be willing to march into hell for a heavenly cause 
And I know if I'll only be true to this glorious quest 
That my heart will lie peaceful and calm  
when I'm laid to my rest 
And the world will be better for this 
That one (wo)man scorned and covered with scars 
Still strove with his (her) last ounce of courage 
To fight the unbeatable foe, to reach the unreachable star… 
v 
Dr. S. Roelandt with Don Quichote 
La Mancha, Spain, 2015 
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Don Quixote 
An ingenious, good-natured and slightly insane idealist who goes to battle on his 
exhausted old horse "Rocinante", with rusty armour, a paper helmet and a bean 
stalk as a jousting lance, to fight wind mills and other formidable enemies 
during his medieval quest for chivalrous romance 
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DANKWOORD 
PhD staat voor ‘Doctor of Philosophy’ 
(Wikipedia) 
Filosofie mag hier in de brede zin geïnterpreteerd worden, volgens de originele Griekse 
betekenis φιλοσοφία: "liefde voor de wijsheid". Het doctoraats-diploma wordt door Europese 
universiteiten al sinds de middeleeuwen uitgereikt wanneer een kandidaat bewezen heeft 
problemen te kunnen aanpakken door vraagstelling, kritisch nadenken, een systematische aanpak 
en rationele argumenten (tot zover Wikipedia).   
Per toeval is σοφία nu net mijn naam ? dat creëert redelijk hoge verwachtingen voor de 
φιλο. En laat een PhD hedentendage nog steeds een soort middeleeuwse queeste zijn voor de 
doctorandus/-a, met als climax een verdediging van een proefschrift, waarvan het maken het 
gevecht met de draak zou kunnen evenaren. Je ziet direct dat voor deze hachelijke onderneming 
een flinke dosis filosofie vereist is, maar een goed harnas (tegen peer review), een bewezen 
strijdros (promotor) en geschikte wapens (software en geld) zouden zeker niet misstaan, ondanks 
de gesofisticeerde 21e eeuw waarin we leven...  
Ik heb dan ook niet enkel veel over TBEV en labo’s geleerd, maar ook over verschillende 
vormen van filosofie: de antropologishe (wat voor een beest is de mens?), de politieke (verdeling 
van macht, van kansen en mogelijkheden in een samenleving of organisatie) en de sociale 
(Human Behaviour = ƒ(Person, Environment, Context). Aangezien een PhD onvermijdelijk 
uitmondt in een existentiële crisis (Waarom doe ik dit doctoraat? Waarom ben ik begonnen aan 
deze queeste van constante uitdagingen?) is het existentialisme ook van pas gekomen gedurende 
de laatste jaren. Hier en daar een snuifje dialectiek is ook nuttig gebleken om de redenaars-balans 
tussen logos, ethos en pathos verder te optimaliseren.  
Om deze filosofische beschouwingen af te ronden, een citaat dat in deze tijden van zoönosen 
en one health toestanden zijn pluimen nog niet verloren is:  “Le sort des animaux est d'une plus 
grande importance pour moi que la crainte de paraître ridicule; il est indissolublement lié 
au destin des hommes” (Émile Zola, 1840-1902). Zola volgde de literaire stroming van het 
naturalisme, die werd beïnvloed door het realisme en de ideeën van Auguste Comte, Karl Marx 
en Charles Darwin. 
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gekomen. Vooreerst wil ik mijn sterk gewaardeerde (co-)promotoren Prof. Dr. Yves Van der 
Stede, Dr. Stefan Roels en Prof. Dr. Steven Van Gucht hartelijk bedanken voor hun 
onuitputtelijke toewijding en steun. Bedankt om mij de juiste weg te wijzen (doctoreren voor 
dummies die geen tijd hebben) en me gedurende al die jaren zowel op persoonlijk als op 
wetenschappelijk vlak verder te laten ontplooien. Na al die jaren van interessante informele 
discussies, labotesten, data verwerken, schrijven en herlezen mag het resultaat hopelijk gezien 
worden!  
Hartelijk dank aan alle gedistingeerde leden van de Begeleidings- en Examencommissies: 
Prof. Dr. Hans Nauwynck, Prof. Dr. Jeroen Dewulf, Prof. Dr. Edwin Claerebout, Dr. Muriel 
Vervaeke, Dr. Guy Hendrickx, en Dr. Martin Beer. Uw gezamenlijk werk en opbouwende kritiek 
hebben significant bijgedragen tot de kwaliteit van dit proefschrift. U heeft mijn dankbaarheid in 
de vorm van een goede fles wijn en receptie zeker verdiend ! 
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mijn die gezaag hebben moeten aanhoren in onze gezamenlijke bureau: Matthias, Valerie, Hanne, 
Mickaël en Genevieve. Ik heb ook altijd kunnen rekenen op Estelle, Sarah, Marc, Flavien en 
Michel, Isabelle en Katia, mijn collega ERASURV’ers van wie ik enorm veel geleerd heb !  
Verder wens ik ook een heel grote dankuwel uit te brengen aan Dr. Vanessa Suin, Sophie 
Lamoral, en Dr. Bernard Brochier van het WIV-ISP voor het vele werk in het laboratorium en 
voor de goede samenwerking gedurende dit doctoraat: mag het nog lang zo verder gaan ! Dank 
voor de goede samenwerking aan het FAVV (Dr. Jef Hooyberghs), DGZ (Dr. Mia Vanrobaeys) 
en collega’s), ANB (Dr. Muriel Vervaeke), AviaGIS (Dr. Els Ducheyne) en het INBO (Dr. Jim 
Casaer). Dank ook aan de kleine huisdieren Laboratoria (Labo Bruyland, Kortrijk; Laboratoires 
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We mogen hier zeker ook de familie en vrienden niet vergeten, eigenlijk teveel mensen om 
op te noemen, maar bij wie we wel altijd terecht kunnen voor de nodige ontspanningsmomenten 
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hun filosofisch geluier op mijn PC en papieren. 
At the end of the day, the most overwhelming key to a child’s success 
is the positive involvement of its parents (Jane D. Hull, Amerikaans politicus). 
En het blijft een waarheid als een koe, ook als je al halverwege de 30 aan het doctoreren 
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Ik draag het op aan mijn Moeder Catheline: Zij die mij als baby vertroetelde, als kind mijn 
huiswerk opvroeg, als tiener op en af naar school voerde, tijdens mijn studententijd zorgde dat ik 
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 BACKGROUND I.1
Tick-borne encephalitis virus (TBEV) is the most important arthropod-borne virus in Europe 
(Herpe et al., 2007; Ramelow et al., 1993). In Europe, the Western subtype of this highly 
pathogenic neurotropic flavivirus is carried by Ixodes ricinus (Kreil et al., 1997; Labuda and 
Randolph, 1999; Stjernberg et al., 2008). Tick-borne encephalitis (TBE) has become a 
considerable public health risk in several European countries (Haglund, 2002; Süss et al., 1997), 
with currently on average 3,000 hospitalized cases per year (ECDC, 2012; Mansfield et al., 2009; 
Süss, 2011). In many patients the disease results in long-term sequelae and disability (Donoso 
Mantke et al., 2008a).  
Recent increases and fluctuations in human incidence in Central and Eastern European 
countries (e.g. Switzerland, Germany, Poland, Baltic States) (Süss, 2008a, b) and the emergence 
of the disease in Finland (Jääskeläinen et al., 2006), Norway (Csángó et al., 2004); (Skarpaas et 
al., 2006; Skarpaas et al., 2004), Denmark (Skarpaas et al., 2006; Skarphedinsson et al., 2005) 
and France (Herpe et al., 2007) have sparked international concern and research. TBE is also 
emerging in Europe’s canine population, and the numbers of clinical cases in dogs are expected 
to increase (Beugnet et al., 2009; Leschnik et al., 2002).  
This review aims to highlight important features of TBE epidemiology, the clinical course in 
humans and the surveillance possibilities for this tick-borne flavivirus. Afterwards, it will enter 
the discussion of whether Belgium could be at risk for TBE and whether national veterinary 
surveillance, in addition to medical surveillance, could be of benefit. 
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  EPIDEMIOLOGY I.2
 EPIDEMIOLOGICAL CONCEPTS I.2.1
Since the early days of recognition of TBE disease in the early 20th century, it has been 
known that the ecology and epidemiology of TBEV is a complicated story (Figure I-1) (Pfeffer 
and Dobler, 2011). As with most infectious diseases, the complexity of the real life situation may 
be reduced and simplified with the help of the classic epidemiological concept of the 
epidemiological triad: agent – host – environment + vector (Figure I-1). A host and an external 
agent are brought together in an environment, causing the disease in the host. A vector may 
transmit from one host to another (Lengerich, 2016). 
Hence, we can review the recent advances in a large part of TBE research from these 
different eco-epidemiological viewpoints that are connected by the vector. Of all separate parts of 
the epidemiological triad and of the multifactorial drivers that contribute to the TBEV 
transmission cycle, our understanding continues to increase (See I.2.2- I.2.7). 
 
Figure I-1 : Transmission cycle of TBEV with parts of the epidemiological triad. 
Agent - Host - Environment – Vector; Adapted from Pfeffer and Dobler, 2011 and Lengerich, 2016 
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The zoonotic iceberg (Figure I-2) is another analogy which helps to explain such 
complicated observed variability in human TBE incidence. It involves investigating the lower 
parts of bulk of the iceberg that are invisible and submerged, i.e. domestic animal exposure and 
the much more extensive endemic wildlife transmission cycles between vectors and wildlife 
hosts, in order to explain the variable human infections and cases at the visible tip of the iceberg..  
In other words, the bulk represents the transmission potential of a risk area, while the tip 
represents the human exposure and contact rates with TBEV through ticks and the environment 
(Randolph and Sumilo, 2007). It is very important to select the right part of the iceberg for the 
right kind of surveillance (See under I.5 and VII.1-2). 
 
Figure I-2: The Zoonotic Iceberg Analogy  
Created based on (Randolph and Sumilo, 2007) and (Liverpool, 2015) 
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 PATHOGENIC AGENT: TBEV I.2.2
TBEV is a small spherical enveloped RNA virus that belongs to the genus Flavivirus 
(Flaviviridae), which contains many neurotropic pathogenic arthropod-borne viruses. Its genome 
consists of a 10.5kb single positive strand of RNA, encoding three structural and seven non-
structural proteins (Gould et al., 2004; Heinz, 2003; Heinz and Allison, 2000). Three lineages of 
TBEV have been described, namely the Western subtype (W-TBEV) transmitted by I. ricinus 
ticks and the Siberian (S-TBEV) and Far Eastern (FE-TBEV) subtypes transmitted by I. 
persulcatus (Donoso Mantke et al., 2008a; Gubler et al., 2007). Besides the co-circulation of all 
subtypes in Estonia and Latvia (Golovljova et al., 2004) and one focus of the Siberian subtype 
discovered in Finland (Jääskeläinen et al., 2006), only the Western subtype is present in Europe 
(Heinz, 2008). Hereafter, only the Western subtype will be discussed, unless specified otherwise. 
 TICK VECTORS I.2.3
The castor-bean syn. sheep tick I. ricinus (Family Ixodidae) is the most important and most 
widespread European tick species (Figure I-3) (VBORNET, 2015) and it was long believed to be 
the only tick in nature capable of sustaining infection with the Western TBEV (W-TBEV) 
subtype (Heinz, 2008; Labuda and Randolph, 1999).  
 
Figure I-3. Distribution of I. ricinus ticks in Europe.  
Red zone: presence of I. ricinus in the area; Grey zone: no data or no presence (VBORNET, 2015) 
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I. ricinus is a three-host tick with three life stages (larva, nymph, adult) and a two/three-year-
long life cycle during which TBEV infection is passed transstadially, horizontally, and 
transovarially/vertically (Figure I-4a). TBE infected ticks can be co-infected with many 
pathogens, but mainly with Borrelia spp., Babesia spp., Anaplasma spp. or Coxiella burnetii 
(Heinz, 2008; Süss, 2003). After the blood meal, TBE virus replication takes place in the tick’s 
midgut wall cells. Infection of the salivary glands then occurs prior to transmission by tick saliva 
into the next host during the next blood meal, within 1-3 hours after attachment (Figure I-4a) 
(Gresikova and Noseck, 1966; Mansfield et al., 2009; Nuttall et al., 1994; Ruzek et al., 2013; 
Weitlauf et al., 2007).  
Horizontal tick-to-tick transmission may thus occur through mating, through viremic hosts, 
or through simultaneous co-feeding of larvae with nymphs on the same (immune) host (Figure I-
4b) (Donoso Mantke et al., 2008a; Heinz, 2008; Labuda et al., 1993a; Labuda and Randolph, 
1999; Mansfield et al., 2009; Vene et al., 1998). Transmission to the host happens (1) via 
Langerhans cell infiltration/migration in local host skin (Figure I-4c)(Labuda et al., 1996), or (2) 
via saliva mixing in the same feeding pool (Figure I-4d) (Alekseev and Dubinina, 2002; Nuttall et 
al., 1994; Ruzek et al., 2007a) or (3) through the host’s viraemia (Süss, 2011). The I. ricinus 
transmission of W-TBEV as well as their infection level of these ticks is still being studied and 
becoming better understood (Biernat et al., 2014b; Hubalek and Rudolf, 2012; Stefanoff et al., 
2013).  
It is known that the ornate dog tick Dermacentor reticulatus (Amblyommidae) is also 
involved in the circulation of TBEV; however, its relative importance for TBE epidemiology 
remains unknown (Biernat et al., 2014b). When experimentally infected with W-TBEV, D. 
reticulatus shows virus proliferation and TBEV transmission to a new host within 1 hour of 
attachment (Alekseev et al., 1996; Rehacek et al., 1987), but it seems to exhibit lower 
transmission rates (Gresikova and Kaluzova, 1997).   
General Introduction 
7 
 
 
Figure I-4: Tick-to-tick ransmission of tick-borne encephalitis virus  
(a) Important tick anatomy for TBEV transmission: mouth parts (chelicerae and hypopharynx), salivary glands, 
midgut (Edwards et al., 2009); (b) Transmission throughout the tick life cycle (Mansfield et al., 2009); (c) Cellular 
co-feeding transmission - Immunocytochemical localization of TBE viral antigen (red) in MHC class II-positive 
Langerhans cells in mouse skin (blue) (Labuda et al., 1996); (d) Trans-salival co-feeding transmission - 1: donor, 2: 
recipient,3: feeding site (Alekseev and Dubinina, 2002). 
 VERTEBRATE HOSTS  I.2.4
I. ricinus has more than 100-300 known natural hosts, including mammals, birds and reptiles. 
Most of these hosts become subclinically infected with TBEV and become immune for life 
(Leschnik et al., 2002; Süss, 2003; WHO, 2011). D. reticulatus also occurs widely in the 
temperate climate zone across Eurasia, parasitizing a wide range of host species (Biernat et al., 
2014b) and its distribution is currently expanding in north-western Europe (Karbowiak and 
Kiewra, 2010). 
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Small rodents such as field and wood mice (Apodemus spp., Myodes spp.) show 
asymptomatic viremia and constitute competent reservoirs for immature ticks (Cerny, 1975; 
Heinz, 2008; Süss, 2003), with rapid population turnover and a constant supply of susceptible 
individuals (Rizzoli et al., 2004a). Additionally, TBEV is able to replicate in immunocompetent 
(Langerhans) cells in the skin of these mice, including immune or aviremic animals. The infected 
cells migrate to lymph nodes and back to feeding sites of uninfected co-feeding ticks. This allows 
non-viremic transmission between simultaneously co-feeding nymphs and larvae, even in 
immune rodents (Labuda et al., 1993d; Labuda and Randolph, 1999).  
Large mammals such as roe deer (Capreolus capreolus), wild boar (Sus scrofa) and domestic 
ruminants mainly serve as tick amplifying hosts. They are considered incompetent hosts (i.e. 
unable to transmit), as they only develop low virus titers, though non-viraemic co-feeding 
transmission may be possible (Labuda et al., 1993d; Rizzoli et al., 2004a; Süss, 2003). TBEV is 
excreted in the milk of viremic cows, goats and sheep and can be transmitted to humans this way 
(Gould et al., 2006; Heinz, 2008). Birds also host immature I. ricinus and experience a short 
TBEV viremia. They seem to contribute to the spread of infected ticks (Gould et al., 2006; Gould 
et al., 2004; Heinz, 2008).  
Dogs and horses appear to be relatively less frequently infected by TBEV, though they may 
carry infected Ixodid ticks from endemic to non-endemic areas and into close vicinity of humans 
(Balmer et al., 2007a; Chomel, 2013; Gresikova et al., 1972; Higgins and Snyder, 2006; Leschnik 
et al., 2002; Rees, 2010). Although in most of these animals there is seroconversion without 
clinical signs (Grešíková et al., 1972; Janitza-Futterer, 2003; Klimeš et al., 2001; Leschnik et al., 
2002; Rushton et al., 2013), TBEV can nevertheless cause general and multifocal neurological 
clinical signs (Bjöersdorff, 2002; Dietz and Huskamp, 2005; Kirtz, 1999; Müller et al., 2006). 
Humans are accidental dead-end hosts for ticks and for TBEV as, despite noticeable viremia, 
humans do not transmit the disease (Heinz, 2008; Süss, 2003).  
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 ENVIRONMENT I.2.5
Around 90% of TBEV endemic foci fall within specific climatic boundaries, such as the 7-
8°C annual isotherm and the 800 mm per annum precipitation minimum, resulting in the high soil 
humidity and 92% relative humidity required by I. ricinus for survival (Gritsun et al., 2003b; 
Heinz, 2008; Labuda and Randolph, 1999). Infected I. ricinus are often found questing for a host 
in mixed deciduous woodland with dense, humid ground layers and in animal feeding and resting 
places (Heinz, 2008; Randolph, 2001).  
Co-feeding of larvae and nymphs can only occur in areas where rapid autumnal cooling 
inhibits questing of unfed larvae, which will go into diapause until the next spring. At this time, 
rapidly rising temperatures will cause simultaneous reactivation of larvae and nymphs (Gritsun et 
al., 2003b; Randolph, 2001). Nymphal and larval seasonal feeding patterns will then overlap and 
this leads to co-feeding transmission (Labuda and Randolph, 1999).  
Without co-feeding, TBEV does not seem to persist and an endemic focus should not develop 
(Gould et al., 2004; Randolph, 2002). No vertical transmission route can be sufficient without 
additional horizontal amplification. Virus passing from one female to 50% of her offspring will 
die out within a few generations, unless infected offspring have double the normal survival rate 
(Randolph, 2011).  
Labuda’s laboratory work on transmission pathways together with the quantitative features of 
tick survival are considerred sufficient to explain persistent TBE virus cycles (Labuda et al., 
1996; Labuda et al., 1993a; Labuda et al., 1993b; Labuda et al., 1993c; Labuda et al., 1997b; 
Labuda et al., 1993d; Labuda and Randolph, 1999; Randolph et al., 1999). 
In natural conditions, it seems that a reproduction ration (R0) above 1 (which is an indicator 
for ongoing transmission with possible outbreaks,  only occurs when there is transmission of non-
systemic infections from infected nymphs to larvae by co-feeding (Randolph et al., 1999; 
Hartemink et al., 2008). 
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 DISTRIBUTION AND INCIDENCE I.2.6
The distribution of TBEV (all 3 subtypes) spans almost the entire Southern part of Eurasia 
(Figure I-5)(Barrett et al., 2008; Kollaritsch et al., 2011b; Süss et al., 2010), presently from 
Alsace-Lorraine/Southern Norway (Donoso Mantke et al., 2008a) to Vladivostok/Northeastern 
China/Japan, and it consists of up to 30,000 endemic foci (Gritsun et al., 2003b; Korenberg and 
Kovalevskii, 1999). Worldwide, 10,000-12,000 cases of human TBE are reported annually (Süss, 
2003), of which more than 3,000 cases in Europe (Charrel et al., 2004; ECDC, 2012; Gritsun et 
al., 2003a; Gunther and Haglund, 2005; Haglund, 2002). European TBEV is endemic in 27 
countries (Süss, 2008a), of which the Central European countries, the Baltic States and Russia are 
most severely affected (Korenberg and Kovalevskii, 1999; Süss et al., 1992). 
 In many of these countries TBE accounts for 50% of all cases of central nervous system 
(CNS) infection (Kaiser, 2008a; Kunz, 2008). Western European incidence is currently <4 
cases/100,000 inhabitants (Gubler et al., 2007; Stjernberg et al., 2008). However, in Great 
Britain, Ireland, Iceland, Belgium, the Netherlands, Spain and Portugal no autochthonous TBE 
cases have been reported to date (Donoso Mantke et al., 2008a; ECDC, 2012; Kunz, 2008). 
During the last three decades, the TBE incidence has risen dramatically (2- to 17-fold) in 
most of the affected countries (e.g. Lithuania 1033%, Germany 574%, Europe as a whole 400%) 
(Randolph and Rogers, 2000; Stjernberg et al., 2008; Süss, 2008a, b). Recently, new endemic 
foci have appeared in France, Greece, Denmark, Norway (Donoso Mantke et al., 2008a), Italy 
(Pugliese et al., 2007), Sweden (Stjernberg et al., 2008), Finland (Jääskeläinen et al., 2006) and 
Germany (RKI, 2009), and new risk areas are being discovered every year. TBE has rapidly 
become a growing public health problem (Süss, 2008a, b) and is currently the most important 
vector-borne viral infection in Europe (Donoso Mantke et al., 2008a; Labuda et al., 2006).  
It is known that TBE risk areas in countries can be very large and static, but they can also be 
small and dynamic in time and space, with sudden dis- and re-appearances of human cases, even 
outside previously recognized endemic areas (Kupca et al., 2010; Randolph and Sumilo, 2007). 
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Figure I-5. Known distribution of the TBE virus  
(Kollaritsch et all, 2011; Barrett et al., 2008; Süss, 2010). 
 
 DRIVERS AND RISK FACTORS I.2.7
During the last 30 years, European TBE incidence trends were characterized by wild 
fluctuations, relative stability and gradual increases in different areas, while spatio-temporal 
endemic area distribution was patchy/variable (Nuttall, 1999; Randolph and Sumilo, 2007; Süss, 
2011). Several authors discussed the many various sociological, technological and ecological 
(a)biotic1 etiological risk factors that may cause a rise in incidence, prevalence and distribution of 
vector-borne diseases (VBDs), and specifically of TBE. (Figure I-6; Table I-1).  
Whereas recent TBE emergence in Scandinavia has been linked predominantly to climate 
change (milder winters and earlier springs) (Lindgren and Gustafson, 2001), expansion of roe 
deer and tick populations (Randolph, 2001, 2008) and increased awareness (Haglund, 2002), 
increases in incidence in certain areas of Germany during the 1990s seem to be related to 
increased surveillance and improved diagnostics (Randolph, 2001). As opposed to this, in Eastern 
European countries the political change caused by the end of communism also resulted in many 
agricultural and social changes (Randolph, 2001).  
                                               
1 Living organisms and chemical/physical parts of the environment that affect living organisms and the 
functioning of ecosystems 
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As a consequence, the increased consumption of unpasteurized milk and the increased use of 
forests and previously abandoned countryside areas for food collecting or leisure activities have 
led to increased exposure to I. ricinus and TBEV (Beltrame et al., 2006; Randolph and Rogers, 
2000). Finally, data indicate that some dramatic increase of human TBE cases in several 
European countries during hot summers can be explained mainly by an increase in human 
outdoor activity in response to the unusual weather (Randolph, 2004; Randolph et al., 2008). 
Since risk factors such as changes in climate/weather, society, politics, public health actions, 
land use, wildlife abundance and human behavior can strongly influence TBE-incidence 
(Lindgren, 1998; Mansfield et al., 2009; Randolph, 2004; Randolph and Sumilo, 2007; Süss, 
2008b), monitoring and evaluating these drivers may ultimately enable prediction of the 
multifactorial and heterogeneous changes in incidence and potential emergences of TBE as 
observed in the field (Jaenson et al., 2012; Randolph and Sumilo, 2007).  
Changes in hunting practices have led to increasing European game populations, providing 
greater feeding opportunity for questing ticks (Sumilo et al., 2008b; Rizzoli et al., 2009; Rizzoli, 
2009). Some authors have assumed that, since game are dead end hosts, this would lead to 
dilution effects and thus a decrease in TBE incidence (Kriz et al., 2014; Perkins et al., 2006; Rosa 
and Pugliese, 2007; Pugliese and Rosa, 2008; Cagnacci et al., 2012; Bolzoni et al., 2012).  
However, this view did not take into account co-feeding non-viraemic transmission (Labuda 
et al., 1993a/b/c; Randolph et al., 1996; Randolph and Sumilo, 2007) or vertical/transovarial 
transmission (Kriz et al., 2014). Indeed, the increasing host abundance and extending distribution 
has led to enhanced tick reproduction with associated spread of TBEV to higher 
latitudes/altitudes and the emergence of new endemic foci outside woods in agricultural and 
suburban areas (Medlock et al., 2013; Jaenson et al., 2012; Gomez Martinez, 2014; Cisak et al., 
2012/2014; Kriz et al., 2014).  
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Figure I-6: Risk factors of tick-borne diseases. 
Schematic relationship between several (a)biotic drivers; Lindgren, 1998. 
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Table I-1: Risk factors influencing incidence, prevalence and distribution of tick-borne encephalitis, ticks 
and Lyme disease 
Risk Factor References (non-exclusive) 
Increased human population and 
density -  Increased urbanization 
and abandonment of countryside - 
Migration towards suburban areas 
(Beltrame et al., 2006; Beugnet and Marie, 2009; Heinz, 2008; Linard et 
al., 2007; Linard and Vanwambeke, 2009; Merino et al., 2000; Racz et al., 
2006; Randolph, 2001; Randolph and Sumilo, 2007; Süss, 2003; Süss, 
2008a)  
Exotic disease introduction through 
increased travel of humans/pets and 
increased transport of goods and 
domestic/wild animals  
(Beugnet and Marie, 2009; BSAVA, 2009; Donoso Mantke et al., 2008a; 
Haglund, 2002; Heyman, 2009; Kunz, 2008; Leschnik et al., 2002; Luyasu, 
2009; Rendi-Wagner, 2004; Süss, 2003; Süss, 2008a)  
Change in leisure and outdoor 
activities 
(Donoso Mantke et al., 2008a; Heinz, 2008; Kunz, 2008; Lindgren and 
Gustafson, 2001; Randolph et al., 2008; Randolph and Rogers, 2000)  
Social/political/economic factors and 
change - Displacement due to 
conflict/war 
(Beltrame et al., 2006; Beugnet and Marie, 2009; De Keukeleire et al., 
2015; Donoso Mantke et al., 2008a; Heinz, 2008; Linard et al., 2007; 
Linard and Vanwambeke, 2009; Merino et al., 2000; Randolph, 2001; 
Randolph et al., 2008; Randolph and Rogers, 2000; Süss, 2003; Süss, 
2008a; Vanwambeke et al., 2010; Zeimes et al., 2014)  
Change in agricultural practices - 
Increased consumption of raw milk 
(Heinz, 2008; Randolph, 2001; Randolph et al., 2000; Süss, 2003; Süss, 
2008a) 
Occupational exposure: farmer, 
military, forester, hunter, laboratory 
(Donoso Mantke et al., 2008a; Randolph, 2001; Süss, 2003; Süss, 2008a) 
Landscape structure, configuration, 
fragmentation, geology and land use  
(Achazi et al., 2011; Beltrame et al., 2006; Beugnet and Marie, 2009; 
Brownstein et al., 2005; Bunnell et al., 2003; Daniel et al., 1998; Das et al., 
2002; De Keukeleire et al., 2015; Dister et al., 1997; EEA, 2012; Falco et 
al., 1999; Glass et al., 1995; Guerra et al., 2002; James et al., 2013; Kiffner 
et al., 2010; Li et al., 2012a; Li et al., 2012b; Linard et al., 2007; Linard 
and Vanwambeke, 2009; Randolph, 2001; Randolph et al., 2008; 
Vanwambeke et al., 2010; Wilson et al., 1985; Zeimes et al., 2014) 
Increased reforestation/conservation 
of tick habitat and changed hunting 
or wildlife management practices, 
leading to increasing host and tick 
populations  
(Allan et al., 2003; Beugnet and Marie, 2009; Gómez-Martínez, 2014; 
Haemig et al., 2011; Haglund, 2002; James et al., 2013; Kiffner et al., 
2010; Knap and Avsic-Zupanc, 2013; Kriz et al., 2014; Li et al., 2012a; Li 
et al., 2012b; Linard and Vanwambeke, 2009; Lindgren and Gustafson, 
2001; Randolph, 2001; Randolph et al., 2008; Rizzoli et al., 2009; 
Stjernberg et al., 2008; Süss, 2008a; Wilson et al., 1985) 
Climatological (climate change) or 
meteorological (local microclimate)  
(Achazi et al., 2011; Beugnet and Marie, 2009; Brownstein et al., 2003; 
Daniel et al., 2011; De Keukeleire et al., 2015; Donoso Mantke et al., 
2008a; EEA, 2012; Haglund, 2002; Heinz, 2008; Heyman, 2009; James et 
al., 2013; Labuda et al., 1997a; Labuda and Randolph, 1999; Li et al., 
2012a; Li et al., 2012b; Lindgren and Gustafson, 2001; Lindh et al., 2008; 
Palo, 2014; Randolph, 2001; Randolph et al., 2000; Randolph and Sumilo, 
2007; Rizzoli et al., 2007; Stjernberg et al., 2008) 
Environmental factor: biotope, 
vegetation 
(Beugnet and Marie, 2009; Estrada-Pena, 2002a; Haglund, 2002; Heinz, 
2008; James et al., 2013; Linard et al., 2007; Randolph, 2001; Rizzoli et 
al., 2009; Stjernberg et al., 2008; Tack et al., 2012; Zeimes et al., 2014)  
Higher awareness in the medical 
community and among the 
population in general  
(Beltrame et al., 2006; Donoso Mantke et al., 2008a; Haglund, 2002; 
Lindgren and Gustafson, 2001; Randolph, 2001; Stjernberg et al., 2008) 
Improved diagnostic procedures and 
increased surveillance 
(Beltrame et al., 2006; Donoso Mantke et al., 2008a; Haglund, 2002; 
Randolph, 2001; Stjernberg et al., 2008) 
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  CLINICAL CASES   I.3
 EXPOSURE I.3.1
Humans and animals usually become infected with TBEV through bites from I. ricinus 
larvae, nymphs or adults. In affected countries, people contract TBE during spring and summer 
through working outdoors (e.g. farmers, forest workers, military personnel) (Donoso Mantke et 
al., 2008a; Haglund, 2002) or through leisure activities such as sports, hunting, fishing, 
rambling/hiking, berry/mushroom/wood collecting, or through the consumption of raw 
(unpasteurized) goat, cow and sheep milk (Heinz, 2008; Süss, 2003; Süss, 2008a). The risk of 
human infection after a single tick bite in an endemic area varies from 1/1000 to 1/200 (Süss, 
2003; Süss, 2008a).   
 CLINICAL COURSE   I.3.2
TBEV is neurotropic and clinical signs vary from mild fever to meningitis, encephalitis or 
myelitis (Haglund et al., 2003). Between one-third and two-thirds of human patients experience a 
typical biphasic course, as in Figure I-7 (RicHard-59, 2011), starting with non-specific influenza-
like symptoms and a brief viremia (1-4 days), followed by an asymptomatic interval (Kaiser, 
1999, 2008a; Lešničar et al., 1997). A second febrile stage starts around two to four weeks post-
exposure, during which patients will develop one of four possible clinical manifestations: 
meningitis, meningo-encephalitis, meningo-encephalomyelitis or meningo-radiculoneuritis 
(Donoso Mantke et al., 2008a; Kaiser, 1999, 2008a).  
 
Figure I-7: Stages and symptoms of TBEV infection.  
Adapted from RicHard-59 (2011). 
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This is when seroconversion starts developing and when usually medical advice is sought and 
the first diagnostic investigations take place (Holzmann, 2003). Natural infection results in 
lifelong immunity (Mickiene, 2008). A mortality rate of 0-3.9% has been reported in Europe 
(Donoso Mantke et al., 2008a; Haglund, 2002; Süss, 2008a), but morbidity and mortality rates 
increase with increasing age of the patient  (Gunther et al., 1997; Lešničar et al., 1997; Mickiene 
et al., 2002). 
In animals, neurological symptoms after TBEV-infection are often non-specific and can 
range from a (per)acute and lethal to a mild subacute course (Klaus et al., 2013). Typical canine 
TBE features pyrexia, lethargy/apathia, aggressiveness/fear, anorexia, and multifocal 
neurological signs (Bjöersdorff, 2002; Pfeffer and Dobler, 2011), including motor failures, 
paresis/paralysis and epileptic seizures (Bjöersdorff, 2002; Csángó et al., 2004; Janitza-Futterer, 
2003; Kießling, 2005; Kirtz et al., 2001; Reiner and Fischer, 1998; Reiner et al., 1999; 
Stadtbaumer et al., 2004; Tipold et al., 1993; Wandeler et al., 1972; Weissenbock et al., 2010).  
The early equine signs may resemble lameness or mild ataxia, but this quickly progresses to 
severe general signs with intermittent tonic-clonic convulsions and paresis/paralysis (Dietz and 
Huskamp, 2005; Grabner, 1993; Janitza-Futterer, 2003; Klaus et al., 2013; Long, 2011; Müller et 
al., 2006; Waldvogel et al., 1981). Similar clinical courses after natural/experimental infection 
have been observed in monkeys (Klaus et al., 2010a; Pripuzova et al., 2013; Süss et al., 2007), a 
mouflon (Bago et al., 2002) and even occasionally in the rodent reservoirs (Tonteri et al., 2013).  
 PROGNOSIS I.3.3
Symptomatic patients need hospitalization for weeks to months, and between 35% and 58% 
of them are left with permanent sequelae called “post-encephalitic syndrome” (Gunther et al., 
1997; Haglund et al., 1996; Kaiser, 1999, 2008a). These individuals require many years of costly 
treatment and rehabilitation due to long-term neurological symptoms, cognitive and psychiatric 
dysfunctions, social distress, inability to work and life quality loss. TBE comes at a very high 
cost to society and the health care system due to this high morbidity (Baumhackl, 2009; Kunz, 
2008; Mickiene et al., 2002). The outcome of veterinary TBE is fatal much more often than 
humane cases and due to the very rapidly deteriorating clinical situation (within 3-7 days to a 
natural death), euthanasia is often requested by the owners (Pfeffer and Dobler, 2011; Waldvogel 
et al., 1981; Weissenbock et al., 2010).  
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 DIFFERENTIAL DIAGNOSES  I.3.4
Medical TBE has to be differentiated from many other infectious encephalitides, including 
Lyme borreliosis, human granulocytic anaplasmosis, herpes simplex viruses, varicella-zoster 
virus. Epstein-Barr virus, mumps virus, measles virus, and enteroviruses are considered to be the 
major causes of viral encephalitis in immunocompetent humans worldwide (Donoso Mantke et 
al., 2008b; Horger et al., 2012; Mickiene, 2008; Skarpaas et al., 2004; Storch, 2007). In Europe, 
the most important arboviral pathogens responsible for encephalitis are tick-borne encephalitis 
virus (TBEV), West Nile virus (WNV) and Sandfly fever virus (Donoso Mantke et al., 2008b; 
Kallio-Kokko et al., 2005). 
Likewise, veterinary TBE has to be differentiated from e.g. Louping ill, rabies, Aujesky’s 
disease, equine encephalitis viruses, distemper, West Nile virus, and metabolic or toxicologic 
causes (Bago et al., 2002; Dietz and Huskamp, 2005; Long, 2011; Müller et al., 2006; Smith, 
2002). Additionally, it is known that Ixodes spp. may carry different pathogens at the same time, 
which they can also transmit to the human or animal host simultaneously, e.g. TBEV, Borrelia 
burgdorferi spp. (Lyme disease), Anaplasma  phagocytophilum (Anaplasmosis), Ehrlichia spp. 
(medical: monocytic ehrlichiosis) and Babesia spp. (veterinary babesiosis)(Bajer et al., 2013; 
Kaiser, 2008a; Korenberg, 1994; Süss, 2011). 
 TREATMENT AND PREVENTION I.3.5
As opposed to Lyme borreliosis, which can be managed by antibiotic therapy, TBE can only 
be treated symptomatically through maintenance of hydration and caloric intake, 
analgesics/antipyretics and anticonvulsants/sedatives. Strict rest and physiotherapy are also 
paramount to avoid complications, both in humans and animals (Kirtz, 1999; Kunz, 2008; Kunze, 
2008; Long, 2011; Pfeffer and Dobler, 2011; Tipold et al., 1993). Medical TBE can easily be 
prevented by vaccination, which is strongly advised for people of all ages who live or travel in 
endemic areas (Kunz, 2008; Mutz, 2008; Steffen, 2009). General prevention also includes 
avoidance of tick-infested areas, wearing light-colored clothing covering as much skin as 
possible, application of tick repellents, and skin inspection (BCFI, 2015; ITG, 2008; Luyasu, 
2009; Mutz, 2008).  
  
General Introduction 
18 
Veterinary prevention and landscape management may involve any or several of the 
following strategies:  
1) Tick habitat avoidance for dogs (Dryden, 2009); 
2) Use of spray or pour-on acaricides in domestic animals (Baggott et al., 2011; BCFI-vet, 
2014; Berrada and Telford, 2009; Birkett et al., 2011; Dantas-Torres et al., 2012; Dryden, 
2009; Jongejan et al., 2011; Jongejan et al., 2015; Müller et al., 2006; Otranto et al., 2010; 
Otranto and Wall, 2008; Taylor, 2012; Thein, 2009); 
3) Use of acaricides in wild animals, by using passive application of a topical acaricide in deer 
poster bait stations or in a food bait or cotton wool box for rodents (Conover and Vail, 
2015; Deblinger and Rimmer, 1991; Dolan et al., 2004; Gortazar et al., 2015; Grear et al., 
2014; Leprince and Lane, 1996; Mejlon et al., 1995; Piesman, 2006; Poland, 2001; Pound 
et al., 2010; Stafford, 1991; Stafford et al., 2009);  
4) Use of natural tick repellents, such as plant oils (Birkett et al., 2011; Jaenson et al., 2006; 
Otranto and Wall, 2008);  
5) Pasture management, such as rotational grazing, keeping wildlife fenced  out and keeping 
vegetation short, may help to reduce tick burden, if wildlife abundance is not too high 
(Dantas-Torres et al., 2012; Gortazar et al., 2015; Pound et al., 2010; Walker, 2011);  
6) Inspection and tick removal (Dantas-Torres et al., 2012; Gortazar et al., 2015; Pound et al., 
2010; Walker, 2011);  
7) Wildlife population control (culling, hunting) (George, 1990; Gortazar et al., 2015)  
8) Habitat management e.g. keeping vegetation and undergrowth short, acaricide spraying 
(CDC, 2014a; Dolan et al., 2004; Gortazar et al., 2014b; Piesman, 2006; Poland, 2001; 
Stafford, 2004; Tack et al., 2012; Uspensky, 1996; WHO, 2011);  
9) Placement of tick traps with chemical or pheromone baits (Taylor, 2012; Otranto and Wall, 
2008); 
10) Off-license TBE vaccination (Klaus et al., 2011; Müller et al., 2006; Müller, 1997; Wurm 
et al., 2000); 
11) Anti-tick vaccines, which remain in the research stage (de la Fuente and Kocan, 2003; de la 
Fuente et al., 2011; Guerrero et al., 2012; Jonsson et al., 2000; Merino et al., 2013; Odongo 
et al., 2007; Otranto and Wall, 2008; Schuijt et al., 2011; Trimnell et al., 2005; Willadsen et 
al., 2005), but seem to have a reducing effect on TBEV transmission (Labuda et al., 2006).  
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 SPECIFIC DIAGNOSTIC ASSAYS I.4
 COMMERCIAL REAGENTS AND ASSAYS I.4.1
An overview of specific commercial medical and veterinary reagents and assays currently 
available in Europe is shown in Table I-2 that were adapted from ENIVD (ENIVD, 2014).  
 
Table I-2: Commercially available reagents and assays for TBEV diagnosis 
Name Type  Target Contents / Matrices Producer 
Serion® CFT 
Reagents TBE-virus 
CFT Antigen 
Control  
Samples 
Human  Antigen (Ag) – Control Ag 
- Positive Control - 
Negative Control 
Institut Virion\Serion GmbH 
Serion Immundiagnostica GmbH  
http://www.virion-serion.de/en/ 
Serion® ELISA 
control 
TBE  IgG/IgM 
Control 
Samples 
Human  / Institut Virion\Serion GmbH 
Serion Immundiagnostica GmbH  
http://www.virion-serion.de/en/ 
Euroimmun® TBEV 
IgA/IgG/IgM IIFT 
IFA Human  IgG positive control 
IgM positive control 
Negative control 
IgA, IgG, IgM 
Euroimmun 
http://www.euroimmun.de 
Euroimmun® TBEV 
Controls 
Control 
Samples 
Human  Strain K23: IgM/IgG/for 
CSF/RF absorbent; 
Vienna antigen; 
IgM/IgG pairs of controls; 
IgG positive control 
Euroimmun 
http://www.euroimmun.de 
Test-Line® TBEV -
CF-Ag Complement 
Fixation Antigen 
CFT  
Antigen 
Human  / Testline 
http://www.testlinecd.com/ 
Virotech FSME/TBE 
IgG CSF Standards 
Control 
samples 
Human  Cerebrospinal fluid Sekisui Diagnostics - Genzyme 
Virotech  
http://www.sekisuidiagnostics.com 
Virotech FSME/TBE 
IgG Antibody Index 
Control 
Control 
Samples 
Human 
 
Cerebrospinal fluid/serum 
pairs 
Sekisui Diagnostics - Genzyme 
Virotech  
http://www.sekisuidiagnostics.com 
Sacace® Tick-borne 
diseases (also TBEV) 
Real Time PCR kit 
PCR Human 
Veterinary 
Biological materials 
 
Sacace Biotechnologies 
http://www.sacace.com/ 
Genesig® TBE 
research qPCR kit 
PCR and 
primer/probe 
mix 
Human 
Veterinary 
Biological materials Genesig PrimerDesign Ltd 
http://www.genesig.com/ 
Reagena® ReaScan 
TBE IgM  
(Rapid Test) 
LFD Human  Serum - 
Cerebrospinal fluid 
Oy Reagena Ltd 
http://www.reagena.fi/en/ 
Euroimmun® TBEV 
IIFT BIOCHIPs  
IFA Human  TBE virus infected and non-
infected cells - single slide 
test  
Euroimmun 
http://www.euroimmun.de 
Western Blot  WB Human 
Veterinary 
Serum Immuno 
http://www.progen.de/en/ 
Table I-2: Commercially available reagents and assays for TBEV diagnosis. 
Adapted from European Network for Diagnostics of Imported Viral Diseases (ENIVD, 2014); CFT: complement 
fixation test; IFA: immunofluorescence Assay; LFD: lateral flow device; PCR: polymerase chain reaction; EIA: 
enzyme immune assay; ELISA: enzyme-linked immunosorbent assay; quant/qual: quantitative or qualitative 
interpretation 
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Table I-2: Commercially available reagents and assays for TBEV diagnosis (continued) 
Name Type  Target Matrices Producer 
Serion® ELISA 
classic FSME virus 
IgG/IgM quantitativ 
ELISA quant/qual Human Serum – Plasma –  
Cerebrospinal fluid 
Institut Virion\Serion GmbH 
Serion Immundiagnostica GmbH 
http://www.virion-serion.de/en/ 
Immunozym® 
FSME (TBE) 
IgG/IgM 
ELISA 
quant/qual 
Human  Serum – Plasma –  
Cerebrospinal fluid 
Progen 
http://www.progen.de/en/ 
Immunozym® 
FSME IgG All 
species 
ELISA quant/qual Veterinary Serum Progen: http://www.progen.de/en/ 
Euroimmun® Anti-
TBEV ELISA 
IgG/IgM 
ELISA 
quant/qual 
Human 
Veterinary 
Serum – Plasma –  
Cerebrospinal fluid 
Euroimmun 
http://www.euroimmun.de 
Euroimmun® Anti-
TBEV IFA or 
ELISA IgG/IgM 
IFA 
ELISA quant/qual 
Veterinary Serum – Plasma –  
Cerebrospinal fluid 
Euroimmun: 
http://www.euroimmun.de 
Test-Line® EIA 
TBEV IgM or 
IgG+avidity 
ELISA semiquant/ 
qual 
Human Serum – Plasma –  
Cerebrospinal fluid 
Testline 
http://www.testlinecd.com/ 
Test-Line® EIA 
TBEV  
ELISA 
semiquant 
/qual 
Human 
Veterinary 
Serum Testline 
http://www.testlinecd.com/ 
Virotech® FSME 
IgG/IgM ELISA 
ELISA 
quant/qual 
Human Serum –  
Cerebrospinal fluid 
(with extra controls) 
Sekisui Diagnostics - Genzyme 
Virotech  
http://www.sekisuidiagnostics.com 
NovaLisa™ TBEV 
IgM/IgG/IgG (plus) 
ELISA 
quant/qual 
Human Serum – plasma 
(plus: quant. with extra 
control) 
NovaTec Immundiagnostica GmbH 
http://www.novatec-id.com/ 
Reagena® TBE IgM 
and IgG EIA 
ELISA 
quant/qual 
Human Serum Oy Reagena Ltd 
http://www.reagena.fi/en/ 
IBL® TBE IgG or 
IgM ELISA 
ELISA Human Serum – Plasma - 
Cerebrospinal fluid 
IBL International GmbH 
http://www.ibl-
international.com/en/tbe-fsme-igg 
Abcam® 
TBE/FSME Virus 
plus IgG or IgG or 
IgG plus Human 
ELISA  
ELISA 
Quant/qual 
Human Serum - Plasma Abcam 
http://www.abcam.com/ 
Enzygnost® Anti-
TBE/FSME Virus 
IgG/IgM  
in BEP-III-system 
ELISA 
 
Human 
Veterinary 
Serum Dade Behring Holding GmbH 
(Siemens) 
http://www.healthcare.siemens.com
/infectious-disease-
testing/systems/bep-iii-
system/assays 
Labor Alomed  
in-house ELISA 
ELISA Veterinary Serum Analytisches Labor Dr. Werner 
Müller Alomed 
http://www.alomed.de 
DRG® TBE/FSME 
IgG EIA  
ELISA Human Serum  DRG Diagnostics GmbH 
http://www.drg-diagnostics.de 
Mastazyme FSME/ 
TBE IgM/IgG 
ELISA 
ELISA Human Serum Mast Group Diagnostica GmbH 
http://www.mast-diagnostica.com 
RecomWell FSME / 
TBE Virus IgG/IgM 
ELISA Human Serum – Plasma –  
Cerebrospinal fluid 
Mikrogen Diagnostik GmbH 
http://www.mikrogen.de 
ELISA-VIDITEST 
anti-TBEV IgM/IgG 
ELISA Human Serum –  
Cerebrospinal fluid 
VIDIA spol. s r.o. 
www.vidia.cz 
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The suitability of each type of test for specific TBE diagnosis depends on the stage in the 
biphasic pathogenic course of a TBEV infection as demonstrated in Figure I-8 (Holzmann, 2003). 
Like other arboviruses, TBE virus is only present in serum and cerebrospinal fluid (CSF) for 2-5 
days during the first viraemic phase, hence direct tests have to be requested very timely (Donoso 
Mantke et al., 2007b; Holzmann, 2003; Mazlo and Szanto, 1978; Pfeffer and Dobler, 2011; 
Sonnenberg et al., 2004). These may include reverse transcription polymerase chain reaction 
(RT-PCR), virus isolation (VIS) and sequencing (Donoso Mantke et al., 2007a; Donoso Mantke 
et al., 2008a; ECDC, 2012; Holzmann, 2003; Kim et al., 2008; Saksida et al., 2005; Takashima et 
al., 1997), antigen-capture assays (Mikryukova et al., 2014; Ternovoi et al., 2007), 
immunohistochemistry (Donoso Mantke et al., 2007a; Holzmann, 2003; Süss et al., 2007; Tipold 
et al., 1993; Weissenbock et al., 2010) and electron microscopy (Mazlo and Szanto, 1978). 
 
 
Figure I-8: Suitable tests for specific TBE diagnosis.  
According to biphasic course of a TBEV infection with symptoms and antibody development (source: 
Holzmann, 2003); PCR: polymerase chain reaction; VIS: virus isolation;  
IgM ab - IgG ab: immunoglobulins of class M or G.  
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Sensitive real-time PCR methods are often used in veterinary and vector TBE surveillance 
and in clinical diagnostics (Achazi et al., 2011; Andreassen et al., 2012; Huang et al., 2001; 
Puchhammer-Stockl et al., 1995; Schwaiger and Cassinotti, 2003; Wójcik-Fatla et al., 2011); 
primers and probes were listed (Achazi et al., 2011; Gaumann et al., 2010; Katargina et al., 
2013). Subsequent multiplexing and sequencing of positive samples is strongly advised for 
improved FE-S-W-TBEV subtype differentiation and to study TBEV molecular-epidemiology. 
This is based on primer sets for the well studied TBEV strains: Western (Hypr, Noedorfl), Far 
Eastern (Sofjin),  Siberian (Est54) as well as  (Ruzek et al., 2007b).  
A number of animal models may be employed to study the neuropathogenicity of TBEV 
(Mansfield et al., 2009) or for anti-tick vaccination trials (Labuda et al., 2006; Trimnell et al., 
2005). This includes mice (Andzhaparidze et al., 1978; Denk and Kovac, 1966; Labuda et al., 
2006; Mandl, 2005; Trimnell et al., 2005), hamsters (Andzhaparidze et al., 1978) and monkeys 
(Andzhaparidze et al., 1978; Pripuzova et al., 2013; Zlontnik et al., 1976). 
Antibodies are almost always present in serum and CSF at the time of CNS symptoms (≥2-4 
weeks after the tick bite, second phase) and so the diagnosis of most TBE cases/exposures will be 
a serological one (Donoso Mantke et al., 2008a; Holzmann, 2003; Sonnenberg et al., 2004). In 
parallel with the pathogenesis of a TBEV infection, IgM based tests allow a qualitative 
interpretation of an acute clinical situation while IgG serves as a more quantitative and long term 
seroconversion indicator. IgM-antibodies may be detectable in serum for several months after 
infection, whereas IgG-antibodies may persist for a lifetime and prevent reinfection (Holzmann, 
2003; Mickiene, 2008; Remoli et al., 2015).  
Currently, the following types of medical serology are used for humans in EU countries: 
enzyme-linked immunosorbent assays (ELISA), complement fixation tests (CFT), virus 
seroneutralisation or plaque reduction neutralisation tests (SNT/PRNT), haemagglutination 
inhibition assays (HIT), immunofluorescence assays (IFAT), Western blots (WB) and Luminex 
antibody tests (LAT) (ECDC, 2012; ENIVD, 2014), with well-accepted standardized methods 
(Clarke and Casals, 1958; Heinz and Kunz, 1975; Shope and Sather, 1979; Stage, 1992; Treib et 
al., 1996). In ELISA, samples with VIEU units ≥127/ml are considered positive (Holzmann et al., 
1996; Litzba et al., 2014). 
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In comparison, relatively few serological tests are commercially available for veterinary 
use: indirect immunofluorescence assay (Euroimmun®), three ELISA kits (Progen® – Testline® 
- Enzygnost®), or Western Blot (Immuno®). The ELISA manufacturers claim that the kits are be 
suitable for “all species” (Progen, 2014; Progen, 2006) or “all vertebrates except mice” (Testline, 
2015) or not mentioned (Siemens, 2016). To our knowledge, veterinary test evaluation studies 
have not been published for any of these kits, except for the Progen® kit (Klaus et al., 2011). 
For an unequivocal diagnosis of acute disease, both IgM and IgG should be tested and 
should be positive (Donoso Mantke et al., 2008a; Holzmann, 2003; RKI, 2009). Paired sera are 
strongly indicated to demonstrate a clear rise in IgG antibody titers (Domingo et al., 2012; 
Donoso Mantke et al., 2008a; Holzmann, 2003).  
In dogs and horses, only a detection of IgM or a four-fold rise in IgG antibodies in paired 
serum (or liquor) 2-3 weeks apart confirms the diagnosis (Müller et al., 2006; Pfeffer and Dobler, 
2011). When the asymptomatic seroprevalence is expected to be high in known endemic areas, it 
is even more important to test paired sera, since in these cases antibody presence does not 
necessarily imply causality (Müller et al., 2006). Since DIVA-tests to “Distinguish Infected from 
Vaccinated Animals” are not available, flaviviral vaccination always needs to be ruled out in the 
anamnesis (Thein, 2009). 
A major issue when using serology (especially IgG assays) for TBE diagnosis is the frequent 
cross-reactions induced by other flavivirus infections or vaccinations. In humans it most often 
concerns Yellow Fever virus (YFV), Dengue virus (DEV), West Nile virus (WNV) and Japanese 
Encephalitis virus (JEV), and Louping ill virus (LIV) (Aslan Basbulut et al., 2012; Beck et al., 
2013; Domingo et al., 2012; Donoso Mantke et al., 2008a; Holzmann, 2003; Niedrig et al., 
2007a; Niedrig et al., 2007b).  
In the case of European dogs, exposure to WNV (though dogs are not easily infected) or LIV 
(which produces similar canine encephalitis cases) may interfere (Dobler, 2010; Klimeš et al., 
2001; Müller, 2010; Pfeffer and Dobler, 2011). For horses, TBEV-, WNV-, DENV- and -SLEV-
seropositivity interfere with WNV-ELISA and WNV-SNT (Ledermann et al., 2011; Rushton et 
al., 2013) and in the case of ruminants and for pigs/wild boar, WNV/LIV or WNV/LIV/JEV are 
good candidates to rule out respectively (Hubalek et al., 2014).  
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It is strongly recommended to check for flaviviral cross-reactivity by verifying any TBE-
positive results from screening test. Hereto, the use of comparative and specific in-house 
seroneutralisation tests (plaque reduction or microneutralisation tests) are preferred, despite the 
need for specialized biosafety level 2+ or 3 facilities and higher costs (Achazi et al., 2011; 
Donoso Mantke et al., 2008a; Holzmann, 2003; Holzmann et al., 1996; Janitza-Futterer, 2003; 
Kiffner et al., 2012; Klaus et al., 2011; Klaus et al., 2014; Litzba et al., 2014; Sîkutova et al., 
2009; Vene et al., 1998; Venturi et al., 2009; Weissbach and Hirsch, 2015).  
TBE-SNT titers from ≥1/10 are considered positive and offer sufficient protection in humans 
(Holzmann et al., 1996; Kollaritsch et al., 2011a; Venturi et al., 2006; Weissbach and Hirsch, 
2015; WHO, 2011) and when titers in a particular SNT/IFAT are ≥4-fold higher against TBEV 
than against other flaviviruses, this is accepted as a proof of specificity (Escribano-Romero et al., 
2015; Litzba et al., 2014).  
 QUALITY ASSESSMENT OF TBEV DIAGNOSTIC ASSAYS I.4.2
In RT-PCR proficiency tests, the (Schwaiger and Cassinotti, 2003) RT-PCR protocol used 
with commercial extraction kits usually leads to significantly improved classification. This 
protocol has an analytical sensitivity ≥10 copies of TBEV synthetic transcript in presence of 50 
copies of internal control. In the proficiency test by Donoso Mantke (2007), a model was used to 
show the 50% of all test results would be correctly positive with 80 copies of virus RNA/ml of 
sample, and  95% with more than 350,000 copies/ml (Donoso Mantke et al., 2007a). 
Additionally, quantitative RT-PCR has offered improved rapidity, sensitivity, reproducibility and 
reduced risk of cross-contamination (Donoso Mantke et al., 2007b). Currently, there is still a 
need to improve the sensitivity of RT-PCR (Achazi et al., 2011). 
When older in-house and commercial serological tests were evaluated for routine medical 
use, the diagnostic accuracy (sample classification potential) was often quite low and variable: 
diagnostic sensitivity (DSe) 73-99% and diagnostic specificity (DSp) 14-94%, with many 
flaviviral cross-reactions (Holzmann et al., 1996; Niedrig et al., 2001; Sonnenberg et al., 2004).   
Since then, commercial flaviviral tests have much improved accuracy in proficiency tests. In 
2007, overall European laboratory accuracy was between 58-96%, IgM/IgG seropositives were 
correctly recognized by 46-88% and 83-95% of the laboratories respectively. False IgG positive 
results were obtained with DENV, WNV and negative sera (Niedrig et al., 2007a).  
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Hence, cross-reactions and unspecific reactions can still not be excluded 100%, especially in 
IgG ELISA but even in the gold standard SNT (Domingo et al., 2012; Litzba et al., 2014; Niedrig 
et al., 2007a; Niedrig et al., 2007b; Weissbach and Hirsch, 2015). Currently, reliable SNT 
protocols are now used in most reference laboratories and IFA also is a good alternative for 
doubtful IgG ELISA results. It is advised that commercial ELISA companies should still continue 
to standardize the existing kits (VIEU units, standard samples, cut-offs) (Litzba et al., 2014). 
When executed by expert laboratories under external quality assurance programs, and used as a 
confirmatory test with well-characterized controls and standardized protocols, SNT strongly 
improves the quality of TBE diagnosis (Donoso Mantke et al., 2007a; Donoso Mantke et al., 
2008a; Niedrig et al., 2007a). 
Since the available commercial veterinary serological assays are not fully validated for all 
relevant veterinary species, it is important to include control sera for the correct species (Müller 
et al., 2006). Klaus et al. evaluated the Immunozym® FSME IgM in an adapted IgG+IgM 
protocol (Klaus et al., 2011; Müller, 1997) and the All-species IgG ELISA kits for goats, versus 
an adapted SNT test as veterinary gold standard (Holzmann et al., 1996; Klaus et al., 2010c). The 
All species kit (IgG) showed a DSe and DSp of 57% and100%; for the medical ELISA kit the 
DSe and DSp were 89% and 95% respectively. Species-specific veterinary unit cut-offs were 
afterwards calculated for horses, cattle, sheep, goats, pigs, mice, dogs, rabbits and monkeys, 
using field sera from assumed negative populations and vaccinated animals (Klaus et al., 2011). 
The study also confirmed very high sensitivity of SNT on the vaccinated samples with a 
satisfactory correlation of the observed results between the ELISA-kits and the SNT. In 
comparison to serum ELISA, milk ELISA in cattle with the slightly modified All Species IgG 
ELISA reached a diagnostic specificity (DSp) of 96.4%, a positive predictive value (PPV) of 
37.5% and a diagnostic sensitivity (DSe) of merely 25% (Leutloff et al., 2006).  
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 TBE EPIDEMIOLOCIAL SURVEILLANCE  I.5
 MEDICAL SURVEILLANCE  I.5.1
Sero-epidemiological studies in occupational TBE risk groups (e.g. foresters, hunters, 
farmers, military personnel) or in the overall unvaccinated population proved useful in the early 
days of TBE surveillance, with seroprevalences of 0-48% recorded, even in areas where no 
clinical cases were officially reported (Asmera and Heinz, 1972; Drăgănescu et al., 1975; Günes 
et al., 2010; Körting, 1981; Matile et al., 1981; Oehme et al., 2002; Walder et al., 2006; 
Wohlfarth et al., 2009). However, from the nineties onwards professionals were often widely 
vaccinated as soon as endemic foci were detected (Kunz, 1992; Roggendorf et al., 1994), hence it 
became difficult to perform meaningful serosurveillance in humans (Gerth et al., 1995; Kunz, 
2003; Kunze, 2011). 
It is vital to (inter)nationally report clinical TBE cases to implement public health 
interventions, for detection/description of endemic foci and for risk assessments (ECDC, 2012; 
Kollaritsch et al., 2011a; Kollaritsch et al., 2011b; Süss, 2011; WHO, 2011). Although by 2010 
comprehensive national surveillance systems with mandatory reporting were already 
implemented for TBE in the majority of EU countries (in 60% of MS), important differences still 
existed in terms of case definitions, clinical syndromes reported (in 50% of MS), and laboratory 
testing protocols (ECDC, 2012). Since September 2012, TBE is included on the EU notifiable list 
of human diseases, with an official medical case definition based on the clinical picture of TBE 
(biphasic: flu-like + meningo-encephalitis), the serological diagnosis (IgM/IgG, cross-reactions), 
and on epidemiological factors (tick exposure, raw milk consumption, risk areas, vaccination 
status)(Amato-Gauci and Zeller, 2012; Süss, 2011; Süss et al., 2010).  
Human incidence is currently usually reported at the country level as in Figures I-9 and I-10 
(Beck et al., 2013; ECDC, 2012). However, for TBE risk assessment, for distinguishing real 
incidence trends, as well as for the development of a multi-factorial predictive framework, case 
data should ideally be collected at higher resolution to take into account the very variable biotic 
and abiotic drivers of TBE disease risk (ECDC, 2012; Randolph and Sumilo, 2007). The medical 
incidence recorded during 60 years of surveillance has shown considerable spatio-temporal 
heterogeneity between and within countries (Mansfield et al., 2009; Randolph, 2008; Randolph 
and Sumilo, 2007; Süss, 2011).  
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However, a 400% increase in TBE morbidity was observed in central Europe during the 
1990’s (Süss, 2008b), and the virus can now be found in regions that were previously unaffected 
(Charrel et al., 2004). Shifting distributions and patchiness have also been observed, mainly in 
Western Europe (Jääskeläinen et al., 2006). 
The number of alimentary (milk-borne) TBE cases has increased in many endemic areas 
(Balogh et al., 2010; Holzmann et al., 2009; Kerbo et al., 2005; Kriz et al., 2009; Kriz et al., 
2014; Labuda et al., 2002; Leutloff et al., 2006) and currently accounts for approximately 1-30% 
of the total incidence depending on the year and the country (Süss, 2011). Alimentary TBE 
usually manifests as small to large point outbreaks (Hubalek et al., 1986; Labuda et al., 2002; 
Süss, 2011), and can occasionally be traceable to a single or a few ruminants (Balogh et al., 2010; 
Caini et al., 2012; Hudopisk et al., 2013). 
Medical TBE case-reporting tends to be unreliable even in regions where TBE is highly 
endemic (Süss, 2008b, 2011), as incidence is often based on place of residence – not necessarily 
place of infection, since seasonal data and the necessary local spatial resolution are often missing 
(ECDC, 2012), and as incompatibility exists with the prevalence of TBEV in ticks (Bormane et 
al., 2004; Brinkley et al., 2008; Makowka et al., 2009; Süss et al., 2006). Additionally, it has been 
amply shown that the majority of human TBEV exposures do not lead to clinical signs, hence the 
confirmed cases represent only the very tip of the zoonotic iceberg (Drelich et al., 2014; 
Randolph and Sumilo, 2007).  
 
Figure I-9: Overview of TBE surveillance implemented in EU/EFTA countries. 
Dark green: mandatory surveillance, light green: other surveillance, blue: no surveillance; 
extract from ECDC, 2012. 
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Figure I-10: Map of reported human TBE cases in Europe.  
Aggregated human cases (2000–2009) per country; Beck et al., 2013 
 
Hence, the current medical data do not really reflect the complete picture or the complexity 
of TBE’s epidemiology correctly and can severely distort or underestimate the true TBEV 
prevalence in an endemic focus (Drelich et al., 2014; ECDC, 2012; Randolph and Sumilo, 2007). 
As a consequence, ECDC recommends the additional collection of data from tick and animal 
surveys to better define TBE endemic areas (ECDC, 2012). Not only are people mobile, but so 
are the hosts that may transport virus-infected engorged ticks to other parts of a given habitat 
(Waldenström et al., 2007).  
When endemic foci shift and (re-)emerge spatially and temporally they may be discovered 
and characterized by virus detection in ticks and serosurveillance in domestic and wildlife 
sentinel animals, and this in presence or absence of any autochthonous human cases (ECDC, 
2012; Gaumann et al., 2010; Kollaritsch et al., 2011b; Labuda et al., 2002; Leutloff et al., 2006; 
Rieger et al., 1997; Rieger et al., 1999; Süss, 2011; WHO, 2011). 
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 VETERINARY SURVEILLANCE  I.5.2
I.5.2.1 Domestic Species 
a. Companion Animal Studies 
Dogs are frequently exposed to ticks (Beck et al., 2014; Claerebout et al., 2013; Foldvari and 
Farkas, 2005; Schreiber et al., 2014) and may experience asymptomatic TBEV-infections which 
raise a clearly detectable long-lasting immune response to the virus (Pfeffer and Dobler, 2011). 
Clincal canine TBE cases have been known in endemic areas for over 40 years and seem to be 
emerging among Europe’s canine population (Beugnet and Marie, 2009; Leschnik et al., 2002) 
with its distribution expanding over Western Europe in parallel with human TBE spread.  
Until now, only small numbers of canine clinical cases were published, often in local 
language case reports from known endemic foci of Sweden (Åblad, 2007; Bjöersdorff, 2002; 
James, 2008; Lindblad, 1960; Wandeler et al., 1972), Switzerland (Gresikova et al., 1972; Tipold 
et al., 1993; Wandeler et al., 1972), Austria (Kirtz, 1999; Weissenbock et al., 2010), Germany 
(Reiner and Fischer, 1998), and Italy (Zanoni et al., 2009), and summarized in (Pfeffer and 
Dobler, 2011).  
Several canine antibody surveys have been performed in endemic areas in the Northern 
hemisphere (see Table I-3). In the majority of these canine subjects no CNS clinic was observed 
and seroprevalence was estimated between <2% and 31% with ELISA or HIT. When the results 
are confirmed by SNT testing, the seroprevalence turns out lower than estimated by the screening 
test (Kirtz, 1999; Lindhe et al., 2009; Pfeffer and Dobler, 2011).  
More asymptomatic and clinical caninecases are likely to be detected as awareness increases 
in the veterinary community.  (Beugnet and Marie, 2009; Leschnik et al., 2002; Pfeffer and 
Dobler, 2011). Furthermore, dogs live close to their human owners and may form a human 
exposure risk. This species may also travel which can sometimes obscure the exact place and 
time of TBEV-exposure, as in humans (Beugnet and Marie, 2009; Leschnik et al., 2002; Pfeffer 
and Dobler, 2011) Pfeffer and Dobler, 2013). 
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Cats have not been used in any TBE sentinel study so far. However, they are more sedentary 
than dogs and may predate TBEV-reservoirs. Most cats stay within 300 meters of structures with 
a home range around 0.05-3 km2 (Gehrt et al., 2013; Horn et al., 2011; Kitts-Morgan et al., 2015). 
They are documented tick hosts and may carry I. ricinus and pathogens into human habitats 
(Chomel, 2013; Claerebout et al., 2013; Jongejan and Uilenberg, 2013; Pfeffer and Dobler, 
2013). Until present, cats have not been reported to develop clinical TBE (Greene, 2013; 
Leschnik et al., 2002; Shaw, 2005).  
The proportion of asymptomatic equine infections is not exactly known, but seroprevalence 
studies have always found many asymptomatic seropositives (Janitza-Futterer, 2003; 
Luckschander, 1998; Rushton et al., 2013; Vesenjak-Hirjan et al., 1976a, b, c). Equine cases 
have been described (Grabner, 1993; Luckschander et al., 1999; Waldvogel et al., 1981).  
Sentinel seroprevalence studies in horses (Table I-3) were performed in former Yugoslavia 
(Vesenjak-Hirjan et al., 1976a, b, c) and in Hungary (Sîkutova et al., 2009), and in Austria, where 
increasing prevalences of 14% to 26.1% ELISA-positives were detected, in line with human TBE 
case incidence, and most seropositive horses originating from known endemic areas (Janitza-
Futterer, 2003; Luckschander et al., 1999; Müller et al., 2006; Rushton et al., 2013). Horses are 
suitable for mapping exercises and to detect and investigate endemic risk areas, since they are 
relatively less mobile than dogs (Imhoff et al., 2015; Janitza-Futterer, 2003; Klaus et al., 2013). 
b. Domestic Ruminant Studies 
Though ruminants are mostly infected with TBEV asymptomatically, they are good 
sentinels in endemic areas (Bjöersdorff, 2002; Leschnik et al., 2002; Sîkutova et al., 2009) Cattle 
seroprevalence in known TBEV-endemic foci may be low around 0-4%, but can be much higher, 
from 13-30% and up to 91% in certain high risk areas (Table I-3)(Cisak et al., 2010). There may 
be remarkable differences in within-herd prevalences (Gerth et al., 1995) and seroprevalence 
fluctuations throughout the seasons (Ernek and Kozuch, 1970; Rieger et al., 1997), which reflect 
the temporo-spatial nature of TBE risk well (Imhoff et al., 2015). 
In raw milk of high risk areas, RNA and antibody prevalences of 11-22% and 0-15% 
respectively were found (Cisak et al., 2010). TBEV transmission by raw milk presents a potential 
food chain risk (Verraes et al., 2015). In case of alimentary TBE outbreaks, TBEV RNA may 
sometimes be detected in serum and milk of the source animal(s), if they are still in the viraemic 
phase (Caini et al., 2012; Hudopisk et al., 2013).   
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Table I-3: Overview of veterinary sentinel studies in domestic animals  
Species Country Test Prevalence and sample size References 
Dogs 
Canis 
familiaris 
Belgium ELISA - SNT 1.13% - 0.11% (n=880) (Roelandt et al., 2011) 
Austria Serology 24% (n=545) (Kirtz, 1999)  
HIT 22.22% (n=36) (Sixl et al., 1973) 
Germany EIA 0-31% (n=100)  (Müller, 1997)  
EIA < 2-31% ~region (n=1,000) (Müller, 2000) 
ELISA 31.38% (n= 54 healthy) 
53.57% (n= 56 CNS) 
(Reiner et al., 2002) 
ELISA 29.2% (n=243) (Janitza-Futterer, 2003) 
Sweden Serology 7.06% (n=255) (Wattle, 1992) 
Switzerland Serology 3.6% (n=657) (Matile et al., 1981) 
Japan  SNT - 
Isolation 
73.68% (n=19) 
30% (n=10) 
(Takashima et al., 1997) 
Czech 
Republic  
HIT 3.3% (n=151) (Klimeš et al., 2001) 
Norway  ELISA  16.4% (n=317) (Csángó et al., 2004) 
Denmark ELISA/SNT 30% / 4.8% (n=125) (Lindhe et al., 2009) 
Netherlands ELISA/SNT/HI 0.0% (n=24) (van der Poel et al., 
2005) 
Horses 
Equus 
caballus 
Germany ELISA 23.4% (n=205) (Janitza-Futterer, 2003) 
ELISA 5.2% (n=155) (Klaus et al., 2013) 
Croatia HIT/CFT/SNT 91.67%/100%/86.96% 
(n=24) 
(Vesenjak-Hirjan et al., 
1976b) 
HIT/CFT/SNT 62.50%/45.83%/58.83% 
(n=24) 
(Vesenjak-Hirjan et al., 
1976c) 
Austria ELISA/SNT 35.61% / 12.79%  (n=469) (Luckschander, 1998; 
Luckschander et al., 
1999) 
ELISA/SNT 2.9% (n=240) (Müller et al., 2006) 
ELISA/SNT 26.1% (n=257) (Rushton et al., 2013) 
Hungary ELISA/SNT 0.0% (n=40) (Sîkutova et al., 2009) 
Ruminant 
Milk 
Poland 
Germany 
RT-PCR  
ELISA  
22.2%-14.8% (n=27 sheep); 
20.7%-0% (n= 29 goats); 
11.1%-3.2% (n=63 cows) 
(Cisak et al., 2010) 
ELISA 1-8% (n=506 cows) (Leutloff et al., 2006) 
Pigs  
Sus scrofa 
Hungary HIT 0% (n=217) (Girjabu et al., 1985) 
Austria HIT / SNT 4 pigs exposed to goat milk (Holzmann et al., 2009) 
HIT 0.41% (n=244) (Sixl et al., 1973) 
Birds Hungary HIT 0% (n=214 geese +           
171 ducks) 
(Girjabu et al., 1985) 
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Table I-3 (Cont.): Overview of veterinary sentinel studies in domestic animals  
Species Country Test Prevalence and sample size References 
Cattle 
Bos taurus 
Belgium ELISA - SNT 3.85% -  2.61% pos and 
0.9% borderline (n=650) 
(Roelandt et al., 2014) 
Slovakia SNT Spring 0-3.1%; Autumn: 
7.3-60% (n=340) 
(Ernek and Kozuch, 1970) 
HIT - SNT 13% (n=60) (Hubalek et al., 1986) 
Finland Serology 91% (n=?) (Brummer-Korvenkontio et al., 
1973) 
Austria HIT 10.64% (n=94) (Sixl et al., 1973) 
Croatia HIT - CFT - SNT 51.16%/16.33%/53.73% 
(n=86) 
(Vesenjak-Hirjan et al., 1976b) 
HIT - CFT -SNT 54.54%/1.82%/60.00% 
(n=55) 
(Vesenjak-Hirjan et al., 1976c) 
Germany ELISA 2-10%~region (n=506) (Leutloff et al., 2006) 
Poland  ELISA 4.1% (n=123) (Cisak et al., 2012) 
Germany ELISA 6.3-15.0% (n=126 before 
and after grazing) 
(Rieger et al., 1997) 
Lithuania HIT 2.4% (n=423) (Juceviciene et al., 2005) 
Russia HIT - CFT 17% - 29% (n=1,414) (Korenberg et al., 1984) 
Japan ELISA - SNT 0%   (n=54)  (Takashima et al., 1997) 
Hungary HIT 1.4% (n=214) (Girjabu et al., 1985) 
ELISA - SNT 26.5% (n= 260) (Sîkutova et al., 2009) 
Netherlands ELISA - SNT - HIT 4.44% - 0.0% - 0.0% 
(n=180) 
(van der Poel et al., 2005) 
Small 
ruminants 
Ovis aries 
Capra hirus 
Hungary HIT 1.1% (n= 179 goats) ; 0% 
(n= 161 sheep) 
(Girjabu et al., 1985) 
ELISA - SNT 7.0% (n=100 sheep) (Sîkutova et al., 2009) 
Switzerland ELISA - homemade 
absorption test 
4.3% / 1.2% (n=4,114 
goats)  
(Rieille et al., 2013) 
Italy Serology 12.0% (n=459 goats)  (Rizzoli et al., 2007) 
Germany ELISA - SNT 1/7 goats positive in non-
endemic area 
(Klaus et al., 2010c) 
ELISA - SNT 9% (n=100) (Klaus et al., 2010a) 
ELISA - SNT 3.2% (n=3,793 goats)  
5.9% (n= 3,590 sheep)  
(Klaus et al., 2012) 
ELISA - SNT 7.0% (n= 701 goats) (Klaus et al., 2014) 
Lithuania HIT 4.2% (n=118 sheep); 
0.7% (n=561 goats) 
(Juceviciene et al., 2005) 
Russia HIT - SNT - CFT  27% - 25% - 32% 
(n=1,641 goats) 
(Korenberg et al., 1984) 
Slovakia HIT 3.29% (n=700 sheep) ;  
37.12% (n=167 goats)  
(Labuda et al., 2002) 
HIT - SNT 18% (n=120 sheep);  
54% (n=26 goats) 
(Hubalek et al., 1986) 
Croatia HIT 56.09% (n=82 sheep) (Vesenjak-Hirjan et al., 1976a) 
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 Wildlife SpeciesI.5.2.2  
a. Requirements for Surveillance 
Generally, wildlife disease surveillance is most useful and informative when it is risk-based, 
targeted, sentinel or syndromic surveillance (Warns-Petit et al., 2009), although the latter would 
not be applicable to TBEV (asymptomatic infections). The third study in this thesis was 
performed in wild boar (Chapter V) and confirmed a potentially important role for wildlife 
sentinel surveillance in TBE risk assessment, mapping, control and prevention of TBE.  
An important problem in epidemiological wildlife research is the estimation of the 
population’s size (abundance, density) and demographic structure (age groups, sexes). This is 
complicated since often there are no gold standard methods, as e.g. for roe deer and wild boar 
(Bonenfant and Gaillard, 2015; Gortazar et al., 2014a). Therefore, a good cooperation between 
veterinarians and wildlife managers is necessary (Ryser-Degiorgis, 2013; Warns-Petit et al., 
2009), Fortunately, international efforts to harmonize counting methods are now initiated and 
ongoing, e.g. in the APHAEA project www.aphaea.eu (Ryser-Degiorgis, 2013). 
For large game species, hunting bag data are currently the only available index that could 
be harmonized at National/European scale, if the hunting effort (animals-per-hunter-day) is 
documented in detail and is not limited by quota. Moreover, larger sampling areas 
(region/country scale) must be considered to reduce bias (Acevedo et al., 2014; Apollonio et al., 
2010; Engeman et al., 2013; Gortazar et al., 2014a; Imperio et al., 2010). The hunting bag data 
can be used with spatially explicit modelling procedures to obtain distribution and abundance 
(Acevedo et al., 2014; Bosch et al., 2012). Such spatial models have also been used with small 
sample sizes to give accurate density estimates e.g. of extensively kept livestock (Bryssinckx et 
al., 2014; Bryssinckx et al., 2012).  
For small songbirds and lagomorphs point counts or line transects are to be preferred for 
density and distribution estimations (Acevedo and Gortazar, 2014; Barrio et al., 2010; Buckland 
et al., 2004; Fernández-de-Simón et al., 2011; Gortázar et al., 2015; Gregory et al., 2004; Thomas 
et al., 2010). Ornithological databases on migrating or resident ringed birds are also key resources 
(Gortázar et al., 2015; Martínez et al., 2009). In voles and mice, the gold standard is live trapping 
with a capture-mark-recapture method (Southwood and Henderson, 2000) (Drewes et al., 2015; 
Sibbald et al., 2006), or the less laborious lethal snap trapping under specific permits. Both 
methods are known to give well correlated estimates (Drewes et al., 2015; Hanski et al., 1994).  
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Sampling may be called convenience/opportunistic at low sample sizes, as one simply uses 
everything that is collected over several years (Boadella et al., 2011; Ryser-Degiorgis, 2013; 
Tavernier et al., 2015). This is an acceptable method, as long as the sampling stays representative 
of the population (spatial/demographics/habitat preferences) {Leutloff, 2006 #1106; (Roelandt et 
al., 2016). More ideally, sampling should be probability-based, randomized and stratified 
(Boadella et al., 2011; Leutloff et al., 2006; OIE, 2010; Ryser-Degiorgis, 2013). Sufficient care 
should be taken in the study design to establish a reasonable sampling effort and sample size, and 
to properly stratify the population according to relevant infection risk factors (Boadella et al., 
2011; Munoz et al., 2010; Ryser-Degiorgis, 2013; Vicente et al., 2007; Vicente et al., 2006).  
An absolute necessity for wildlife surveillance is to dispose of sample and data storage 
facilities to provide centralized baseline data. Furthermore, this will enable multi-disciplinary 
retrospective, longitudinal, prospective or trend analyses of emerging infectious diseases such as 
Bluetongue and Schmallenberg, provided that the samples are stored long term (Boadella et al., 
2011; Linden et al., 2010; Müller, 1997; Ryser-Degiorgis, 2013; Warns-Petit et al., 2009). 
Regional and local 24-hour freezer networks and laboratories are often used (AEP, 2014; 
Lamarque and Artois, 1997; Linden, 2005). Alternatively, a centralized delivery and storage 
location can be used together with clear shipping and handling instructions for hunters and 
members of the public (ANB, 2015; CWHC, 2015; MEDI, 2015).   
b. Wildlife TBEV Studies 
Table I-4 shows an overview of wild species that have been used as sentinels (Tables I-4). 
Game species have been used frequently as sentinels for TBE(V) surveillance and for marking 
out risk areas, as flavivirus seroprevalence is usually higher and therefore presence is easier to 
detect than in domestic animals (Boadella et al., 2012; Jimenez-Clavero et al., 2007). These 
seroprevalences usually fall within medium (2.5-15%) to high (25-50%) intervals (Gerth et al., 
1995; Kiffner et al., 2012) and seem to be representative of human  incidence and of the risk in 
the area (Cisak et al., 2010; Gerth et al., 1995; Rieger et al., 1999). Authors’ opinions are divided 
as to which game species may be the “best” sentinel. However, this may be determined by local 
ecological factors, such as relative population densities and habitat availability.  
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Cervids play an important role in TBE surveillance and positive correlations have been made 
between the abundance of roe deer, clusters of TBE seroprevalence and TBE risk (Carpi et al., 
2009; Carpi et al., 2008; Gerth et al., 1995; Rizzoli et al., 2014). Their home ranges are 
approximately 0.5-1 km2 with occasional dispersal up to 10-20km (Duscher et al., 2015a; Gerth 
et al., 1995; Radda et al., 1968; Reimoser et al., 1999). The roe deer population is well spread 
over most of the Belgian territory and roe deer hunting bags have increased steadily between 
1960-2012 (Casaer and Licoppe, 2010; Scheppers et al., 2013). Free-living Red deer are 
currently present in southern Belgium (DGARNE, 2015a; Mercelis, 2003; Prévot and Licoppe, 
2013; Scheppers et al., 2013, 2014). 
Though traditionally deer spp. (Table I-4) have been considered as the main amplification 
host for I. ricinus ticks (Borcic et al., 1990; Skarphedinsson et al., 2005) (Gómez-Martínez, 2014; 
Kiffner et al., 2011; Kiffner et al., 2012; Knap and Avsic-Zupanc, 2013; Rizzoli et al., 2009) and 
deer hunting bag data may correlate well with TBE incidence (Kiffner et al., 2010; Knap and 
Avsic-Zupanc, 2013; Rizzoli et al., 2009; Zeman and Januska, 1999), it has been recently shown 
that large or increasing, endemic or reintroduced populations of wild boar may play an equal or 
larger epidemiological role in comparison to cattle and deer: see Table I-4 (Cisak et al., 2012; 
Gómez-Martínez, 2014; Kriz et al., 2014). Unregulated wildlife populations showing rapid 
exponential growth, such as the current European wild boar populations, may partially drive the 
spread of TBEV into suburban areas (Kriz et al., 2014).  
Red Foxes are highly exposed to I. rixinus ticks of all life stages (Meyer-Kayser et al., 2012) 
in their habitats. They have a home range of approx. 7-10 km2 and play an epidemiological role 
in urban TBE. The seroprevalence is often, but not always well correlated with TBE-risk 
(Haemig et al., 2011; Palo, 2014; Rizzoli et al., 2014): the reason for this is unknown. 
Nonetheless, foxes should not be disregarded as TBE-sentinels at the community level, since the 
species is present all over Belgium (DGARNE, 2015b; Libois, 2006; Van Den Berge and Pauw, 
2003). In Flanders, the red fox has been recolonizing areas during the last decades of the 20th 
century, after a long absence (DGARNE, 2015b; Van Herzele et al., 2015).  
Belgian wild boar populations are increasing in density and spreading and as a result may 
become an important tick/TBE risk factor (Apollonio et al., 2010; Rizzoli et al., 2014). During 
the 20th century, wild boar populations remained in Wallonia (Casaer and Licoppe, 2010; 
Scheppers et al., 2013), 
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expanding there over the last 30 years while progressively invading all agro-forested areas 
(DGARNE, 2015c; Prévot and Licoppe, 2013; Prévot and Morelle, 2012). More recently, a 
Flemish wild boar population has been developing north of Samber and Maas rivers in northern 
Belgium. This population is now steadily increasing in abundance/range in two subpopulations 
(Scheppers et al., 2013, 2014; Vervaeke, 2012). Wild boar in Belgium have home ranges, 
expansion velocity and subadult dispersal that are representative of Belgian community size: see 
the detailed description and references in Chapter VI.  
TBE reservoir rodents are ubiquitous and abundant with a suitably limited home range 
(300-2,500 m2) for TBEV surveillance. As the reservoir, they develop high-grade viraemia, 
produce TBEV-specific antibodies (Imhoff et al., 2015; Tonteri et al., 2013) and can be 
persistently infected. Sero-prevalence studies in rodents show good correlation with local human 
TBE incidence (Achazi et al., 2011; Imhoff et al., 2015; Knap et al., 2012). These arguments 
make them good targets for attempts to isolate locally circulating TBEV-strains. Wild rodents 
have therefore frequently been studied in endemic areas (Table I-4). Rodents are promising 
sentinels particularly in areas of low TBEV circulation, as they are ubiquitous, show persistent 
TBEV-infection and they offer good proxies for human incidence (Achazi et al., 2011). 
Ecological studies of rodent reservoirs have also been found useful in the assessment of human 
health risks from other rodent-borne diseases (Zizi et al., 2002).  
In birds fewer studies have been done (Table I-4) (Juricova and Hubalek, 1999; Mikryukova 
et al., 2014). In wildlife surveys, it must not be forgotten that an adequate sample size is needed 
to arrive at valid conclusions, especially at low expected prevalence (Gerth et al., 1995; Perkins 
et al., 2003). Common and migratory songbirds may carry ticks/TBEV south from endemic areas 
in Russia and Scandinavia (Kazarina et al., 2015; Lommano et al., 2014; Waldenström et al., 
2007). Blackbirds, robins, song thrushes, winter wrens and great tits have proved to be important 
I. ricinus hosts and reservoirs in Borreliosis natural cycles, including in Belgium (Heylen et al., 
2013; Heylen et al., 2014; Kipp et al., 2006; Marsot et al., 2012).  
Other wild mammals have been investigated on occasion, incuding moose (Alces alces), 
Bison (Bison bonasus), European Brown hares (Lepus europaeus), Mouflon (Ovis musimon), and 
Chamois (Rupicapra rupicapra). Even monkeys, small mammals, reptiles and amphibians have 
been studied (Table I-4).  
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Table I-4: Overview of veterinary sentinel studies in wild animals 
Species Country Test Prevalence and sample 
size 
References 
Roe deer - 
Capreolus 
capreolus 
Belgium SNT 4.90% (n=98; Flanders) (Tavernier et al., 2015) 
ELISA - SNT 12% - 0.4% (n=498; 
Wallonia)  
(Linden et al., 2012) 
Czech Republic  HIT 10.9% (n=55) (Juricova and Hubalek, 
1999) 
HIT 21% (n=33) (Hubalek et al., 1993) 
Austria 
 
IFAT 2.4% (n=945) (Duscher et al., 2014) 
HIT 15.2% (n=223) (Radda et al., 1968) 
Germany SNT 22.9% (n=105) (Kiffner et al., 2012)  
ELISA - HI - 
SNT 
26% - 24.5 % - 22% 
(n=192) 
(Gerth et al., 1995) 
ELISA - IFAT - 
SNT 
22.86% (n=35) (Balling et al., 2014) 
Croatia HIT 24% (n=37) (Borcic et al., 1990) 
Poland ELISA 9.1%  (n=11) (Cisak et al., 2012) 
Sweden ELISA 50.0% (n= 22) (Gómez-Martínez, 2014) 
Denmark HIT 8.7% (n=237) 
 
(Skarphedinsson et al., 
2005) 
Netherlands ELISA - HIT - 
SNT 
0.0%- 0.0%- 0.0% (n=13) (van der Poel et al., 
2005) 
Fallow deer – 
Dama dama 
Czech Republic HIT 12.0% (n=209) (Juricova and Hubalek, 
1999) 
HIT 0% (n=4) (Hubalek et al., 1993) 
Poland ELISA 15.0%  (n=14) (Cisak et al., 2012) 
Sweden ELISA 25.0% (n= 60) 
 
(Gómez-Martínez, 2014) 
Red deer  
Cervus elaphus 
Austria HIT 22.6% (n=31) (Radda et al., 1968) 
Czech Republic HIT 10.7% (n=56) 
 
(Juricova and Hubalek, 
1999) 
HIT 9% (n=24) 
 
(Hubalek et al., 1993) 
Sweden ELISA 41.7% (n= 24) (Gómez-Martínez, 2014) 
Poland ELISA 8.3%  (n=12) (Cisak et al., 2012) 
Croatia Nested RT-PCR 1.1% (n=182) (Jemersic et al., 2014) 
HIT 39% (n=102) (Borcic et al., 1990) 
Deer  Poland  Nested RT-PCR 2.7% (n=43 roe + red + 
fallow) 
(Cisak et al., 2012) 
Slovakia HIT - SNT 27.8% (n=18) - 35.3% 
(n=190) 
(Labuda et al., 2002) 
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Table I-4 (Cont.): Overview of veterinary sentinel studies in wild animals 
Species Country Test Prevalence and sample size References 
Wild boar 
Sus scrofa 
Belgium ELISA - SNT 4.20% (n=238) Roelandt et al., 
accepted 
Czech Republic HIT 10.0% (n=150) (Juricova and Hubalek, 
1999) 
HIT 6% (n=34) (Hubalek et al., 1993) 
Poland ELISA 16.8% (n= 95) (Cisak et al., 2012) 
Sweden ELISA 32.0% (n= 122) (Gómez-Martínez, 
2014) 
Croatia HIT 39% (n=81) (Borcic et al., 1990) 
South Korea Nested RT-PCR 0% (n=16) (Kim et al., 2008) 
Netherlands ELISA - HIT - 
SNT 
7% - 0% - 0% (n=666) (van der Poel et al., 
2005) 
Slovakia HIT/SNT 36.8% (n=38) (Labuda et al., 2002) 
Austria HIT  1/2 (Radda et al., 1968) 
Germany ELISA/IFAT/ 
SNT 
10.26% (n=1,851) (Balling et al., 2014) 
Moose  
Alces alces 
Sweden ELISA 41.9% (n= 31) (Gómez-Martínez, 
2014) 
Bison  
Bison bonasus 
Poland Nested RT-PCR  0% (n=95)  (Biernat and 
Karbowiak, 2014) 
Brown hare  
Lepus europaeus 
Czech Republic HIT 3.6% (n=193) (Juricova and Hubalek, 
1999) 
HIT 2% (n=48) (Hubalek et al., 1993) 
Croatia HIT 0% (n=25) (Borcic et al., 1990) 
Slovakia SNT 3.7% (n=596) (Labuda et al., 2002) 
Austria HIT 2/13 (Radda et al., 1968) 
Mouflon Ovis 
musimon or 
Chamois 
Rupicapra 
rupicapra 
Czech Republic HIT 7.5% (n=80 mouflon) (Juricova and Hubalek, 
1999) 
HIT 0% (n=2 mouflon) (Hubalek et al., 1993) 
Slovakia HIT 3.8% (n=79 mouflon) (Labuda et al., 2002) 
Austria HIT 1/3 chamois (Radda et al., 1968) 
Fox 
Vulpes vulpes 
 
 
Germany ELISA    
SNT-WB 
2.9 % border and  0.5% pos - 
0.13% pos (n=786) 
(Wurm et al., 2000) 
Germany ELISA 1.8-34.2% ~ region (n total = 
473) 
(Rieger et al., 1999) 
Netherlands ELISA - HIT - 
SNT 
0.5% - 0% - 0% (n=399) (van der Poel et al., 
2005) 
Austria HIT 38.5% (n=26) (Radda et al., 1968) 
HIT 0/4  (Sixl et al., 1973) 
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Table I-4 (Cont.): Overview of veterinary sentinel studies in wild animals 
Species Country Test Prevalence and sample size References 
Small Rodents Slovakia Serology 
 
14.6% (3.3-18.1% ~spp.) 
(n=2,922) 
(Kozuch et al., 1990) 
South Korea Nested RT-PCR 16.6% (n=24) (Kim et al., 2008) 
Hungary RT-PCR 4.2% (n=405) (Pinter et al., 2014) 
SNT 5.19% (n=539) (Zöldi et al., 2014) 
Croatia IFAT / real-
time RT-PCR  
0.0% / 0.0% (n=194) (Svoboda et al., 2014) 
Germany Real-time RT-
qPCR 
10.2% (n=441) 
 
(Achazi et al., 2011) 
Nested RT-PCR 0% (n=300 spleens + 59 
brains) 
(Kießling, 2005) 
Russia Nested RT-PCR 
- 
ELISA –  
HIT 
61.4% -60.3% (n=3921) 
0.65% (Sorex) ;  1.65% 
(Apodemus) ; 4.87% 
(Clethrionomys) 
(Bakhvalova et al., 
2006) 
Italy PCR/ELISA 0% (n=108 C. glareolus) ; 
3.3% (n=238 A. flavicollis) 
(Rizzoli et al., 2004b) 
Finland IFAT - real-
time RT-PCR 
4%- 11.9% (n= 202) (Tonteri et al., 2011) 
Austria SNT 47.9% (n= 47 A. flavicollis); 
29.4% (n=34 C. glareolus) 
(Labuda et al., 1993e) 
HIT 21.43% (n=42 Apodemus 
spp.); 7/13 C. glareolus; 1 /2 
M. minutus; 0/1 M. musculus 
(Sixl et al., 1973) 
Slovenia IFAT 5.9% (n=1,401) (Knap et al., 2012) 
Netherlands ELISA - HIT - 
SNT 
0.0% (n=90) (van der Poel et al., 
2005) 
Finland Isolation 7 strains = 1.92% (n=52 
Sorex, Clethrionomys, 
Apodemus, Microtus) 
(Brummer-
Korvenkontio et al., 
1973) 
Switzerland IFAT + avidity 0%-9.9% (n= 63-333 
~region) 
Burri et al., 2012 
(Burri et al., 2012) 
Birds Czech Republic HIT 4 strains = 7.4% (n=162  P. 
colchicus) 
(Juricova and Hubalek, 
1999) 
Russia RT-PCR -  
Ag-capture EIA 
9.7% - 22.8% (n=779 
diverse spp.) 
(Mikryukova et al., 
2014) 
Finland Isolation 2.84% (n=161 diverse spp.) (Brummer-
Korvenkontio et al., 
1973) 
Hemi-nested 
RT-PCR 
0% (n=100 waterfowl 
cloacal/tracheal swabs) 
(Lindh et al., 2008) 
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Table I-4 (Cont.): Overview of veterinary sentinel studies in wild animals 
Species Country Test Prevalence and sample size References 
Monkeys  Germany ELISA/SNT 2.6% (n=283 Macaca Sylvanus) (Klaus et al., 2010a) 
Other small 
mammals 
Austria HIT 0/3 wild cats; 0/1 badger; 0/1 weasel (Radda et al., 1968) 
HIT Positive: 0/19 bats; 0/2 marmots ; 0/6 
hamsters; 6/61 hedgehogs; 3/14 
ground squirrels; 2/6 rabbits  
(Sixl et al., 1973) 
Reptiles and 
Amphibians 
Austria HIT Positive: 1/15 lizards; 10/39 snakes (Sixl et al., 1973) 
Finland Isolation 0/8 reptiles; 0/12 amphibians (Brummer-Korvenkontio 
et al., 1973) 
 
I.5.2.3 Influential factors 
It is important to note that some factors are known to influence the seroprevalence observed 
in animals in veterinary surveillance programs:   
Longevity of antibodies has not been extensively assessed in animals, but in most TBEV-
exposed dogs a strong IgG immune response is detectable for >2 months in CSF to 9 months in 
serum (Bjöersdorff, 2002; Leschnik et al., 2002; Rendi-Wagner, 2004), though the exact antibody 
lifespan is not known (Pfeffer and Dobler, 2011). In sheep and goats, TBEV-specific antibody 
titers could be detected for >1 year or up to 28 months after respectively natural infection or four 
immunizations with a commercially available TBEV vaccine (Klaus et al., 2011; Klaus et al., 
2014).  
Seroprevalence rates are higher in older animals due to higher lifetime exposure: dogs, 
cattle, sheep and horses (Janitza-Futterer, 2003; Klaus et al., 2013; Sîkutova et al., 2009; 
Vesenjak-Hirjan et al., 1976a, b, c, d), but with a decrease in the oldest horses (Rushton et al., 
2013). The season may play a role in cattle, with observation of higher seroprevalence during 
tick season (summer) (Juceviciene et al., 2005; Sîkutova et al., 2009) and large breeds seem to be 
more exposed in dogs (Janitza-Futterer, 2003). 
Male horses may have higher tick infestation rates due to frequent transfers to other regions 
or due to unknown biological reasons (Rushton et al., 2013). A preferential attraction of ticks to 
male hosts and the 20/80 rule (the observation that 20% of the hosts carry 80% of the vectors or 
parasites) were also observed in the yellow-necked mouse (Apodemus flavicollis) (Burri et al., 
2011; Perkins et al., 2003; Randolph and Green, 1999; Randolph et al., 1999) and in fallow deer, 
though the opposite has been found in moose, roe deer and wild boar (Gómez-Martínez, 2014).  
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 VECTOR SURVEILLANCE  I.5.3
Tick surveillance by PCR testing has been performed in a large number of studies. Ticks 
have the advantage of offering direct evidence of TBEV presence and some authors have found 
tick surveillance useful to describe natural foci (Klaus et al., 2010b; Oehme et al., 2002; Süss et 
al., 2002). Ticks are usually collected in the field by blanket dragging or alternatively collected 
from human patients or animal hosts (Drelich et al., 2014; Falco and Fish, 1992; Klaus et al., 
2010b; Süss et al., 2004). These studies are summarized in Tables I-5 and I-6. 
However, tick studies have shown very variable TBEV prevalence (Mansfield et al., 2009), 
with estimates ranging from 0-5% (Dumpis et al., 1999; Gaumann et al., 2010; Oehme et al., 
2002; Randolph, 2011), which is often remarkably lower than in sentinel species serosurveillance 
in the same endemic areas (Andreassen et al., 2012; Brinkley et al., 2008; Drelich et al., 2014). 
Ticks may even not show any positivity for many years, leading to sudden “re-emergence” of 
natural foci after very long intervals (up to 15 years) of apparent non-activity (Frimmel et al., 
2014). The prevalence may be significantly higher in engorged ticks removed from hosts, up to 
>40% (Bormane et al., 2004; Süss et al., 2006; Süss et al., 2004). 
Testing large numbers (1,000s) of collected questing ticks cannot consistently assure virus 
detection in well-known endemic foci in many studies (Stefanoff et al., 2013). This may partly be 
due to inclusion in the analysed tick pools of ticks from uninfected areas or immature ticks, 
and/or due to shortcomings in the laboratory tests (Pettersson et al., 2014). Indeed, only a small 
percentage of the overall tick population has a high enough viral load to reach the detection limit 
in PCR (Süss, 2003), which suggests that the proportion of infected ticks in the study area may be 
much higher than estimated by insensitive or not appropriately validated PCR assays (Drelich et 
al., 2014).  
Since it often lacks sensitivity, PCR screening of ticks cannot be recommended as sole 
assessment of human TBE risk without long-term sentinel serology (Klaus et al., 2010b; Rizzoli 
et al., 2014; Stefanoff et al., 2013). In practice, TBE risk areas, cases and outbreaks can only be 
accurately explored if all available direct and indirect epidemiological evidence is collected and 
analyzed together: data from humans, ticks, reservoir rodents, and wild/domestic sentinel animals 
(Gaumann et al., 2010; Holzmann et al., 2009; Klaus et al., 2010a; Klaus et al., 2010b; Klaus et 
al., 2013; Leutloff et al., 2006; Süss, 2011).  
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Table I-5: Overview of prevalence studies in questing ticks 
MIR: Minimum Infection Rate: number of positive pools/total number of ticks assayed,   
with the assumption that only one tick in each pool is positive. 
Species Country Test Prevalence and sample size References 
Questing    
Ixodid 
Ticks 
Poland Nested RT-PCR 1.6% (I. ricinus) (n=875) 
10.8% (D. reticulatus) (n=148) 
(Wójcik-Fatla et 
al., 2011) 
Real-time RT-PCR 0.31% (0.19-1.11%) 
(n= 4,350)  
(Drelich et al., 
2014) 
Real-time RT-PCR 0.00% (n=7,436)  (Stefanoff et al., 
2013) 
RT-qPCR MIR: 0.21% (n=7,270 I. ricinus 
in pools) ; MIR: 0.33% (n=600 
D. reticulatus in pools)
(Katargina et al., 
2013) 
Nested RT-PCR MIR: 0.96%  (n=2,075 I. 
ricinus) 
(Biernat et al., 
2014a) 
Nested RT-PCR 2.12% (0.99-12.5% ~region) 
(n=471 D. reticulatus) 
(Biernat et al., 
2014b) 
Real-time RT-PCR MIR: 0.11% (n=5,160 I. ricinus 
in 157 pools) 
(Cuber et al., 
2015) 
South Korea Nested RT-PCR 0.6% (n=635 ticks) 
10.25% (n= 38 pools) 
(I. nipponensis + H. longicornis) 
(Kim et al., 2008) 
Nested RT-PCR 0.08 (n=13,053 ticks ; 1,292 
pools) ; MIR: 0.06% (H. 
longicornis), 0.17% (H. flava), 
2.38% ( I. nipponensis) 
(Yun et al., 2012) 
Lithuania Nested RT-PCR 0.1-1.7% (n= 3,234 ticks) ; 
1.4% (n=436 pools) 
(Han et al., 2005) 
Real-time RT-PCR 1.38% (range 1.03-
16%)(n=3,234 ticks - 436 pools)  
(Juceviciene et 
al., 2005) 
RT-qPCR MIR: 0.30% (n= 1,990  I. 
ricinus in pools) 
(Katargina et al., 
2013) 
Estonia RT-qPCR MIR: 0.46%  (n= 2341  I. 
ricinus) ; 4.23%  (n= 946 I. 
persulcatus) 
(Katargina et al., 
2013) 
Sweden RT-PCR 0.10-0.51%(n=2,074 nymphs) ; 
0.55-4.48%                  (n=906 
adults) 
(Pettersson et al., 
2014) 
Real-time RT-PCR 0.10-0.42% (n=7,630) (Brinkley et al., 
2008) 
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Table I-5 (Cont.): Overview of prevalence studies in questing ticks 
MIR: Minimum Infection Rate: number of positive pools/total number of ticks assayed,   
with the assumption that only one tick in each pool is positive. 
Species Country Test Prevalence and sample size References 
Questing    
Ixodid 
Ticks 
Finland Nested RT-PCR 0.34% (n=589 ticks)  (Han et al., 2001) 
Isolation MIR : 0% (n=183) ; 0.29% 
(n=12,001); 0.32% (n=9,063) 
(Brummer-
Korvenkontio et al., 
1973) 
Finland/ 
Russia 
RT-PCR 1.00% (n=2,411) (Jääskeläinen et al., 
2010) 
Russia RT-PCR 5.7% (I. persulcatus +  I. 
pavlovskyi) (n=?) 
(Chausov et al., 
2010) 
Germany Nested RT-PCR 0-5.3% ~region/lifestage 
(n=15,400 I. ricinus) 
(Süss et al., 2002) 
PCR 0.38% (nymphs) - 6.9%  (n=820) 
; 1.17% (adults) - 9.3%  (n=90) 
(Süss et al., 2004) 
Nested PCR 0- 2.3% (n= 9,189) (Oehme et al., 2002) 
PCR 0.12% (95% CI: 0.05-0.44%) 
(n=1,657) 
(Holbach and Oehme, 
2002) 
Nested RT-PCR 0.4±4.8% (Süss et al., 1999) 
Nested RT-PCR 2.4% (n=250)  (Frimmel et al., 2010) 
Nested RT-PCR 0.0% (n=16,089) -Between 1992-
2003 
(Frimmel et al., 2014; 
Klaus et al., 2010b) 
Nested RT-PCR 2.7% (n=150) (Frimmel et al., 2014) 
Nested RT-PCR 0% (n=212 pools) (Kießling, 2005) 
Real-time RT-PCR 0.00% (n>16,000) (Stefanoff et al., 
2013) 
Real-time RT-PCR 0.08% of pools ; adult females: 
1.28% ; (n=  9,115 ticks - 505 
pools) 
(Bingsohn et al., 
2013) 
Real-time RT-PCR  0.00% (n=3,741) (Klaus et al., 2010b) 
Real-time RT-PCR / 
RT-qPCR 
0% (n=294 unfed) (Klaus et al., 2010a) 
Real-time RT-PCR 0.06% (n=1,700) (Klaus et al., 2012) 
Norway Real-time RT-PCR 0.53% pools (n=563) pools); 
0.11-1.22% ticks (n=5,630) 
(Andreassen et al., 
2012) 
Netherlands Real-time RT-PCR 0% (n=906) (van der Poel et al., 
2005) 
Spain  Real-time RT-PCR 0% (n=1,800 nymphs in pools + 
630 adults) 
(Barandika et al., 
2010) 
Luxemburg RT-PCR 0% (n=1,394) (Reye et al., 2010) 
Mongolia RT-PCR 1.32% (n=680 I. persulcatus) (Muto et al., 2015) 
Real-time RT-qPCR 0%/0.68% n=1,557 ticks  (Klaus et al., 2013) 
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Table I-5 (Cont.): Overview of prevalence studies in questing ticks 
MIR: Minimum Infection Rate: number of positive pools/total number of ticks assayed,  
with the assumption that only one tick in each pool is positive. 
Species Country Test Prevalence and sample size References 
Questing    
Ixodid Ticks 
Austria Isolation  0.44% (n=3,404);  
MIR: 4.4/1000 ticks 
(Labuda et al., 1993e) 
RT-PCR 0% (n=306) (Dobler et al., 2008) 
Hungary Semi-nested  
RT-PCR  
0.08%  (n=2,300 unfed nymphs) (Pinter et al., 2013) 
RT-PCR  0.00% (n= 1,800)  (Egyed et al., 2012) 
Mouse Inoculation 
Test + Isolation 
3 pools (n=9,616) (Zöldi et al., 2014) 
Czech 
Republic 
IFAT 0.2-1.3% (nymphs) ;  5.9-11.1% 
(adults) ;  
MIR: 0.6% (187 pools; 2,968 
ticks) 
Danielova et al., 2002 
Isolation 11 isolates (n=2,157 I. ricinus); 
0.0-4.5% (n=100-640 ♀~region); 
0.3-2.2% (n=60-210 ~region) 
Asmera and Heinz, 1972 
Real-time RT-PCR 0.32% (nymphs) - 0.81% (adults)  
(n= 20,057 I. ricinus) 
Hönig et al., 2015 
Latvia PCR  I. ricinus : 1.7 -26.6% (adults) ;
43% (nymphs) (n=?) 
I. persulcatus : 0 -37.3%. (adults)
(n=?)
Bormane et al., 2004 
Nested RT-PCR 2.8% (n=525 I. ricinus); 5% 
(n=281  I. persulcatus) 
Süss et al., 2002 
RT-qPCR MIR: 1.02%  (n= 3,812 I. ricinus 
in pools); 1.74% (n= 287 I. 
persulcatus)   
Katargina et al., 2013 
Estonia RT-qPCR MIR: 0.46%  (n= 2341  I. ricinus) 
; 4.23%  (n= 946 I. persulcatus) 
Katargina et al., 2013 
Italy Real-time RT-PCR 1.2% (0.5-2.5%) (n=1,739) Carpi et al., 2009 
IFAT/RT-PCR 0.03% (n=13,007) Hudson et al., 2001  
Real-time RT-PCR 2.1% (n=193) Capelli et al., 2012 
Nested RT-PCR 0.21% (n=2,361) D’Agaro et al., 2009 
Switzerland  Nested RT-PCR 14.3% (n=307) Casati et al., 2006 
Real-time RT-PCR 0.46% (n= 62,343) Gäumann et al., 2010 
RT-qPCR 1.99% (95% CL : 0.33-6.06) 
(n=?) 
Rieille et al., 2013 
RT-qPCR 0.16-11.11% ~ region    (n total = 
19,331) 
Rieille et al., 2014 
Real-time RT-PCR MIR: 0.1% (n=6,683) Burri et al., 2011 
Real-time RT-PCR 0.1%  (n= 6,120) (Lommano et al., 2012) 
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Table I-6: Overview of prevalence studies I nticks collected off hosts. 
MIR: Minimum Infection Rate: number of positive pools/total number of ticks assayed,                          
with the assumption that only one tick in each pool is positive. 
Species Country Test Prevalence References 
Foxes  Croatia Nested RT-PCR 1.6% (n=371) (Jemersic et al., 2014) 
Rodents Hungary Semi-nested  
RT-PCR  
0.78%  (n= 431) (Pinter et al., 2013) 
Switzerland  Real time RT-PCR MIR: 0.1% (n=3,303); 
8.6%-50% (n=77 off 2 
rodents) 
(Burri et al., 2011) 
Cervids Germany Real time RT-PCR 0.00% (n=187)  (Klaus et al., 2010b) 
Roe deer Italy  RT-PCR/IFAT 0.23% (n=878) (Hudson et al., 2001) 
Dogs / Cats Belgium TBEV not tested      (n=2,373) (Claerebout et al., 2013) 
Birds 
 
Sweden Nested RT-PCR 0.52% (n=1,155)  (Waldenström et al., 2007) 
Russia RT-PCR  14.1% (I. persulcatus) ; 
5.2%  (I. pavlovskyi) ; 
4.2%  (I. plumbeus) 
(Mikryukova et al., 2014) 
Switzerland RT-qPCR 0.27% (n=1,123) (Lommano et al., 2014) 
Estonia Real time RT-PCR 0.4% (n=249) (Geller et al., 2013) 
Latvia RT-qPCR 14% (n=170) (Kazarina et al., 2015) 
Moldova PCR 0.7% (n= 135 I. ricinus) (Movila et al., 2013) 
Humans Germany Real time RT-PCR 1.3% (n= 239)  (Klaus et al., 2010b) 
Nested RT-PCR 8.8% (n=561)  (Süss et al., 2006) 
PCR 8.4% (n=215)  (Süss et al., 2004) 
Sweden/Finland Multiplex real-time 
RT-qPCR 
0.23% (n=2,167)  
 
(Lindblom et al., 2014) 
 RISK MAPS I.5.4
TBE risk maps based on reported human TBE cases are published regularly (Figure I-11). 
These maps give a good but incomplete picture of the European situation, as they usually do not 
take into account the tick and animal prevalence of TBEV (Rendi-Wagner, 2004; Süss, 2003).  
Alternatively, TBE risk maps may also be based on satellite-derived GIS and RS data on 
environmental and climatic characteristics and based on virus and host survival requirements. 
Such maps can predict TBE risk areas with 85% accuracy (Figure I-12) (Labuda and Randolph, 
1999; Randolph, 2000, 2001; Randolph and Rogers, 2000; Rinaldi et al., 2006).  
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On the basis of climate change predictive models, it could be speculated that endemic regions 
may further disperse geographically in any one, two or even three directions − eastwards, 
northwards and/or even westwards (Randolph, 2001; Randolph and Rogers, 2000), as observed in 
Sweden, Germany and France (Kirtz, 1999; Lindgren and Gustafson, 2001; van der Poel et al., 
2005).  
Figure I-11: TBE in Europe: Established endemic areas in 2013.  
Red zones: TBE risk area; Question mark: potential TBE risk area; Adapted from ISW-TBE, 2013. 
Figure I-12: Predicted spread of tick-borne encephalitis in Europe. 
Red zones: satellite-derived predicted distribution (data 2000) compared with Yellow zones: established foci 
(mapped 1997); Randolph and Rogers, 2000; Randolph, 2000; permission The Royal Society and S. Randolph. 
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 STATE OF THE ART IN BELGIUM ANNO 2009-2016 I.6
 TICK (BITE) SURVEILLANCE I.6.1
In 2015, a human tick bite notification system for the Belgian general public was launched 
(https://tekennet.wiv-isp.be/; Figure I-13)(Lernout, 2016; WIV-ISP, 2015).  
The presence of Ixodes ricinus ticks has now been confirmed throughout the whole Belgian 
territory (Claerebout et al., 2013; ECDC et al., 2015; Obsomer et al., 2013). In fact, this tick 
species seems to have been omni-present long before 2011, as recently demonstrated by the 
mapping of 14 tick collections from different institutes, musea and surveys, and field 
observations by Natuurpunt and Natagora (www.natuurpunt.be; www.natagora.be)(Obsomer et 
al., 2013).  
The temporal distribution in Figure I-14 seems to follow that in other countries (ECDC et al., 
2015; Obsomer et al., 2013). Some other Ixodid ticks present in Belgium are Dermacentor 
reticulatus (in a patchy distribution), Rhipicephalus sanguineus (very localized and imported) 
and Ixodes hexagonus (widely distributed) (Claerebout et al., 2013; Obsomer et al., 2013).  
 
 
Figure I-13: Incidence of reported tick bites by municipality, July-Dec 2015. 
https://tekennet.wiv-isp.be ; (Lernout, 2016)  
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Figure I-14: Temporal distribution of I. ricinus ticks in Belgium.  
Data compiled from several tick collections and studies and adapted from table 4 in Obsomer et al. (2013). 
To date, there is no evidence of ticks carrying TBEV in Belgium, however, no published 
studies have actually tested for this pathogen. Several other pathogens have been found in 
Belgian ticks, such as Borrelia burgdorferi s.s., B. valaisana, B. garinii, B. afzelii, B. spielmani 
and B. lusitaniae (Claerebout et al., 2013; Estrada-Pena et al., 2011).  
Anaplasma phagocythophilum and Rickettsia helvetica/massilae seem to be present 
throughout the country (Claerebout et al., 2013; Lempereur et al., 2012; Obsomer et al., 2013), 
while occasionally Babesia spp. have been detected, e.g. B. divergens (Everaert et al., 2007; 
Famerée et al., 1977; Lempereur et al., 2012; Losson, 1989; Saegerman et al., 2007), B. canis and 
B. caballi (Jongejan et al., 2015; Losson et al., 1999), B. microti and B. EU1 (Lempereur et al.,
2011). Tick and pathogen diversity hotspots may be present in several communities (Obsomer et
al., 2013).
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 MEDICAL TBE SURVEILLANCE I.6.2
During 2000-2010, no autochthonous TBE cases were reported and TBE was not known to 
be endemic in Belgium, despite having climatic and environmental conditions that are conducive 
to the circulation of the TBE virus (ECDC, 2012). In this decade, there was only one published 
paper which tried to identify TBE in four human patients with a viral CNS infection of unknown 
etiology from Belgium. None of the four Belgian patients included in this study were confirmed 
as a TBE case (Haglund et al., 2003). During the same period, the Queen Astrid Military 
Hospital performed a continuous serological screening with the Virotech® IgG/IgM ELISA 
(Sekisui Diagnostics - Genzyme Virotech) in 359 suspected tick bite and neurology patients 
between 07/2000 and 10/2011. Of these, 55 tested IgG positive (15.32%) and 19 tested IgM 
positive (5.29%). However, none of these results could be confirmed in SNT (P. Heyman, 
personal communication, 2015).  
Since 2010, the TBE National Reference Centre (WIV-ISP) has used the European case 
definition (EC, 2012; ECDC, 2012) and has offered serological and PCR screening to the medical 
sector as part of a diagnostic service of the referral laboratory and a limited passive surveillance 
system with voluntary reporting of CNS cases (ECDC, 2012). During 2010-2016, the Belgian 
TBE-NRC (WIV-ISP) has been using Progen Immunozym FSME/TBEV IgM and IgG kits to 
screen human patients (Progen, 2014; Progen, 2012) and the TBEV-SNT as a confirmation test 
(Vene et al., 1998). SNT-results from ≥1/10 onwards are considered sufficiently protective 
against clinical TBE, but titers are usually much higher after full vaccination (Holzmann et al., 
1996; Kollaritsch et al., 2011b; WHO, 2011). Additionally, comparative IFA Biochips (Mosaic 3, 
Euroimmun®, Germany)(Litzba et al., 2014) and qRT-PCR (Schwaiger and Cassinotti, 2003) 
have been available at the TBE-NRC and current best practices in TBE-diagnostics are followed.   
As such, TBE tests have been performed on patients suspected of neuroborelliosis and on 
cases that were sent by general practitioners or hospitals based on direct TBE clinical suspicion 
(Dr. Van Gucht S., and Dr. Brochier B., pers. comm., 2015). In 60 samples from 2009, 10 reacted 
in IgG ELISA (borderline or positive), one was positive in IgM-ELISA and seven reacted 
positive in RFFIT-SNT. In 2014, 53 suspected patients were tested and a total of 18 samples were 
IgG-ELISA-positive or -borderline, while three were SNT-positive, but none were IgM-ELISA-
positive.  
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No samples were positive for all three tests together, and since convalescent (paired) samples 
were not available and the TBE/flavirirus vaccination status of the patients is unknown, the 
interpretation of these results remains inconclusive. So far, six imported cases of human TBE 
imported from Scandinavia, Austria, Kyrgyzstan and Slovenia have been confirmed by the 
Belgian NRC (Dr. Suin V. and Dr. Van Gucht S., pers. comm, 2015).  
According to ECDC (2014), Belgium has not yet adopted a comprehensive surveillance 
system and there is no nationwide active surveillance component in occupational risk groups 
(ECDC, 2014). The existing passive surveillance is not mandatory and is based on one reference 
laboratory reporting very fragmentary data with little clinical or vaccination history or follow-up 
(no paired sera), presented by clinicians on a voluntary basis only.  
It is known that TBE notification is not mandatory and is considered unimportant in Belgium 
(Callens, 2016; Donoso Mantke et al., 2008a; Donoso Mantke et al., 2008b; Randolph, 2001; 
Süss, 2008b). TBE is a neglected zoonosis as a large number of Belgian neurologists and general 
physicians are largely unaware of this emerging tick-borne disease as a differential diagnosis to 
test for human encephalitis/meningitis or tick-bite cases (Dr. P. Roelandt, MD, Dr. M. Goethals, 
MD Neurologist, Dr. Van Gucht S., DVM, Virologist).  
Testing for TBEV in human encephalitis cases is in general not even recommended in 
diagnostic protocols, unless there are clear indications in the exposure history (Callens, 2016; 
Solomon et al., 2007). Despite this, the situation may be slowly improving anno 2016, with more 
clinicians and pharmacists seeking information at the current NRC (Institute of Tropical 
Medicine, Antwerp) about preventive TBE vaccination (Dr. Soentjens P., Dr. Maniewski-Kelner 
U., Van den Daele A., Dr. Van Esbroeck M., ITM, pers. comm., 2016). Belgian citizens travel to 
known endemic areas and may be infected there or may return with infected ticks (Heyman, 
2009; Luyasu, 2009), but most likely very few of those tourists are vaccinated: see Table I-7 (Dr. 
Soentjens P., Dr. Maniewski-Kelner U., Van den Daele A., ITM, pers. comm., 2016). 
Vaccination 1999 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Adult 88 53 55 58 39 32 69 29 51 38 60 
Junior 0 2 1 3 0 3 5 0 1 0 2 
Grand 
Total 88 55 56 61 39 35 74 29 52 38 62 
Table I-6: Number of TBE vaccins (FSME® Baxter) administered                                                             
by the Belgian  Institute of Tropical Medicine. 
 (ITM, pers. comm., 2016) 
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 WHY BELGIUM NEEDS VETERINARY TBE SURVEILLANCE I.6.3
Until now, no veterinary or tick screening had been performed, since TBEV is rather a public 
health problem than a disease of large veterinary importance and is not “believed” to be present. 
Additionally, not a single human TBE case has been reported in a person from Belgian 
nationality, despite the fact that:  
(1) Belgium has climatic and environmental conditions that are conducive to the circulation 
of the TBE-virus and similar to those of other European countries where TBEV is endemic 
(AGIV, 2009; ECDC, 2012; FAO, 2001; KMI, 2009; RW, 2009);  
(2) Suitable vectors and hosts are present and populations are abundant or increasing 
(Claerebout et al., 2013; Misonne et al., 1998; Obsomer et al., 2013; Verkem et al., 2003);  
(3) Throughout the past 15 years small numbers of suspected human clinical neurological 
cases have regularly occurred, that could not yet be completely confirmed through lack of 
complete epidemiological investigations, while imported cases have occurred and were 
confirmed (ECDC, 2014);  
(4) Animal tick prevention, owner compliance and education is often insufficient (Dryden, 
2009; Leschnik et al., 2013). Furthermore, dogs and horses often travel with their owners 
(Heyman, 2009; Luyasu, 2009), and wildlife (mammals and birds) can easily cross national 
borders. TBEV-infected ticks can therefore easily be transported into Belgium. 
(5) People travel to endemic areas without vaccine protection. 
 
Extensive research by many authors in Europe and Asia on temporo-spatial heterogeneity in 
TBEV-foci and TBE incidence trends have shown that not detecting human cases at a single time 
point does not substantiate TBEV absence, as there are many underlying (a)biotic factors that 
determine the visible human TBE incidence pattern at the tip of the iceberg. Human cases are 
clearly not sufficient data to completely describe the geographical presence of a TBEV focus or 
to predict future dynamics (Balmer et al., 2007b; Randolph and Sumilo, 2007). Nonetheless, this 
knowledge of the TBEV distribution is essential to ensure an appropriate response to the related 
risks and to decide the appropriateness of vaccination (Holbach and Oehme, 2002).   
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Consequently, both veterinary and ecological TBE studies have clearly proven their value in 
known TBE endemic areas and specifically in areas or countries with (very) few human cases and 
few suspected areas, where one doubts if TBE(V) is even present. The zoonotic iceberg 
phenomenon has been illustrated in the field on several occasions, e.g. in Scandinavia, Germany 
and in Japan. 
All these studies clearly support the usefulness of preventive veterinary TBE surveillance as 
an early warning of suspected endemic areas before the tip of the iceberg  suddenly surfaces in  
the form of human cases (Barandika et al., 2010; Broker, 2002; Chiba et al., 1999; Csángó et al., 
2004; Fomsgaard et al., 2009; Fomsgaard et al., 2013; Frimmel et al., 2010; Frimmel et al., 2014; 
Gaumann et al., 2010; Hayasaka et al., 1999; Kristiansen, 2002; Laursen and Knudsen, 2003; 
Randolph, 2001; Randolph and Sumilo, 2007; Reye et al., 2010; Skarpaas et al., 2004; Skarpaas 
et al., 2002; Skarphedinsson et al., 2005; Süss et al., 2004; Takashima, 1998; Takashima et al., 
2001; Takashima et al., 1997; Takashima et al., 1992; Takeda et al., 1998; Takeda et al., 1999; 
Takezawa et al., 1995; van der Poel et al., 2005; WHO, 2004). 
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 CONCLUSIONS OF THE GENERAL INTRODUCTION I.7
“Even though TBE was described as early as 1931 (Schneider, 1931), this dangerous form of 
encephalitis has been underestimated for a long time” (Kunz, 2008). The absence of any human 
cases in Belgium (even travel related) is perhaps questionable since Belgian citizens and animals 
regularly travel to known endemic areas. Furthermore, Belgium has climatic and environmental 
conditions similar to those of other European countries where TBEV is endemic and suitable 
vectors and hosts are present and abundant.  
However, presently clinicians do not routinely test for TBE(V) and notification of clinical 
cases is not mandatory. Until now, TBE surveillance in Belgium has been very minimal and 
fragmented, therefore cases could currently remain undiagnosed and/or the establishment of 
endemic foci with low prevalence could easily be missed. Just as increased awareness and testing 
have probably contributed to the rise in Belgian human cases of Lyme disease, so too may 
increased veterinary surveillance demonstrate the arrival or circulation of TBE(V) in Belgium. 
Many countries have led the way and showed the great potential of veterinary surveillance to 
increase the overall detection sensitivity of national TBEV surveillance schemes and to greatly 
improve the description of (potential) endemic risk areas, especially in regions where the human 
cases are emerging, extremely rare and/or tick prevalence is undetectably low.  
Until now (2009), veterinary TBE surveillance in Belgium has been non-existent, hence 
human or veterinary cases may currently remain undiagnosed and the introduction and 
establishment of endemic foci with low prevalence could easily be missed. Just as increased 
awareness and testing have probably contributed to the rise in Belgian cases of Lyme disease 
(Ducoffre, 2008a), so too may increased veterinary and human surveillance demonstrate the 
arrival or circulation of TBEV in Belgium.  
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 AIMS OF THE PHD THESIS CHAPTER II 
Questing for Tick-borne Encephalitis virus in Belgium, 
using Veterinary Sentinel Surveys and Risk Factor Mapping 
In Belgium, there are no confirmed autochthonous TBE cases in humans, despite the 
perception in the medical community that occasionally suspected cases have occurred in the past 
and present. However, the etiology often remains unconfirmed and TBEV negative (Dr. Heyman 
P., pers. comm. 2010 and Dr. Van Gucht S., pers. comm., 2015);(Callens, 2016; Haglund et al., 
2003). The ECDC and TBE(V) researchers have stated that in national TBEV-surveillance 
schemes there is a justifiable and acknowledged need for a veterinary surveillance component to 
improve and complement the output from surveillance in humans (ECDC, 2012; Süss, 2011). 
The goals of this PhD were therefore: 
1. To establish veterinary serological evidence pro or contra TBEV presence in Belgium,
based on studies in key species relevant for TBEV epidemiology and surveillance → Chapter III 
(dogs), Chapter IV (cattle), Chapter V (wild boar) and Chapter VII (general discussion). 
2. To map the geographical distribution of the samples and seropositive cases versus a
number of known TBE risk factors → Chapter VI (mapping and modelling). 
3. To evaluate an ELISA first-line test for veterinary screening based on the gold standard
seroneutralisation test → Chapter III (dogs), Chapter IV (cattle), Chapter V (wild boar), Chapter 
VII (general discussion). 
4. To evaluate the selected sentinel species (domestic and wild) regarding their suitability for
ongoing veterinary TBEV surveillance based on the survey experiences and literature/practical 
criteria → Chapter I (introduction), VII (general discussion). 
5. To identify remaining knowledge gaps and suggest priority actions for the future →
Chapter VII (general discussion). 
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 SEROLOGICAL SENTINEL CHAPTER III 
SURVEY  IN BELGIAN DOGS 
 
Adapted from: Sophie Roelandt, Paul Heyman, Marina De Filette, Sirkka Vene, Yves Van 
der Stede, Ann Brigitte Caij, Paul Tavernier, Alexandre Dobly, Hendrik De Bosschere, Philip 
Vyt, Carole Meersschaert, and Stefan Roels 
TICK-BORNE ENCEPHALITIS VIRUS (TBEV) SEROPOSITIVE DOG DETECTED 
IN BELGIUM: SCREENING OF THE CANINE POPULATION AS SENTINELS FOR 
PUBLIC HEALTH. 
Vector-borne and Zoonotic Diseases 2011; 11(10): 1371-1376.  
Mary Ann Liebert, Inc. Publishers.  
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  ABSTRACTIII.1
Tick-borne encephalitis virus (TBEV) is an important emerging tick-borne viral infection of 
humans and dogs in Europe. Currently, TBEV surveillance is virtually non-existent in Belgium, 
which is considered non-endemic. A commercial enzyme-linked immunosorbent assay (ELISA) 
was adapted for the detection of TBEV-specific IgG-antibodies in canine sera. Serum samples of 
Belgian dogs were obtained from three diagnostic laboratories from Northern (n=688) and 
Southern Belgium (n=192). ELISA- positive, and borderline and near-borderline samples were 
subjected to a TBEV rapid fluorescent focus inhibition confirmation test (TBEV-SNT). One dog 
was confirmed TBEV seropositive. Several ELISA-positive and borderline sera underwent 
seroneutralization and hemagglutinin inhibition tests to rule out West Nile and Louping Ill 
viruses, but tested negative. The clinical history of the seropositive dog could not explain beyond 
doubt where and when TBEV infection was acquired. Further surveillance is necessary to 
determine whether this dog remains a single travel-related case or whether it represents an early 
warning of a possible future emergence of TBEV.  
  INTRODUCTIONIII.2
Western subtype tick-borne encephalitis virus (TBEV), transmitted by Ixodes ricinus ticks 
and occasionally by unpasteurized milk from ruminants, is currently the most important 
arthropod-borne viral infection in humans in Europe (Herpe et al., 2007; Ramelow et al., 1993). 
In one to two thirds of patients, tick-borne encephalitis (TBE) is a biphasic disease with fever and 
neurological signs, ranging from meningitis to severe encephalitis with or without myelitis 
(Haglund and Günther, 2003; Kaiser, 2008b). All patients need hospitalization and approximately 
35-58% of patients develop permanent sequelae called “post-encephalitic syndrome” (Haglund et
al., 1996; Kaiser, 2008a). Despite low mortality rates of 0-3.9% (Donoso Mantke et al., 2008a;
Süss, 2008a), Western subtype TBEV results in very high risk to society and health care
(Baumhackl, 2009; Haglund, 2002). TBE is an increasing public health risks in several European
countries (Süss et al., 1997) and 3,000 people are hospitalized every year (ECDC, 2012;
Haglund, 2002). Recently, incidence of TBEV in humans has been fluctuating and increasing in
several endemic countries (Süss, 2008a) and it has emerged in Northern and Western Europe
(Donoso Mantke et al., 2008a).
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TBE is also emerging among Europe’s canine population (Beugnet and Marie, 2009; 
Leschnik et al., 2002). Small numbers of cases were described in endemic foci of Austria, 
Switzerland, Germany and Sweden (Bjöersdorff, 2002; Csángó et al., 2004; Gresikova et al., 
1972; Kirtz et al., 2001; Reiner and Fischer, 1998; Tipold et al., 1993; Weissenbock et al., 2010). 
The distribution of canine TBE is steadily expanding over Western Europe in parallel with 
human TBE. Consequently, a higher number of canine TBE cases are likely to be diagnosed as 
awareness increases in the veterinary community (Beugnet and Marie, 2009; Leschnik et al., 
2002). Although in 50% of dogs seroconversion occurs without any clinical signs (Klimeš et al., 
2001; Leschnik et al., 2002), TBEV can cause pyrexia, lethargy, loss of appetite and multifocal 
neurological signs (Bjöersdorff, 2002). Most dogs develop a strong IgG immune response  
(Bjöersdorff, 2002; Rendi-Wagner, 2004) which is detectable for more than 2 months in 
cerebrospinal fluid to 9 months in serum (Leschnik et al., 2002). In analogy to human medicine 
(Holzmann, 2003; Rendi-Wagner, 2004), the best diagnostic tests for dogs are indirect IgG 
enzyme-linked immunosorbent assay (ELISA), hemagglutination inhibition (HI), 
seroneutralization assay (SNT) or immunoblotting tests. SNT tests are considered to be highly 
specific confirmation / reference tests (Klimeš et al., 2001; Leschnik et al., 2002; Reiner and 
Fischer, 1998; Vene et al., 1998).  
Due to the close relationship between humans and dogs, the latter are a good sentinel species 
for the spread and risk of TBE.  Increased pet travel (Beugnet and Marie, 2009; Leschnik et al., 
2002; Otranto and Wall, 2008) combined with more frequent contact between dogs and I. ricinus 
often results in higher seroprevalence rates in dogs as compared to humans (Bjöersdorff, 2002; 
Klimeš et al., 2001). Dogs may also carry infected ticks from endemic to non-endemic areas and 
into close vicinity of humans (Grešíková et al., 1972; Leschnik et al., 2002). Sentinel studies in 
Scandinavian dogs revealed geographical areas where TBE was more common than expected, 
discovered new TBEV foci and highlighted the need for better TBE(V) surveillance (Bjöersdorff, 
2002; Csángó et al., 2004; Skarpaas et al., 2004). 
In Belgium, TBE is still considered an exotic disease (Donoso Mantke et al., 2008a; Süss, 
2008a) and medical and veterinary TBEV surveillance is currently non-existent (Roelandt et al., 
2010). Therefore, we conducted a first serological screening of dogs in Belgium for TBEV.   
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  METHODS III.3
 SAMPLING AND STUDY DESIGN III.3.1
Serum samples of Belgian dogs (n=880) were obtained from two diagnostic laboratories from 
Northern (n=688) and one from Southern (n=192) Belgium (Figure III-1). Afterwards, this 
sample size was sufficient to adapt the ELISA kit to canine sera and for the purpose of detecting 
a seroprevalence of 0.35% with a confidence level of 95% (n=855), assuming 100% sensitivity 
and specificity in dogs. All samples were taken by local veterinary surgeons between 15/03/2009 
and 22/06/2009 and submitted to the laboratories for a variety of diagnostic tests.  Samples were 
centrifuged and the sera were stored at 4°C at the laboratories until collected, after which they 
were frozen and stored at -20°C.   
 
Figure III-1: Belgian canine samples (n=880) used in this study. 
Three coloured pins represent the 3 participating laboratories. One dot represents one dog. Purple triangles 
represent ELISA positive and borderline samples. 
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 DIAGNOSTIC SEROLOGY ASSAYS III.3.2
III.3.2.1 TBE virus ELISA  
A commercially available ELISA test kit (Immunozym FSME/TBE IgG All Species-
ELISA®, Progen Biotechnik GmbH, Heidelberg, Germany) was used to detect TBEV- specific 
IgG antibodies in the canine sera.  This non-competitive indirect assay uses horseradish 
peroxidase – Protein G conjugate to detect IgG against whole TBE-virus. The kit can 
theoretically be used for TBEV testing in all species, including humans.  In humans, this ELISA 
has a diagnostic sensitivity of 97% and analytical specificity of 99% for IgG (Progen, 2006) and 
it was previously used as a TBEV screening test in foxes (Wurm et al., 2000). 
The kit was adapted using a known positive canine serum from a clinical case (kindly 
provided by the In Vitro Labor für Veterinärmedizinische Diagnostik und Hygiene GmbH, 
Vienna, Austria) and a mixture of five TBEV-negative sera (SPF laboratory beagles, Janssen 
Pharmaceutica N.V., Beerse, Belgium) alongside human calibrator and control samples of the kit. 
The manufacturer’s instructions were followed, sera were diluted 1:50 and optical densities were 
read at 450 / 620 nm (reference 620 - 690 nm). For each plate, a standard curve was generated 
using the five human calibrator samples. Sample concentrations were read from these curves in 
Vienna Units per ml (VIEU/ml). Sera with <53 VIEU/ml were negative, sera with >126 VIEU/ml 
were positive and those between 53 VIEU/ml and 126 VIEU/ml were classified borderline.  Since 
the true diagnostic sensitivity and specificity of this kit are unknown for dogs, we lowered the 
cut-off by 15% compared to the kit cut-off (63 → 53 VIEU/ml).  
III.3.2.2 Confirmation testing 
A serum panel consisting of all ELISA-positive, all borderline and a number of negative sera, 
was sent for confirmation testing and these sera were used as long as a sufficient volume was 
available. At the Swedish Institute for Infectious Disease Control (Solna, Sweden), the rapid 
fluorescent focus inhibition test (TBEV-SNT) was used, essentially as described by Vene (Vene 
et al., 1998): a mouse monoclonal TBEV-antibody, kindly provided by M. Niedrig, followed by 
FITC-labelled goat-anti-mouse conjugate (Jackson ImmunoResearch,West Grove, PA) were used 
to visualize foci.  Human control samples were used and antibody titres were calculated as the 
reciprocal of the serum dilution that reduced the virus to one FFD50 (50% focus forming dose). 
The lowest detectable canine TBE titer is 1/5 (Dr. Vene S., pers. comm. 2009).  
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The remaining sera were then subjected to a SNT for West Nile virus at the Veterinary and 
Agrochemical Research Centre (CODA-CERVA, Brussels, Belgium). Briefly, serum dilutions 
were incubated in a 96-well plate with 100 TCID50 of WNV (IS 98 strain) for 1 hour at 37°C. 
Chicken control sera (negative/positive) were tested at the same time.  After one hour, Vero cells 
were added to each well and the plate was incubated for 3 days at 37°C with 5% CO2. After 3 
days, the cytopathic effect of virus grown was read by microscopy. 
 A HI test for Louping Ill virus was performed at Moredun Scientific Research Institute 
(Penicuik, Midlothian, Scotland, UK) as described by Clarke and Casals (1958), but modified to 
a microtitre plate version, using ovine control samples and a cut off titre of 1:20. Samples were 
prepared by heat inactivation for 1 hour at 65°C and nonspecific inhibitors and goose erythrocyte 
agglutinins were removed by kaolin and goose erythrocyte absorption. The LIV-HIT was used 
because the LIV-SNT was not available at the time. A retrospective descriptive epidemiological 
investigation was performed for confirmed TBEV ELISA- and SNT-seropositive dogs and 
consisted of telephonic contact with the owners and the veterinarians to obtain a clinical history.  
 RESULTSIII.4
 DIAGNOSTIC SEROLOGYIII.4.1
Based on the VIEU/ml cut-offs we specified above, the control samples reacted conform
expectations clearly positive or negative, two dog sera were found to be ELISA-positive (0.22%) 
and eight were borderline (0.91%). These 10 samples came from all three of the included 
diagnostic laboratories and from Northern and Southern. Five ELISA-negative samples were 
included in the panel of samples for confirmation testing (n=15) that was first sent for SNT 
testing. Among these, two borderline serum samples belonging to the same dog were found 
positive by SNT at a low titer (1/5). Hereafter, these two sera are considered as one SNT-positive 
sample or dog.  
Nine borderline/positive ELISA samples (incl. SNT-positive sample) and two of the negative 
samples were screened for WNV antibodies by SNT: all sera (n=11) were WNV antibody- 
negative.  Five samples (3 borderlines, 1 SNT-positive, 2 negatives) for which sufficient serum 
remained were additionally tested by LIV-HIT at Moredun Scientific Research Institute. Four 
samples were LIV-HIT negative, including the TBEV-positive dog. One borderline sample tested 
LIV-positive (titer 1:160).
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 CASE HISTORY  III.4.2
The TBEV (SNT) seropositive dog was an eight-year-old neutered female West Highland 
White Terrier cross, born in 2001 and living in West Flanders (Northern Belgium, near the red 
laboratory in Figure III-1). The owners obtained it as a six-week-old puppy and it had been 
regularly vaccinated for Canine Distemper, Canine Hepatitis, Parvovirus, Parainfluenza, 
Leptospirosis (DHPPiL or PiL) and Rabies. It was treated against parasites with preventive 
pyrantel/praziquantel (twice a year) and fipronil (once a year in June). It was never offered 
unpasteurized dairy products.  
Though the dog was diagnosed with hypo-adrenocorticism in 2005, this condition was well 
controlled by standard treatment with prednisolone and fludrocortisone. The blood samples tested 
in this study were taken to monitor the animal’s status with regard to this condition. According to 
the owners, this dog never showed any neurological signs or appeared ill, and apart from the 
Addison’s disease episode there was no other disease history. There were no other pets in the 
household.  
This dog had traveled abroad to the German Mosel region in 2002 and to the French Alsace 
region in 2003. On both occasions, it spent a few weeks in the area, though no forested areas 
were visited and no ticks were observed at the time. The dog also visited the Ardennes region in 
Southern Belgium on four occasions during weekend trips in autumn (November). After the end 
of 2004, the dog had not left the North of Belgium. At home, this dog has access to the back 
garden and to the local forested countryside in West Flanders.  
In the summer of 2008, before the positive blood sample was taken, the owners removed a 
small red tick from the dog, at home in the garden.  Apart from a small crust at the attachment 
site, the animal remained asymptomatic following the tick bite. Another tick was observed during 
the summer of 2009, after the diagnostic blood samples included in our study were taken. None 
of the family members in this household ever showed clinical signs compatible with tick-borne 
encephalitis.  
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  DISCUSSION III.5
Our sample of the Belgian canine population has to be considered as a convenience sample. 
The sera came from all provinces in Northern and Southern Belgium, though they were mainly 
obtained from four of the ten provinces (Figure III-1). Furthermore, the serum samples were 
taken either to diagnose illness, to monitor treatment or as pre-anesthetic screening. Therefore, 
they may not necessarily be representative of the entire canine population in Belgium. 
Nonetheless, the available sample was of sufficient size to adapt the ELISA kit and to detect a 
design seroprevalence of 0.35% with a confidence level of 95% (n= 855 needed). 
In the case of TBEV testing, all samples found positive or borderline by ELISA need to be 
confirmed with a reference test such as SNT, since non-specific reactions as well as cross-
reactions of TBEV antibodies with other flavivirus antibodies have been described. The same 
applies for LIV and our results confirm this, as several false positive samples were observed for 
TBEV and likely also one for LIV, despite adequate sample preparation.  It was also clear that the 
canine cut- off of this ELISA kit needs further evaluation, in order to improve sensitivity and to 
avoid false negatives. 
In humans, cross reactions often occur with Yellow Fever virus, Dengue virus and West Nile 
virus antibodies (Holzmann, 2003). A cross-reaction between anti-TBEV and anti-WNV 
antibodies was observed in a dog in the Czech Republic (Klimeš et al., 2001).  Therefore, we 
included WNV as a differential diagnosis for ELISA-positive/borderline but SNT-negative 
samples.  
TBEV is phylogenetically very closely related to LIV and both viruses share I. ricinus as 
vector. LIV can cause sheep or goat encephalitis and has so far been reported in Scotland, Wales, 
England, Ireland, Norway, Denmark, Spain, Greece, Turkey and Bulgaria (Dobler, 2010; Grard et 
al., 2007; Gritsun et al., 2003a). Although few cases have been reported, LIV can occasionally 
cause encephalitis much like TBE in dogs and humans (Dobler, 2010). The dog that tested 
positive for LIV-HIT and negative for TBEV-SNT and WNV-SNT, was lost to follow-up and 
since LIV-SNT was not available, a final conclusion with respect to LIV could not be made.  The 
travel and vaccination history of this animal might have shed some light on the high titre obtained 
despite the standard sample preparation described above.  
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 Other flaviviruses than the ones we considered, are either not known to infect dogs, or only 
occur outside Europe, or depend on maintenance hosts and/or vectors currently not present in 
Belgium. It concerns viruses of the TBEV-serocomplex, (i.e. the mammalian group of tick-borne 
flaviviruses: Langat virus, Powassan virus, Kyasanur forest disease virus, Omsk haemorrhagic 
fever virus, Royal Farm virus, Karshi virus, Gadgets Gully virus and Alkhumra virus), as well as 
Dengue virus and Yellow fever virus (Dobler, 2010; Grard et al., 2007; Gritsun et al., 2003a; 
Gubler et al., 2007). These flaviviruses were considered irrelevant for our differential list/panel.  
The TBEV seropositive dog’s history revealed international travel and tick exposure, though 
these factors did not seem to occur simultaneously.  The specific areas visited in Germany and 
France are not currently listed as endemic areas, though in both cases endemic areas are nearby 
(ISW-TBE and Baxter, 2009; RKI, 2003) and the visits took place during the tick season (Heinz, 
2008). Belgium is currently considered to be non-endemic for TBEV (Donoso Mantke et al., 
2008a), and since the visits to Southern Belgium occurred at the very end of the tick season 
(November)(Heinz, 2008), it seems less likely that the infection would have occurred there. As 
the dog had never been offered unpasteurized food items, the oral route of infection can be 
excluded.  
According to the history of this dog, two possible sources of infection with TBEV can be 
considered. The dog could have become infected by an unnoticed tick during its travels in 
Europe, 5 to 7 years ago. Alternatively, it may have been infected from 2005 onwards, much 
closer to or even at home in West Flanders, where ticks were actually observed on the animal 
during the last two summers. The fipronil administration she received once a year in June is 
severely inadequate to ensure continuous tick protection throughout the whole tick season.  
According to the available literature “TBEV seroneutralizing antibodies provide a lifelong 
protection” in both humans (Mickiene et al., 2002) and dogs (Bjöersdorff, 2002) and because the 
dog had traveled near to endemic areas, a travel-related infection seems plausible. However, 
according to (Leschnik et al., 2002), canine anti-TBEV-IgG are detectable in serum until “up to 9 
months post infection”, so it is possible that we detected an ELISA-borderline and RFFIT- 
positive animal, that was infected  recently (Summer 2008) at home in Belgium. In both 
scenarios, further surveillance is strongly recommended as an early warning system for possible 
future emergence or incursions of TBEV in Belgium.   
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In view of these findings, it would be prudent to further validate and standardize an ELISA 
test for estimating prevalence of infection or exposure to TBEV in several species. Such a test 
would be needed to enable a data-based risk analysis for TBE in Belgium. Continued serological 
screening of TBEV in dogs and other domestic and wild sentinel species in all Belgian provinces 
is therefore advisable to gain more insight into the current situation. Such targeted veterinary 
serological screening of sentinel animals could contribute in a cost-effective way to a continuous 
public health epidemiosurveillance program for TBE(V) (Roelandt et al., 2010), in parallel with 
ongoing Belgian initiatives to improve epidemiosurveillance of vector-borne emerging threats to 
public health (Bottieau et al., 2009; Lizroth and Quoilin, 2009). 
 CONCLUSIONIII.6
During the first serological screening for TBEV in Belgian sentinel dogs, a TBEV-
seropositive dog was discovered. A commercial ELISA test was adapted for use in dogs and was 
followed by a confirmation SNT-test. Belgium is traditionally considered as non-endemic for this 
emerging vector-borne flavivirus. The seropositive dog had traveled to areas near to known 
endemic areas in 2001-2004. However, ticks were only observed on the dog in the period from 
2005 onwards, when it stayed in at home in Northern Belgium. The animal has been 
asymptomatic throughout. Neither a travel-related infection nor the emergence of an 
autochthonous endemic focus can be excluded with certainty. Therefore, it is recommended to 
continue the screening of sentinel animals in Belgium to determine whether this dog is an 
isolated “case” in veterinary travel medicine, or whether it represents an early warning of 
emergence.
Results : Cattle 
67 
 SEROLOGICAL SENTINEL CHAPTER IV 
SURVEY IN BELGIAN CATTLE 
Adapted from: Sophie Roelandt, Vanessa suin, Flavien Riocreux, Sophie Lamoral, Sara Van 
der Heyden, Yves Van der Stede, Bénédicte Lambrecht, Brigitte Caij, Bernard Brochier, Stefan 
Roels, and Steven Van Gucht. 
AUTOCHTHONOUS TICK-BORNE ENCEPHALITIS VIRUS  
(TBEV)-SERO-POSITIVE CATTLE IN BELGIUM: 
A RISK-BASED TARGETED SEROLOGICAL SURVEY. 
Vector-borne and Zoonotic Diseases 2014; 14(9): 640-7. 
Mary Ann Liebert, Inc. Publishers.  
http://www.liebertpub.com/overview/vector-borne-and-zoonotic-diseases/67/   
 
And adapted from: Sophie Roelandt, Flavien Riocreux, Sara Van der Heyden, Ann-Brigitte 
Caij, Bénédicte Lambrecht, Stefan Roels, Yves Van der Stede;  
Vanessa Suin, Sophie Lamoral, Bernard Brochier, Steven Van Gucht 
TYPE II EVALUATION OF COMMERCIAL DIAGNOSTIC REAGENTS: USE OF 
RFFIT (SNT) AND FSME “All Species” - ANTIBODY ELISA® DURING A RISK-BASED 
SCREENING FOR TICK-BORNE ENCEPHALITIS (TBE) AB IN BOVINE SERA 
Report submitted to FAVV-AFSCA-FASFC on 13/09/2013 
 
 
Acknowledgements: This work was made possible through the use of “winterscreening” bovine serum samples, 
generously granted by the FASFC (FAVV-AFSCA): the Belgian Federal Agency for the Safety of the Food Chain. 
Primary antibody against TBEV glycoprotein E used for the TBEV SNT was kindly provided by Dr. Mathias 
Niedrig, Robert Koch Institute, Germany. The national reference centre of TBEV is partially supported by the 
Belgian Ministry of Social Affairs through a fund from the Health Insurance System. The development of the mouse 
infection model was funded by the Interuniversity Attraction Poles Programme initiated by BELSPO: the Belgian 
Science Policy Office. 
Results : Cattle 
68 
 ABSTRACTIV.1
The risk of TBEV-introduction into Belgium remains high and the presence of infected 
wildlife in Belgium is suspected. Domestic animals can serve as excellent sentinels for TBEV-
surveillance in order to install an early warning surveillance component for this emerging 
zoonotic disease of public health importance. In a targeted, risk-based and cross-sectional 
sampling design, serological screening was performed on Belgian cattle (n=650), selected from 
the 2010 Belgian national cattle surveillance serum bank.  
All samples were subjected to a gold standard TBEV seroneutralisation test (SNT), based on 
the rapid fluorescent focus inhibition test (RFFIT) protocol. Seventeen bovines were seropositive 
(titer >1/15) and six had borderline results (1/10 < titer < 1/15). The accuracy of the SNT was 
confirmed in a mouse inoculation test. The overall bovine TBEV-seroprevalence in the targeted 
area was estimated between 2.61 and 4.29%. This confirms the presence of infected foci in 
Belgium for the first time. Further surveillance in cattle, other sentinels, ticks and humans at risk 
is recommended to further determine the location and size of endemic foci and the risk for public 
health.  
The IgG protocol of the Progen ELISA® seemed to have an extremely low relative DSe in 
cattle, combined with a fairly reasonable relative DSp. The precision, predictive values, Cohen’s 
kappa and Youden index also followed the same trends, indicating an overall low capacity of this 
test/protocol to distinguish and correctly classify TBEV seropositive and negative cattle. When 
inspecting the cattle ROC curves (AUC=54%), we felt that no great improvement could be made 
to this particular protocol by changing the cut-off in this species. A calculated cut-off (c = μneg + 
2*SDneg) would still have led to a large amount of miss-classification. 
 INTRODUCTIONIV.2
Western subtype tick-borne encephalitis virus (TBEV), transmitted by Ixodes ricinus ticks 
and occasionally by unpasteurized ruminant milk, is currently the most important arthropod-
borne viral infection in humans in Europe (Caini et al., 2012; ECDC, 2012; Herpe et al., 2007; 
Holzmann et al., 2009; Hudopisk et al., 2013; Ramelow et al., 1993). About one third of humans 
infected with TBEV develop neuro-invasive disease, characterized by fever and neurological 
signs, ranging from meningitis to severe encephalitis with or without myelitis (Haglund and 
Günther, 2003; Kaiser, 2008a).  
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These patients need hospitalisation and approximately 35-58% develop permanent sequelae 
(“post-encephalitic syndrome”) (Haglund et al., 1996; Kaiser, 2008a). Despite low mortality rates 
of 0-3.9% (Donoso Mantke et al., 2008a; Süss, 2008a), Western subtype TBEV represents a risk 
for public health and food safety (Baumhackl, 2009; Haglund, 2002). TBE is of growing concern 
in several European countries (Süss et al., 1997) and about 3,000 people are hospitalized yearly 
(Haglund, 2002). Recently, human incidence has increased in several endemic countries (Süss, 
2008a) and TBE seems to emerge in Northern/Western Europe (Donoso Mantke et al., 2008a).   
TBEV seropositivity has been observed in many domestic and wild animals (Bjöersdorff, 
2002; Rieger et al., 1999). Vertebrate host (sero)prevalence can be much higher than in local tick 
or human populations and may correlate better to the true TBEV endemicity of an area (Leschnik 
et al., 2002; Merino et al., 2000; Rieger et al., 1999; Süss, 2008a). Therefore, veterinary sentinel 
screening remains a valuable tool in identifying and characterizing endemic foci. TBEV-infected 
ruminants usually remain asymptomatic, but can transmit live virus in unpasteurized milk 
products such as cheese (Balogh et al., 2012; Kriz et al., 2009). Bovines have proved to be useful 
sentinels (Bjöersdorff, 2002; Leschnik et al., 2002). TBE is also emerging among Europe’s 
canine population: its distribution and clinical incidence is increasing in Western Europe in 
parallel with human TBE (Beugnet and Marie, 2009; Leschnik et al., 2002; Pfeffer and Dobler, 
2011). European canine TBE cases and screening studies were recently summarized by Pfeffer 
and Dobler (2011), while cases in European horses were summarized by Müller et al. (2006). 
Though these veterinary cases remain relatively rare, they are often severe with fatal outcome 
(Müller et al., 2006; Pfeffer and Dobler, 2011).  
In Belgium, TBE is still considered an exotic disease (Donoso Mantke et al., 2008a; Süss, 
2008a) and until recently, medical and veterinary TBEV surveillance was minimal (Roelandt et 
al., 2011; Roelandt et al., 2010). However, in 2010 a seropositive dog was detected in Belgium, 
though the exact origin of the infection (autochthonous or travel-related) could not be traced 
(Roelandt et al., 2011). Also in 2010, a National Reference Centre (NRC, WIV-ISP, Brussels, 
Belgium) was established to confirm the diagnosis of TBE in humans. Until now, one imported 
case of human TBE was diagnosed in a Belgian unvaccinated tourist returning from Austria 
(Brochier, personal communication, 2012). Two roe deer from south Belgium were found to be 
seropositive, once again indicating the possible existence of endemic foci within Belgium 
(Linden et al., 2012).  
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The aims of this study were to screen the Belgian cattle population for the presence of 
TBEV-specific seroneutralising antibodies. This screening was conducted following a risk-based 
cross-sectional design, in order to detect endemic areas in a targeted area of Belgium. 
 METHODSIV.3
 SAMPLING AND STUDY POPULATIONIV.3.1
In order to screen the Belgian cattle population, a study population was defined and a subset
of samples was selected. The serum samples of the “TBE Targeted Population” (TBE-TP) 
originated from the yearly infectious disease screening (winter-)campaign for Belgian cattle 
(sampling frame), edition 2010. This population is assumed to be grazing cattle, since almost all 
Belgian cattle have outdoor access, particularly in summer. Sera were obtained by local 
veterinary surgeons between 01/01/2010 and 29/02/2010, a period when cattle are often stabled 
for winter, and submitted to regional laboratories for diagnostic testing. Samples were 
centrifuged and stored at 4°C at these laboratories. The selected samples were centralised by 
CODA-CERVA and stored at -20°C in the serum bank until TBEV testing. 
The targeted geographical area was selected in a risk-based approach in order to maximize 
the probability of detection of any low prevalence endemic foci in a predefined “risk zone”. Since 
TBEV displays westward expansion and is already present in known or recently emerging areas 
in neighbouring Germany and France: Figure IV-1 (Baxter, 2013), we selected the three most 
eastern Belgian provinces (Luxembourg, Liège, Limburg, Brabant Wallonne). Within each 
province, we prioritized all serum samples with postal codes closest to the national borders.  
These provinces are currently also known as endemic for Lyme disease (Borrelia 
burgdorferi): Figure IV-2 (WIV-ISP, 2011), another vector-borne zoonotic disease transmitted by 
(often co-infected) I. ricinus ticks. In general, the most prominent clusters of both diseases 
largely correspond to each other, though the presence of TBEV seems mostly confined to a 
smaller subset of Lyme disease locations (Heinz, 2008; Süss, 2003; Zeman, 1997).  
The age cohort selection was equally risk-based. Most samples (>90%) came from older 
cattle (>2 years), as this age category is expected to have higher titers of TBEV-specific 
antibodies. Indeed, older animals have spent more time on pasture and have experienced repeated 
tick infestation (Juceviciene et al., 2005; Sîkutova et al., 2009).  
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Consequentially, TBEV exposure and transmission probabilities also increase with age, 
resulting in higher rates of seropositivity in older animals (Juceviciene et al., 2005; Sîkutova et 
al., 2009). Upon detection of positive samples, additional animals from the positive herds (if 
available) were tested to further substantiate or refute the presence of potential endemic foci. This 
approach resulted in a total selection of n=650 cattle sera from 44 herds in Limburg, Liège and 
Luxembourg, i.e. TBE targeted population (TBE-TP; Figure IV-3).  
 
Figure IV-1: TBEV endemic areas in the vicinity of Belgium. 
Detail of FSME-Verbreitungsgebiete in Europa. Stand: mai 2013 – Baxter,2013 (www.zecken.de). Red areas: known 
TBEV-endemic areas – Orange areas: areas with single TBE cases 
 
 
Figure IV-2: Lyme disease incidence per arrondissement.  
Showing known endemic areas for Lyme disease (B. burgdorferi) in Belgium with estimates of human incidence per 
100.000 inhabitants;WIV-ISP, 2011. 
Results : Cattle 
72 
Figure IV-3: Geographical locations for the TBE targeted population (TBE-TP). 
Each blue dot represents a farm (n=44); the larger the dot, the more animals of the farm were tested. 
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 DIAGNOSTIC SEROLOGY ASSAYS IV.3.2
IV.3.2.1 TBE virus SNT and ELISA 
TBEV neutralising antibody titration in the cattle sera was performed with the SNT (rapid 
fluorescent focus inhibition - seroneutralisation test), which is considered a gold standard for 
TBE diagnosis in humans as well as in animals (Vene et al., 1998). Sera, including positive and 
negative controls, were diluted (1/9, 1/27, 1/81, 1/243) in 50μl Dulbecco’s Modified Eagle 
Medium (DMEM, Gibco, The Netherlands) and supplemented with 10% inactivated fetal calf 
serum (DMEM-FCS, Gibco, The Netherlands) in 96-well microplates. Virus (TBEV Neudoerfl 
reference strain - NCPV#848) was added at a dose of approximately 1.2 log 50% endpoint tissue 
culture infectious doses (1.2 log TCID50) to the wells containing the diluted sera (50μl/well).  
Back titration of the challenge virus was performed in each run. A run was accepted only if 
the back titration yielded a virus dose between 0.8 and 1.4 log TCID50. The virus and serum mix 
was allowed to incubate for 90 min at 37°C and 5% CO2. Following this, BHK-21 cells were 
added to each well (35-45 × 103 cells/100 μl/well). The cells were allowed to grow for 24 h at 
37°C and 5% CO2. Then, the culture medium was discarded and the wells were washed once with 
200 μl of cold PBS and once with 200 μl of cold 100% methanol. Plates were fixed with 100% 
methanol at 4°C for 30 min, after which the methanol was discarded and the plates were left to 
air-dry for 30 min at room temperature. Infected BHK-21 cells were detected by an indirect 
immunofluorescence staining, using a primary mouse monoclonal anti-glycoprotein E antibody 
(Niedrig et al., 1994) and a secondary Alexa fluor-conjugated goat anti-mouse IgG antibody 
(Molecular Probes). Primary and secondary antibodies were incubated at 37°C for 45 min. The 
plates were washed once with PBS-Tween 0.05% and twice with distilled water.  
The number of foci with infected cells was counted under the fluorescence microscope. The 
SN titer was defined as the dilution of test serum that neutralized 50% of the virus (DIL50), 
calculated according to the Reed & Muench method (Reed and Muench, 1938). A DIL50 <1/10 
was considered a negative result (absence of neutralizing antibodies). A DIL50 between 1/10 and 
1/15 was considered doubtful and a DIL50 >1/15 was considered positive. These cut-offs were 
previously selected by the TBE-NRC in the frame of the experience obtained with diagnosis in 
humans. 
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The Immunozym FSME/TBE IgG/IgM All Species-ELISA® (ELISA) (Progen Biotechnik 
GmbH, Heidelberg, Germany) was used previously by CODA-CERVA for the screening of 
Belgian dog sera. This non-competitive indirect assay uses horseradish peroxidase – Protein G 
conjugate to detect IgG and/or IgM against whole TBE-virus.  
The kit can theoretically be used for TBEV testing in all species, including humans. In 
humans, this ELISA has a diagnostic sensitivity of 97% and analytical specificity of 99% for IgG 
(Progen Biotechnik GmbH, 2006). This ELISA also includes a borderline zone, for samples with 
IgG VIEU Units/Liter between 63 and 120.  
In their studies, Klaus et al. (Klaus et al., 2011) used the Immunozym All-species FSME 
IgM kit in an adapted version (Müller, 1997) due to the claimed higher sensitivity of the 
IgG+IgM protocol, since it should additionally detect early infections. The maufacturer’s IgM 
protocol and the IgM+IgG protocol of Klaus et al (2011) were trialled too. 
IV.3.2.2 Rabies virus SNT 
The possible presence of aspecific inhibitors of virus infectivity, such as complement or 
nonspecific contaminants, was evaluated by testing the positive sera in a rabies virus SNT, 
performed at the Belgian NRC of Rabies (WIV-ISP). Since Belgium has been officially rabies-
free Belgium since 2001 (OIE, 2016; Van Gucht and Le Roux, 2008) besides one single imported 
cases in companion animals (FLI, 2015; Vaillant and teams, 2008). The surrounding countries 
have the same status (CDC, 2015), and since cattle are not vaccinated in Belgium, autochthonous 
bovine sera should not contain antibodies against rabies virus. 
The principle of the rabies RFFIT-SNT is the in vitro neutralisation of 100 TCID50 of rabies 
virus (CVS-11 strain: ATCC-VR959), by 4 serum dilutions (1/9, 1/27, 1/81, 1/243), in BHK-21 
cells (OIE, 2013). Infected cells are detected by indirect immunofluorescent antibody staining, 
using a mouse anti-rabies monoclonal antibody coupled to FITC (FDI Fujibio Diagnostics). The 
titer is expressed in international units (IU)/ml (WHO standard)(Reed and Muench, 1938). 
Samples with a titer >0.5 IU/ml are considered positive. 
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IV.3.2.3 West Nile virus ELISA and SNT 
Potential flavivirus cross-reactions with West Nile Virus antibodies were evaluated by WNV-
SNT and WNV-ELISA (performed at CODA-CERVA). For the WNV-SNT, 5-fold serum 
dilutions were incubated in a 96-well plate with 100 TCID50 of WNV (IS-98 STD1 strain, 
Genbank accession no: AF481864) for 1-1.5 hours at 37°C.  
After one hour, Vero cells (CCL-81, ATCC, Molsheim, France) diluted to 1/20 were added 
to each well, corresponding to a seeding density per well of approximately 1.5×103 cells/cm². 
The plate was incubated for 3 days at 37°C with 5% CO2. The cytopathic effect of grown virus 
was read by microscopy.  
A commercially available inhibition ELISA kit (ID Screen West Nile Competition, IDVet®, 
Montpellier, France) was used to detect anti-WNV antibodies, by noting the extent of O.D. 
(optical density) reduction as compared to the negative control sample (N). The manufacturer’s 
instructions were followed: sera were diluted 1/2, and optical densities (O.D.) were read at 
450nm (S). For each plate, positive and negative (N) controls were included in order to allow the 
ELISA validation and calculation of S/N ratio for each sample (S). Sera with O.D. reduction 
resulting in an S/N≤40 were positive, sera with S/N>50 were negative, and those having an S/N 
between 40 and 50 were classified as doubtful. 
IV.3.2.4 Confirmatory mouse inoculation test (MIT) 
A mouse inoculation test (MIT) was set up in order to confirm the presence of TBEV-
specific neutralising antibodies in seropositive cattle. An intranasal inoculation model was 
developed in analogy with the model developed for rabies virus (Rosseels et al., 2011) and was 
approved by the local ethical committee of WIV-ISP (advice nr. 070130-01).  
Female Swiss outbred mice (Harlan®, The Netherlands) were used at the age of 6-8 weeks. 
Four groups of mice (n=30) were inoculated intranasally with TBEV only (Group 1: 102.5 
TCID50), a combination of TBEV and one single negative bovine serum (Group 2: DIL50 neg), a 
combination of TBEV and one single positive bovine serum (Group 3: DIL50:18-23-30) or a 
combination of TBEV and one single positive human serum, obtained from a vaccinated donor 
(Group 4: DIL50 >243).  
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Virus and serum were pre-incubated for 30 min. at 37°C, prior to intranasal inoculation. 
Each mouse was treated with the serum derived from one animal or person. The mice were 
observed daily for general and/or neurological signs, throughout the experiment until 28 days 
after inoculation. Scores ranged from 0 (no disease) to 7 (severe nervous disease). Symptomatic 
mice were euthanized by cervical dislocation when they reached a disease score ≥6.  
TBEV infection in the brain was verified by qRT-PCR (Schwaiger and Cassinotti, 2003) and 
virus-induced lesions were examined by histopathology. Brain samples were fixed in 10% neutral 
buffered formalin, embedded in paraffin wax, sectioned at 4μm and stained with haematoxylin 
and eosin (HE) according to standard light microscopy protocols.  
 STATISTICAL ANALYSISIV.3.3
Sample size calculations for the purpose of disease detection and freedom substantiation
calculations were performed in Survey Toolbox®. The sample size that was available (n=650), 
 was afterwards deemed sufficient for the purpose of detecting a seroprevalence of 0.55% with a 
confidence level of 95% (required: n=544), and assuming 100% diagnostic accuracy for SNT. 
Seroprevalences were calculated with 95% Wald confidence intervals (95%CI). 
For the MIT, Kaplan-Meyer survival curves and log-rank tests were performed in GraphPad 
Prism6®; p<0.05 was considered statically significant. Maps were created in ArcGIS®, using the 
farmers’ addresses/postal codes and the Belgian Lambert 1972 EPSG projection.  
Test precision is defined by repeatability and reproducibility coefficients of variation, 
measuring intra-plate variation (CVrepe) and the inter-plate variation (CVrepro) of samples. The 
Common CVrepro calculates the overall variation, for all samples over all plates together. 
Commonly used precision criteria are CVrepe ≤ 10% (15%) and CVrepro ≤ 15% (20%) and the 
values can be calculated on raw OD (optical density) or on calculated (VIEU: Vienna units/Liter)  
values. 
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 RESULTS IV.4
 DIAGNOSTIC SEROLOGY IV.4.1
Based on SNT results and using the more specific cut-off (≥1/15 DIL50), a total of 17 cattle 
(2.6% [95%CI: 1.4–3.8%]) were classified TBEV-seropositive. Additionally, 6 bovines had 
borderline results (1/10 < titer DIL50 < 1/15), which adds another 0.9% (95%CI: 0.2-1.7%) of 
animals with suspicious results.  
The TBEV-seropositive and -doubtful sera showed no neutralisation of rabies virus (rabies 
virus-SNT titer <0.5 IU/ml), excluding the presence of aspecific inhibitors of virus infectivity. 
One TBEV-seropositive serum showed positive inhibition in the WNV-SNT (titer 1/15), whereas 
none of these samples showed a positive result in WNV-ELISA. However, the SNT-reactor 
sample was of bad quality by the time of WNV testing, which may have influenced the outcome 
of the WNV-SNT. Besides this one inconclusive contaminated sample, all other TBEV-
seropositive samples were negative for WNV-specific antibodies. Available information on the 
TBEV-seropositive and -borderline animals was traced in the national cattle database.  
Most bovines (n=20) were localized in Wallonia and 3 came from Flanders (Figure IV-4). All 
23 animals were autochthonous (not imported), originated from 10 different herds and most were 
female beef cattle older than 2 years. Borderline reactors (orange) were often found in herds 
already containing seropositive animals (red)(Figure IV-4). 
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Figure IV-4: Distribution of RFFIT-SNT seropositive and doubtful bovine cases. 
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 CONFIRMATORY MOUSE INOCULATION TEST (MIT) IV.4.2
In the untreated mice (Groups 1-2), TBEV caused an acute lethal infection in the brain. 
General and neurological disease signs (rough hair coat, conjunctivitis, hunched back, isolation 
from the group, slowness, weakness, incoordination of movements, paralysis of the hind legs) 
started at 8 days post inoculation and mice needed to be euthanized due to severe neurological 
disease between 8-10 days post inoculation (100% mortality, median survival time 10 days).  
Treatment with TBEV-seropositive sera with increasing SNT-titers (Groups 3-4: bovine or 
human) resulted in a delayed onset of neurological signs and a significant increase of the median 
survival time (Group3: 18 DIL50) (p<0.05, Log-Rank test, Graph Pad Prism6®), or complete 
protection against disease (Groups 3-4: DIL50: 23-243). There was a positive and statistically 
significant association (p<0.05) between the seroneutralising antibody titers and the median 
survival time in the MIT. For sera with a titer of 0, 18 or ≥23 DIL50, median survival times were 
respectively 8.5, 11.5 and >28 days (Figure IV-5). 
 
Figure IV-5: Kaplan-Meier survival curves: Neutralisation of TBEV in a mouse inoculation model. 
IN: intranasal; DIL50 : 50% endpoint dilution titer; Median survival times were significantly prolonged in the groups 
treated with positive bovine sera of 18-30 DIL50 (p<0.05, Log-Rank test). 
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Histopathologic examination of the brains collected from the SPF mice, revealed no TBEV 
or virus-specific lesions were detected in the brains of non-diseased survivor mice (Groups 3-4: 
DIL50: 23-243). A focal non-specific gliosis (Figure VI-6a) was observed both in the control 
animals as well as in the human and bovine serum-treated animals, but more so in the controls. 
The non-treated (control mice) brains were further characterized by moderate to marked non-
suppurative meningo-encephalitis with mononuclear cell infiltration in the leptomeninges, 
multifocal (peri-)vasculitis, focal gliosis, and necrosis in the cerebral parenchyma (Figure IV-6b). 
This is compatible with a classical viral meningo-encephalitis, as described also for natural 
TBEV-infection. TBE-virus (qRT-PCR) and clear virus-induced histopathological lesions were 
detected only in the brains of all TBEV-infected control mice upon euthanasia (Groups 1-3: 
DIL50: neg-18).  
Figure IV-6: Histopathological findings after Mouse Inoculation Test. 
a: Gliosis and (peri-)vasculitis in the cerebrum of TBE infected non-treated  mice;  
b: Non-suppurative meningo-encefalitis in TBE infected non-treated mice. 
 EVALUATION OF PROGEN ELISAIV.4.3
First, we present the cross-classified binary test results for all samples in Table VI-1. Both
tests include a zone in which results are considered to be “borderline” (syn. non-interpretable, 
doubtful, grey zone). Samples with SNT titers between 1/10 and 1/15 were considered borderline, 
whereas for the ELISA it concerned samples with IgG VIEU units/ml between 63 and 126. 
Using SNT results as gold standard results, a total of 17 cattle were found to be TBEV-
seropositive by SNT, and a further 6 cattle had borderline SNT results (Table IV-1). 
a b 
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Table IV-1: Cross-classified test results for Complete selection of TBE screening population (n=650).  
IgG ELISA: FSME All Species ELISA IgG protocol; RFFIT: rapid fluorescent focus inhibition test; border(line): 
ELISA VIEU between 63 < x < 126 or RFFIT titer 1/10 < x < 1/15  
The calculated precision CV’s are represented in Tables IV-2. The classic accuracy parameters 
are summarized with 95% confidence intervals (Wald) in Table IV-3. The AUC from the ROC 
curves (data not shown) were approximately 54% for both SNT cut-offs.  
Table IV-2: IgG ELISA Repeatability. 
Variation per sample per plate; CVrepe = STDEV / AVG * 100;  Criterium: <15% 
Sample day 1  
OD 
day 1  
VIEU 
day 2  
OD 
day 2  
VIEU 
day 3  
OD 
day 3  
VIEU 
day 4  
OD 
day 4  
VIEU 
A10108-1436(B) 28.46% 16.63% 7.77% 7.11% 7.25% 11.62% 20.18% 19.08% 
A10108-1436 10.24% 6.32% 6.72% 6.16% 5.28% 8.94% 16.51% 15.57% 
212-192246(B) 20.08% 11.11% 6.79% 6.24% 4.43% 7.11% 1.19% 1.15% 
212-192246 14.52% 8.25% 4.85% 4.44% 5.03% 8.11% 10.41% 9.93% 
SF / / 7.13% 6.53% 3.14% 5.30% / / 
Table IV-2: ELISA Repeatability.  
CVrepe: repeatability coefficient of variation; STDEV: standard deviation; AVG: mean; OD: optical density; VIEU: 
Vienna Units/Liter; Red values: failing criterion. 
 
Table IV-3: IgG ELISA Reproducibility.   
Variation per sample over all plates. 
Sample CV-OD CV-VIEU 
A10108-1436(B) 26.21% 28.16% 
A10108-1436 26.51% 32.50% 
212-192246(B) 10.89% 26.05% 
212-192246 3.45% 23.42% 
FS Foetal Serum 4.90% 32.94% 
COMMON REPRO 18.59% 30.45% 
Table IV-3: ELISA Reproducibility.   
Within plate variation for 5 fetal calf sera in ELISA; CVrepro: reproducibility coefficient of variation, CV repro = 
STDEV / AVG * 100 and Criterium: <20%; STDEV: standard deviation; AVG: mean; OD: optical density; VIEU: 
Vienna Units/Liter; Red values: failing criterion. 
 
Table IV-1: Complete selection TBE-TP. 
 
IgG ELISA 
SNT 
pos border neg Total 
pos 1 0 15 16 
border 2 0 52 54 
neg 14 6 560 580 
Total 17 6 627 650 
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Table IV-4: IgG ELISA Accuracy Characteristics 
Scenario Parameter Estimate 95% Confidence Interval 
Lower limit Upper limit 
Border = pos: 
ELISA vieu >63 
SNT > 1/10 
D Se 13.043% 0.000% 26.807% 
D Sp 89.314% 86.896% 91.732% 
PPV 4.286% 0.000% 9.030% 
NPV 96.552% 95.067% 98.037% 
Youden 0.024 -0.116 0.163 
Kappa 0.012 -0.053 0.033 
App Prev 10.769% 8.386% 13.152% 
True Prev 4.286% 2.118% 4.959% 
Border = neg: 
ELISA vieu >120 
SNT > 1/15 
D Se 5.882% 0.000% 17.068% 
D Sp 97.630% 96.445% 98.815% 
PPV 6.250% 0.000% 18.111% 
NPV 97.476% 96.255% 98.697% 
Youden 0.035 -0.077 0.148 
Kappa 0.036 -0.041 0.113 
App Prev 2.462% 1.270% 3.653% 
True Prev 2.615% 1.388% 3.842% 
Border = mix:  
ELISA vieu >63 
SNT > 1/15 
D Se 17.647% 0.000% 20.578% 
D Sp 89.415% 87.019% 91.812% 
PPV 4.286% 0.000% 9.030% 
NPV 97.586% 96.337% 98.835% 
Youden 0.071 -0.112 0.253 
Kappa 0.028 -0.031 0.087 
App Prev 10.769% 8.386% 13.152% 
True Prev 2.615% 1.388% 3.842% 
Table IV-4: IgG ELISA Accuracy Characteristics. 
Calculated results for parameters of interest under three different borderline scenarios. IgG ELISA: FSME All 
Species ELISA IgG protocol; SNT: rapid fluorescent focus inhibition test; possible cut-offs  ELISA:  VIEU 63 - VIEU 
126 ; possible cut-offs SNT: titer 1/10 - titer 1/15; D Se: diagnostic sensitivity; D Sp: diagnostic specificity; PPV: 
positive predictive value; NPV: negative predictive value; Youden: youden index = D Se + D Sp – 1; Kappa: 
coefficient of test agreement; app prev: apparent prevalence; true prev: true prevalence. 
The IgM+IgG protocol (veterinary units U/L) was also tested with a subset of our cattle sera 
(n=20 SNT positives/doubtfuls and n=23 negatives). Bearing in mind the low number of 
available cattle positives, this did not seem to result in improved sensitivity when compared to 
the SNT: DSe 15% – DSp: 100%). Only 3 samples of this small positive panel showed any 
IgG+IgM reaction (>5 U/L). When tested inthe regular IgM protocol after kaolin treatment, 12 
SNT- positive and 6 SNT-borderline samples all remained negative in the IgM protocol (<40 
VIEU/ml).   
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 DISCUSSION IV.5
 ELISA ACCURACY AND PRECISION IV.5.1
Regardless of the borderline/cut-off scenario used, the IgG protocol of the FSME All Species 
ELISA®, when used with the kit calibrator samples (human origin), seems to have an extremely 
low relative DSe in cattle, combined with a fairly reasonable relative DSp. The predictive values 
and Youden index also follow the same trends, indicating an overall low capacity of this 
test/protocol to distinguish and correctly classify TBEV seropositive and negative cattle (as 
opposed to results in other species). Cohen’s Kappa (Landis and Koch, 1977) equally indicates 
very poor agreement and high discordance between the IgG ELISA and the SNT results.  
The IgM protocols did not improve this at all, thereby supporting our initial hypothesis that 
IgG-testing for previous exposure is potentially more likely to have a higher overall sensitivity in 
field studies, at the inevitable cost of some false positives. 
When evaluating the ELISA precision, we observe that the fetal calf sera show considerable 
variation, both in OD and VIEU calculations values. This variation is larger than the amount that 
would be allowed in official disease surveillance and control programs, even with relaxed criteria 
(15% and 20%). 
This ELISA test was intended as a sensitive screening test in multiple species, however it 
was until now mostly validated in humans and dogs. We remarked previously that the cut-off for 
the IgG protocol could possibly be lowered to evaluate canine sera (Roelandt et al., 2010). 
However, when inspecting the cattle ROC curves (AUC=54-59%; Figure IV-7), we felt that no 
great improvement could be made to this particular protocol by changing the cut-off, since the 
total area under the curve is very close to 50%. In order to reach a DSe of 88%, one would have 
to accept a DSp of 16%, which might only work in a very low prevalence setting.  
A calculated cut-off, based on negative animals is another option: c = μneg + 2*SDneg. 
However, with μneg= 38.90 and SDneg= 29.58, then c = 98 VIEU. When we use the fetal calf 
serum results as an alternative negative group, μneg= 11.427 and SDneg = 3.480, and in this case 
c = 18.387 VIEU. These calculated cut-offs, though quite different, would both still have led to a 
large amount of miss-classification, since the distributions of the SNT-positive and SNT-negative 
cattle greatly overlap, as illustrated in Figure IV-8 (purple and yellow lines). It is questionable 
whether a larger sample size would change this. 
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Figure IV-7: ROC curve for IgG ELISA with SNT borderlines counted as positive. 
Figure IV-8: Possible ELISA cut-offs in relation with cattle test results.  
Green: manufacturer’s cut-off ; Purple: neg. cattle cut-off; Yellow: Fetal calf serum cut-off 
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 INTERPRETATION OF SNT RESULTS IV.5.2
In analogy to human TBE diagnostics (Holzmann, 2003; Rendi-Wagner, 2004), 
seroneutralisation tests are the gold standard for serology in animals, since they are highly 
specific and not affected by cross-reactive antibodies against other flaviviruses (Klimeš et al., 
2001; Leschnik et al., 2002; Reiner and Fischer, 1998; Vene et al., 1998). By SNT testing, a 
TBEV-seroprevalence of 2.6-3.5% was demonstrated in autochthonous Belgian cattle in the 
targeted risk zone in 2010. This is an important finding, since Belgium was until now considered 
to be TBEV-free.  
The specificity of the SNT results was confirmed by the absence of reactivity against other 
viruses (rabies or West Nile) in SNT- or ELISA-tests and by the protection provided by the 
TBEV-seropositive bovine sera in the mouse inoculation test (MIT), which was SNT-titer 
dependent. The WNV inhibition in one contaminated sample might have been due to an 
unspecific contamination of that particular serum. 
The relatively older age profile of the reactor cattle corresponds with the targeted sampling 
design, but also with data in the literature: older animals are expected to show higher rates of 
seropositivity due to prolonged tick and TBEV exposure while grazing on pasture (Juceviciene et 
al., 2005; Sîkutova et al., 2009). Additionally, Juceviciene et al. (2005) comment that 
seroprevalence and titers in cattle may fluctuate with the (tick) season and that values are lowest 
in winter. Consequently, summer TBEV-seroprevalence in cattle from the targeted areas may be 
higher than what could be concluded from these samples, obtained in winter.  
For any design prevalence (0.1-50%), the observed number of positive reactors (17 or 23 
depending on the cut-off) was always too high to substantiate freedom of TBEV for the targeted 
TBE-TP population (Survey Toolbox®, p-values>0.05). Thus, freedom can no longer be 
substantiated in the targeted Belgian provinces. However, the 2010 wintertime TBEV-
seroprevalence can reasonably be expected to be lower than 4.0% (if 17 reactors, p-value = 
0.009) or 5.0% (if 23 reactors, p-value <0.047).  
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In the available European literature, cattle TBEV-seroprevalence in known TBEV-endemic 
foci usually fluctuates around 2-3% (Cisak et al., 2010; Juceviciene et al., 2005; Sîkutova et al., 
2009) and can be as high as 36-91% in the most severely affected areas (Brummer-Korvenkontio 
et al., 1973; Ernek and Kozuch, 1970; Süss, 2008a). Based on this information, it appears that 
there is now evidence that south-east Belgium indeed contains TBEV-endemic foci.  
Up to October 2013, no locally acquired human case of TBE has been confirmed in Belgium. 
The number of human infections might indeed be low, but we cannot exclude some degree of 
underreporting or misdiagnosis of probable cases, due to the generally poor TBE-awareness in 
Belgian health care practitioners. In addition, about two thirds of human infections remain 
asymptomatic or induce only aspecific fever symptoms, which may easily go by undiagnosed in a 
low-prevalence country. 
As expected, we found some locations of TBEV-seropositive cattle (Figure IV-4) within 
known Belgian Lyme disease hot spots (Figure IV-4)(WIV-ISP, 2011), and where we would first 
expect TBEV-incursion from abroad due to vicinity to known endemic foci in the neighboring 
countries (Figure IV-1). These areas are also clearly suitable to support sylvatic virus circulation 
in local wildlife, due to favorable tick habitat, available hosts and climate (Roelandt et al., 2010). 
The prevalence of TBEV outside of the targeted areas remains to be studied. 
This study was based on a risk-based cross-sectional approach, in order to be able to detect 
TBEV - if present - in Belgium. Hence, sample selection was targeted and biased towards certain 
provinces (south-east) and municipalities (border) and towards cattle of an older age category. 
This design is also reflected in the fact that most of the seropositive cattle seem to be located in 
Wallonia. To obtain a more unbiased estimate of the true TBEV-seroprevalence in Belgian cattle 
and of local endemic foci, a future screening may follow a random stratified sampling with larger 
sample size. In Belgium, the yearly official cattle serology campaign remains an excellent source 
of such randomly selected samples and it would suffice to simply adapt the selection process to 
this end.  
Continued serological screening for TBEV in cattle, dogs and other domestic and wild 
sentinel species in all Belgian provinces is advisable, in order to gain more insight into the 
current situation and to better define the localization of endemic foci. Such a veterinary 
serosurveillance tool would contribute in a cost-effective way to target the TBEV surveillance 
program in humans and public health preventive actions. 
Results : Cattle 
87 
 CONCLUSION IV.6
In a risk-based cross-sectional approach, a seroprevalence of 2.6-3.5% was found in older 
cattle located in targeted Belgian provinces. Seropositive cattle were clustered in a few 
municipalities, demonstrating for the first time the presence of TBEV-infected foci in the targeted 
areas in south-east Belgium. 
The IgG protocol of the Progen ELISA® seemed to have an extremely low relative DSe in 
cattle, combined with a fairly reasonable relative DSp. The precision, predictive values, Cohen’s 
kappa and Youden index also followed the same trends, indicating an overall low capacity of this 
test/protocol to distinguish and correctly classify TBEV seropositive and negative cattle. When 
inspecting the cattle ROC curves (AUC=54%), we felt that no great improvement could be made 
to this particular protocol by changing the cut-off in this species. A calculated cut-off (c = μneg + 
2*SDneg) would both still have led to a large amount of miss-classification. 
In conclusion, Belgium should no longer be considered “free” of TBEV. Given the relevance 
of TBEV for the food chain through consumption of unpasteurized milk and cheese and through 
its considerable public health burden in other European countries, the finding of TBEV-
seropositive cattle in Belgium warrants further surveillance and follow-up, both by veterinary and 
public health officials and clinicians. 
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 ABSTRACTV.1
The risk of TBEV-introduction into Belgium remains high and the presence of seroconverted 
wildlife and domestic animals in Belgium has already been demonstrated in multiple studies. In 
the frame of a Flemish wildlife surveillance in 2013, a serological screening was performed on 
sera from Flemish wild boar (Sus scrofa; n=238) in order to detect TBEV-specific antibodies. 
These sera were taken in 2013 throughout the whole Flemish wild boar population range.  
All samples were subjected to gold standard TBEV seroneutralisation (SNT). Seven wild 
boar were seropositive and showed moderate to high SNT-titers - three had borderline results. 
Seroprevalence was estimated around 4.20% (95%CI: 1.65-6.75%). Other Flaviviridae (Classical 
Swine Fever, West Nile Fever, Louping Ill viruses) were ruled out and thirteen available tonsils 
tested negative in TBEV RT-PCR. 
The test characteristics of a commercially available TBEV-ELISA were assessed against the 
gold standard results. Using the manufacturer’s cut-offs and an alternately positive/negative 
interpretation of SNT-borderline results, the IgG protocol of this ELISA showed low diagnostic 
sensitivity and good diagnostic specificity (DSe: 40-57% and DSp: 91-92%). ELISA agreement 
with the SNT was judged “slight to fair”. ROC-analysis showed that for early detection screening 
purposes (with SNT follow-up), the ELISA cut-off might be placed as low as 35 Vienna-units: 
this would result in improved DSe (70-71%) at the cost of DSp (64.04-69.74%).  
This study showed the presence of TBEV-specific antibodies in wild boar and potential 
TBEV-foci in Flanders. Ongoing wild boar surveillance could serve as sentinel warning system 
for public/human health prevention. Additional active surveillance and direct testing are now 
recommended to attempt virus detection and to further determine the characteristics of endemic 
foci, while continued passive medical and veterinary surveillance is indicated to monitor the 
potential risk for Belgian public health.  
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 INTRODUCTION V.2
Tick-borne encephalitis remains a significant public health concern wherever Ixodid tick 
vectors are present: thousands of medical cases are reported annually throughout Eurasia. The 
Western/European subtype of TBEV first causes an influenza-like illness, followed in 30% of 
cases by serious neurological disease 4-10 days post-recovery. TBE may result in death or long-
term neurologic/neuropsychiatric sequelae (CDC, 2014b; ECDC, 2012; WHO, 2011, 2014a, b).  
Though veterinary cases remain relatively rare, they are often fatal (Müller et al., 2006; 
Pfeffer and Dobler, 2011). There exists an international consensus that veterinary surveillance 
(ECDC, 2012; Süss, 2011) may provide superior information on the true eco-epidemiological 
situation than medical TBEV-surveillance, especially in low prevalence areas (ECDC, 2012; 
Klaus et al., 2011; Klaus et al., 2010a; Süss, 2011).  
While small rodents are TBEV-reservoirs, larger wild/domestic mammalian hosts will 
support TBE-virus indirectly by amplifying ticks (ECDC, 2012; Gritsun et al., 2003b; Süss, 
2011). These hosts can be used as sentinels: TBEV-seropositivity was indeed observed in 
Eurasian wild boar (Sus scrofa) (Balling et al., 2014; Borcic et al., 1990; Cisak et al., 2012; 
Hubalek et al., 1993; Juricova, 1992; Kriz et al., 2014; Zeman and Januska, 1999). This 
seroprevalence may be higher than in other hosts (Cisak et al., 2012; Gómez-Martínez, 2014) and 
wild boar may be a risk factor for human exposure (Pugliese et al., 2007; Pugliese et al., 2002). 
At sufficient sample sizes wild boar studies may allow spatial interpretations at municipality 
level (Cisak et al., 2012).  
In Belgium, TBE was until recently considered exotic (Donoso Mantke et al., 2008a; ECDC, 
2012; Süss, 2008a). Until 2014, five imported cases of human TBE from Scandinavia, Austria 
and Kyrgyzstan were detected at the Belgian National Reference Centre (WIV-ISP, Brussels, 
Belgium). Meanwhile, serological evidence was collected from veterinary surveys in dogs 
(Roelandt et al., 2011), roe deer (Linden et al., 2012; Tavernier et al., 2015) and cattle (Roelandt 
et al., 2014).  
Results : Wild Boar 
92 
The Flemish wild boar population (northern Belgium) is steadily increasing in numbers/range 
(Scheppers et al., 2011; Scheppers et al., 2013), as are many European populations (Apollonio et 
al., 2010). Its potential density was estimated based on natural resources present in proposed wild 
boar management zones: Figure V-1a (Scheppers et al., 2011). Moreover, data on hunting bags 
per community were used to determine relative high density zones: Figure V-1b (Scheppers et al., 
2013, 2014; Vervaeke, 2012). 
The aims in the following survey were: (1) screening a representative sample of Flemish wild 
boar for TBEV-specific seroneutralising antibodies; (2) detecting potential TBEV-endemic areas 
in wild boar habitat; (3) evaluating accuracy of a commercial veterinary ELISA. 
 MATERIALS AND METHODSV.3
 STUDY POPULATION AND SAMPLINGV.3.1
During 2013, Flemish wild boars were primarily reported/shot in the province of Limburg
and secondarily in West-Flanders, Antwerp and East-Flanders: see Figure V-1 (Scheppers et al., 
2014). Population size was estimated at roughly 1,000-3,000 heads (Vervaeke, pers.comm.). 
TBEV-foci are often located in subsets of Lyme disease locations (Heinz, 2008; Randolph and 
Sumilo, 2007; Süss, 2003; Zeman, 1997), such as Limburg (WIV-ISP, 2011). 
Since 2011, surveillance is performed in this hunted wild boar population for Aujeszky’s 
disease, Classical Swine Fever virus and Brucellosis (Vervaeke, 2012). Blood was aspirated from 
the heart or large blood vessels straight after the kill (Vervaeke, 2012). The samples were 
identified, cooled and transported to the regional laboratory DGZ and the National Reference 
Laboratories at CODA-CERVA for veterinary testing and were stored afterwards at -20°C. 
Our study population (Figure V-2) was defined as 238 sera from hunted animals from the 
2013 surveillance in Limburg and Antwerp (n=153+8) and West Flanders (n=77). The samples 
were obtained from 24 official municipality NIS-codes (Statbel) (Figure V-2) and contained 
roughly 33% females, 33% males and 33% unknowns. As many samples as possible were 
retained from the whole geographic range from that year’s hunting bag (n=628) (Scheppers et al., 
2014). This was to increase sample size and detection probability, and to avoid sampling bias, i.e. 
to find TBEV seropositivity only in a pre-defined “risk zone” in the eastern parts of Belgium, as 
in (Roelandt et al., 2014). As such, it would be possible to draw conclusions about the whole 
Flemish wild boar range, instead of extrapolating. 
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Figure V-1: Flemish Wild boar population estimates.  
1a. Numbers estimated based on natural resources, per management zone (Scheppers et al., 2011); 
1b. Numbers reported by the public, per municipality (Scheppers et al., 2014) 
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Figure V-2: The study population (n=238).  
LIM: Limburg+Antwerp provinces; WFL: West Flanders province 
 DIAGNOSTIC ASSAYSV.3.2
V.3.2.1 TBEV testing
a. Serology
Neutralising antibodies were titrated in kaolin-treated wild boar sera (Van der Stede et al., 
2003) Radda et al., 1968) with the RFFIT-SNT (rapid fluorescent focus inhibition 
seroneutralisation test), considered a gold standard for medical/veterinary diagnosis (Vene et al., 
1998). The test was performed by WIV-ISP, as described in (Roelandt et al., 2014). Virus 
neutralization was measured by assessing reduction in microscopic fluorescent TBEV-foci. Two 
cut-offs were used to classify results (<1/10: negative; 1/10-1/15: borderline; >1/15: positive).  
A commercially available ELISA (Immunozym FSME/TBE IgG All-Species-ELISA®, 
Progen Biotechnik GmbH, Heidelberg, Germany) was used to detect TBEV- specific IgG-
antibodies in the sera. This non-competitive indirect assay uses horseradish peroxidase – Protein-
G conjugate to detect IgG against whole TBE-virus.  
LIM 
WFL 
Results : Wild Boar 
95 
The kit can theoretically be used for TBEV testing in all species, including humans. 
However, it was only validated for humans, where the IgG-protocol has diagnostic sensitivity 
(DSe) of 97% and analytical specificity of 99% (Progen, 2006). It was previously used as 
screening test in foxes (Rieger et al., 1999; Wurm et al., 2000) and wild boar (Cisak et al., 2012). 
We followed the manufacturer’s instructions (Progen, 2014): sera were diluted 1/50 and optical 
densities were read at 450-620nm (reference 620-690nm). Standard curves were generated with 
five kit calibrator samples. Sample concentrations were read from these in standardized Vienna 
Units (VIEU/ml; <63: negative - 63-126: borderline - >126:  positive). 
b. RT-PCR 
There was not enough serum volume left to allow qRT-PCR testing. Instead, homogenized 
tonsillar tissue (in PBS) was recovered at CODA-CERVA, for thirteen animals from the original 
study population. These samples were tested at WIV-ISP using an in-house TBEV-specific qRT-
PCR protocol based on Schwaiger and Cassinotti’s (Schwaiger and Cassinotti, 2003). Tonsils 
were homogenized in lysis buffer (from Rneasy mini kit, Qiagen) by using lysis kit stainless 
beads (0.9-2 mm) (Next advance technology).  
A 200 μl of homogenate was extracted by using the Rneasy mini kit from Qiagen. Reverse 
transcription was performed using qScript cDNA SuperMix (Quanta BioSciences). 18 μl of RNA 
was added to a final volume of 20 μl with 5 × reaction buffer qScript supermix (Quanta 
BioSciences,). This mixture was incubated for 5 min at 25°C, for 30 min at 42°C and finally for 
5min at 85 ◦C. The qPCR amplification was performed on an MXPro3000 from Stratagene. The 
reaction mix consisted of 12.5 μL of 2 x qPCR Supermix (Quanta BioSciences), 5 ?L of RT 
product, 0.4 μM of each TBEV primers and probe and 0.4 μM of each 18RS primers and 0.08 
μM probe.  
Cellular ribosomal 18RS RNA was used as an extraction control. Primers and probe used for 
amplification were synthesized by IDT. All samples were analyzed in duplicate. The 
amplification program consisted of 2 min at 95°C for initial denaturation followed by 45 cycles 
of 15s at 95°C, 30s at 55°C and 30s at 72°C. Real-time PCR performed on an MxPro3000 real-
time PCR system (Stategene). All samples were analyzed in duplicate on MxPro3000 real-time 
PCR system (Stategene). 
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V.3.2.2 Cross-reactivity testing
A commercial indirect immunofluorescence test (IFA; Biochip Flavivirus-Mosaic-3,
Euroimmun®, Germany) was adapted to detect porcine antibodies. The slides are coated with 
virus-infected cells: TBEV, West Nile (WNV), dengue (DENV types 1-4), Japanese encephalitis 
(JEV) or yellow fever (YFV). The manufacturer’s instructions were followed, using diluted sera 
(1/10, 1/100, 1/1000). Virus-specific antibodies were detected by secondary goat anti-swine 
antibody (1/1000, AbD Serotec®) and tertiary FITC-labelled rabbit anti-goat antibody (1/500, 
Molecular Probes®). Read-out was performed under an Olympus® fluorescence microscope 
(Figure V-3a-c). 
Louping Ill was investigated by haemagglutination inhibition (LIV-HIT; Clarke and 
Casals,1958) at Moredun Scientific Research Institute (Scotland, UK), modified to microtitre 
plate version with cut-off 1/20, after heat inactivation (1h/65°C) and absorption (kaolin - goose 
erythrocytes).  
In-house WNV-SNT and USUV-SNT tests were performed by Instituto Nacional de 
Investigación y Tecnologia Agraria y Alimentaria (INIA, Spain), using susceptible Vero cells and 
2-fold sample dilutions from 1/20 onwards, after heat inactivation (1h/65°C) (Alonso-Padilla et
al., 2009; Escribano-Romero et al., 2015).
CSFV-E2 antibodies were investigated with HerdChek CSFV-ELISA (IDEXX, The 
Netherlands) with values expressed as blocking percentages (30-40%: doubtful - >40%: positive). 
Neutralizing response was determined according to the OIE Manual (Anonymous, 2004) using 
the Alfort/187 strain. The 50%-neutralising doses (ND50) were expressed as the last dilution 
giving virus neutralization (≥10: positive).  
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V.3.2.3 Statistical Analysis 
Sample size calculations for disease detection were performed in Survey Toolbox® 
AusVet1.04 (Cameron, 1999) and WinEpiscope®2.0 (Thrusfield et al., 2001). We assumed 100% 
diagnostic accuracy for SNT and total population size of 3,000. Our obtained sample size 
(n=238) was afterwards deemed sufficient for the purpose of detecting a seroprevalence of 1.25% 
with 95% confidence and 5% error (required: n=227).  
Provincial sample sizes for Limburg+Antwerp (actual: n=161; estimated: N~2,200) and West 
Flanders (actual: n=77; estimated: N~800) were suitable to detect design prevalences of 1.80% 
(required: n=159) and 3.50% (required: n=77) respectively. Probability of freedom despite an 
observed number of SNT-reactors was investigated with design prevalence ranging between 0.1-
10% and with SNT as gold standard (100% DSe/DSp; Survey Toolbox®). 
ELISA accuracy evaluation was performed in R (CoreTeamR, 2013), using package epiR 
(Stevenson et al., 2014), with Fleiss kappa’s (Fleiss et al., 2003) and post-test disease 
probabilities (Hunink and Glasziou, 2001). Package pROC was used to construct a non-
parametric ROC-curve (receiver operating characteristic) (Robin et al., 2011), with DeLong 
95%CI for area under the curve [AUC] (DeLong et al., 1988).  
SNT-seroprevalences and confidence intervals according to sample size, (Wald: n>100, 
Agresti-Coul: 30<n<100, Exact-Binomial: n<30; (Brown et al., 2001) were calculated using 
Prevalence package (Devleesschauwer et al., 2013).  
The study population (Figure V-2) and its seroprevalence (Figure V-5) were mapped using 
QGIS®2.2-Valmiera (DevelopmentTeam, 2014), using a Flanders vector layer in Belgian 
Lambert 1972 EPSG-projection.  
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 RESULTSV.4
 DIAGNOSTIC TEST RESULTSV.4.1
TBEV-serology results were cross-classified (Table V-1): 11 boars tested ELISA-
seropositive and 14 were classed as borderline. Based on RFFIT-SNT results using the more 
specific cut-off (>1/15), seven boars (2.9%; 95%CI: 0.79-5.09%) were classified TBEV-
seropositive, including three ELISA-negatives. Four seropositives presented with moderate 
(1/17-1/25-1/33-1/47) and three with high SNT-titers (1/127-1/164-1/243). Three animals were 
SNT-borderline (1/12-1/10-1/14), adding another 1.26% (95%CI: 0.00-2.68%) of reactors. 
Fourteen ELISA-borderlines and most (7/11) ELISA positives were found SNT-negative. TBE-
virus was not detected in any of the 13 tonsils by qRT-PCR.  
Table V-1: Cross-classified TBEV serology results 
ELISA 
SNT 
pos borderline neg/NI Total 
pos 4 0 7 11 
borderline 0 0 14 14 
neg 3 3 207 213 
Total 7 3 228 238 
Table V-1 : Cross-classified TBEV serology results.  
ELISA: Immunozym FSME/TBE IgG All Species-ELISA® ; SNT: seroneutralisation test, i.e. reduction of fluorescent 
focus inhibition test RFFIT; NI: non-interpretable SNT, considered to be negative. 
The results of the cross-reactivity tests for 10 TBEV-reactor samples (SNT-positive/doubtful 
and/or ELISA-positive) are summarized in Table V-2. Six of these samples showed borderline 
(1/20) or positive (1/40-1/80) reactions in the LIV-HIT. Sample no.8 tested positive in 
WNV/USUV-SNT and LIV-HIT. Two samples reacted in CSF-ELISA, but this was not 
confirmed in CSF-SNT and they were considered negative. Highly TBEV-SNT/ELISA-positive 
samples (no.2,3,4) reacted TBEV-IFA positive and negative for the other flaviviruses 
(WNV/JEV/YFV/DENV1-4), while low SNT-positives (no.1,9,10) and SNT-negatives/ELISA-
positives (no. 5,6,7) did not (Figure V-3a-c). 
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Figure V-3a-c: Immunofluorescence Assay (IFA) images at 20x magnification.  
3a: TBEV seropositive sample results in granular fluorescence in the cytoplasm of TBEV-infected cells;  
3b: TBEV seronegative sample gives no staining of TBEV-infected cells;  
3c: TBEV-seropositive sample gives no staining of West Nile virus-infected cells 
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Table V-2: Cross-Reactivity Results of the Confirmation Panel (TBEV-reactors) 
Sample TBEV TBEV TBEV LIV CSFV USUV  WNV WNV DENV  YFV JEV 
IgG 
ELISA 
SNT IFA HIT ELISA/SNT 90%PRNT  90%PRNT IFA 1-4 
IFA 
IFA IFA 
(VIEU/ml) (titer) (titer) (titer) (titer) (titer) (titer) (titer) (titer) (titer) 
1 
POS POS NEG NEG 
NEG 
NEG NEG NEG NEG NEG NEG 
230 1/33 <1/10 <1/20 <1/20 <1/20 <1/10 <1/10 <1/10 <1/10 
2 
POS POS POS border 
NEG 
NEG NEG NEG NEG NEG NEG 
>540 1/164 1/1000 1/20 <1/20 <1/20 <1/10 <1/10 <1/10 <1/10 
3 
POS POS POS POS 
NEG 
/ / NEG NEG NEG NEG 
490 1/243 1/3200 1/40 <1/10 <1/10 <1/10 <1/10 
4 
POS POS POS POS 
/ 
NEG NEG NEG NEG NEG NEG 
520 1/127 1/3200 1/40 <1/20 <1/20 <1/10 <1/10 <1/10 <1/10 
5 
POS NEG  NEG NEG 
NEG 
NEG NEG NEG NEG NEG NEG 
>540 <1/10 <1/10 <1/20 <1/20 <1/20 <1/10 <1/10 <1/10 <1/10 
6 
POS NEG  / border 
/ 
/ / / / / / 
430 <1/10 / 1/20 / / / / / / 
7 
POS NEG  NEG NEG 
/ 
NEG NEG NEG NEG NEG NEG 
265 <1/10 <1/10 <1/20 <1/20 <1/20 <1/10 <1/10 <1/10 <1/10 
8 
NEG POS NEG POS 
NEG 
POS POS NEG NEG NEG NEG 
15 1/140 <1/10 1/80 1/320 1/390 <1/10 <1/10 <1/10 <1/10 
9 
NEG POS NEG border 
NEG 
NEG NEG NEG NEG NEG NEG 
35 1/17 <1/10 1/20 <1/20 <1/20 <1/10 <1/10 <1/10 <1/10 
10 
NEG POS NEG NEG 
/ 
NEG NEG NEG NEG NEG NEG 
15 1/25 <1/10 <1/20 <1/20 <1/20 <1/10 <1/10 <1/10 <1/10 
Table V-2: Cross-reactivity results for the confirmation panel (TBEV-reactors).  
Bold = positive result – not bold = negative or borderline result – NEG: negative result; / : no result due to bad 
quality or lack of volume sample. 
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 ELISA ACCURACY  V.4.2
a. 2X2 Tables 
Two-by-two tables were constructed, depending on RFFIT-SNT thresholds, to interpret the 
doubtfuls once as true positives and once as true negatives, both times including the ELISA-
borderlines as ELISA-positives. The classical accuracy measures were calculated on 
dichotomized test results (Dohoo et al., 2009b), as summarized in Table V-3.  
Summary of 2 by 2 table output  
for 2 SNT-titer thresholds 
Parameter Estimates (95 % exact binomial CI) 
SNT cut-off >1/10 SNT cut-off >1/15 
Test 
Accuracy 
ELISA vs. 
SNT 
DSe 0.40 (0.12 - 0.74) 0.57 (0.18 - 0.90) 
DSp 0.91 (0.86 - 0.94) 0.92 (0.88 - 0.95) 
PPV 0.16 (0.05 - 0.36) 0.16 (0.05 - 0.36) 
NPV 0.97 (0.94 - 0.99) 0.99 (0.96 - 1.00) 
LR+ 4.34 (1.83 - 10.28) 6.86 (3.20 - 14.68) 
LR- 0.66 (0.40 - 1.10) 0.47 (0.20 - 1.10) 
post-test 0.16 0.18 
Kappa 0.18 (0.07 - 0.29) 0.22 (0.11 - 0.31) 
Wild Boar 
Prevalence 
Apparent 0.11 (0.07 - 0.15) 0.10 (0.06 - 0.14) 
True 0.04 (0.02 - 0.08) 0.03 (0.01 - 0.05) 
Table V-3:  Summary of 2 by 2 table output for 2 SNT-titer thresholds.  
SNT: RFFIT seroneutralisation test; ELISA: Progen Biotechnik TBE/FSME All species ELISA; CI: confidence 
interval; DSe/DSp: diagnostic sensitivity/specificity; PPV/NPV: positive/negative predictive value; LR+/-: likelihood 
ratio positive/negative; post-test: disease probability after a positive ELISA test; kappa: Fleiss’ kappa; Sample size: 
n=238. 
 
The seroprevalence in the whole dataset (n=238) was estimated between 3-4% by SNT and 
the ELISA had DSe=40-57% and DSp=91-92%, relative to SNT. The positive predictive value 
was fairly low: we can expect 84% of ELISA-positives to be false in a low-prevalence setting. 
The negative predictive value is much higher: only a few true positives (1-3%) were missed by 
this ELISA. The positive likelihood ratio indicates that when wild boar test ELISA-positive, they 
are 4-7 times more likely to be TBEV-infected (Dohoo et al., 2009b).  
Consequently, if pre-test probability of disease is calculated as the percentage of RFFIT-SNT 
reactor samples (7/238=2.94% - 10/238=4.20%), post-test disease probability for an ELISA-
positive becomes 16-18%. Kappa’s (0.18-0.22) indicated “poor” agreement with SNT (Fleiss et 
al., 2003), or “slight” to “fair” agreement (Landis and Koch, 1977).  
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b. ROC-analysis
ROC-analysis (Figure V-4) showed that ELISA overall discriminatory ability (=AUC) was 
only 59.74% (95%CI: 32.94%-86.54%) when SNT-borderlines were assumed to be true positives 
(ST1), and 69.11% (95%CI: 37.21%-100%) when including the same animals as true negatives 
(ST2). For ST1, the associated DSe/DSp were estimated at 98.68% (95%CI: 96.93-100%) and 
40% (95%CI: 10-70%) respectively, and for ST2 the associated DSe=57.14% (95%CI: 14.29-
85.71%) and DSp=98.70% (95%CI: 96.97-100%).  
The optimal cut-off for this ELISA, determined by Youden’s J-statistic (Youden, 1950), 
turned out to be 155 VIEU/ml. However, with a view to use the ELISA for screening (i.e. with 
SNT follow-up), the cut-off might be lowered to 35 VIEU: this would result in improved 
DSe=70-71.43% (for ST1-ST2), at cost of DSp=64.04-69.74% (for ST1-ST2). 
Figure V-4:  ROC analysis of the TBEV ELISA as compared to RFFIT-SNT gold standard. 
VIEU: standardized Vienna units per ml; animals with SNT-borderline results (n=3) are alternately considered as 
true positives (ST1: Status 1) or true negatives (ST2: Status 2); Numbers on display represnt ideal VIEU cut-off 
according to Youden J statistic, (DSp and DSe associated with this cut-off); AUC: Area under the curve: overall 
discriminatory capability of ELISA. 
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 SEROPREVALENCE AND PROBABILITY OF FREEDOM V.4.3
SNT-reactor seroprevalence is summarized in Table V-4 and Figure V-5. Seven reactors 
were localized in Limburg province and three in West Flanders. Borderlines were found in 
municipalities already containing a seropositive animal. For both provinces (LIM – WFL) and for 
the whole of Flanders, the Wald and Agresti-Coul confidence intervals excluded 0%, indicating 
infected populations.   
SNT Reactors  
 Sampled SNT-Reactors Prevalence 95%CI* 
WFL 77 3 3.90% 0.88 - 11.30% 
LIM 161 7 4.35% 1.20 - 7.50% 
FLA  238 10 4.20% 2.56 -  8.31% 
*95%CI: if n>100 Wald, if 30<n<100 Agresti-Coul  
Table V-4: SNT-reactor prevalence in LIM, WFL and Flanders.  
Reactors are SNT -positive or –borderline animals; 95%CI: 95% confidence interval, calculated according to Wald 
if n>100,or accordingto Agresti-Coul if 30<n<10; WFL: province of West Flanders; LIM: provinces of Limburg 
and Antwerp – FLA: whole Region of Flanders.  
 
The possibility of freedom despite the observed number of SNT-reactors was further 
investigated for West Flanders (2 or 3 SNT-positives/reactors), Limburg+Antwerp (5 or 7 SNT-
positives/reactors) and Flanders (7 or 10 SNT-positives/reactors), with design prevalences 
between 0.1-10% and with using a 100% accuracy for the SNT-test. We could not substantiate 
freedom of TBEV (probability of not infected = 0.000), not even in the conservative case using 
only the SNT-positives (>1/15). However, the true prevalence can be expected to be below 2.5%.  
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Figure V-5: Reactors in SNT and ELISA tests. 
Per sampled municipality (NIS-code); NEG: negative;SNT+/b: seroneutralisation positive (titer>1/15)  or 
borderline (1/10<titer<1/15); ELISA+: enzyme-linked immunosorbent assay positive; WFL: West Flanders 
subpopulation; LIM: Limburg+Antwerp subpopulation 
 
  
LIM 
WFL 
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 DISCUSSION V.5
 DIAGNOSTIC TESTING FOR TBEV V.5.1
Seroneutralisation testing is the gold standard for veterinary TBEV-serology, being highly 
specific and least affected by cross-reactive antibodies (Klaus et al., 2011; Klimeš et al., 2001; 
Leschnik et al., 2002; Vene et al., 1998). In this study, ten wild boar reacted positive or 
borderline in the SNT, three of which presented with very high anti-TBEV SNT-titers (>1/125). 
This argues for highly specific test results and for classification as true positives. It is nonetheless 
recommended to check positive SNT-result specificity in comparative tests using a panel of 
flaviviruses known to circulate in the region (Beck et al., 2013; Klaus et al., 2014).  
We selected several flaviviruses to be included in the cross-reaction tests. IFA results 
confirmed the high specificity of the TBEV-SNT: highly SNT-positive sera tested TBEV-
positive in IFA, whereas SNT-negative/low positive sera did not. Moreover, ELISA-positive 
SNT-negative sera did not react in IFA. LIV-HIT revealed several positive reactions, however, 
the titers were markedly lower than the associated TBEV-titers, and most samples were negative 
in all other tests. Hence, following worldwide accepted specificity criteria, these reactions were 
TBEV-specific. Sample nr.8 showed strong cross-reactivity and TBEV-specificity could not be 
definitively assessed. 
None of these flaviviruses are considered endemic in Belgium. USUV was found in only two 
wild birds with neurological signs in southeastern Belgium (Ashraf et al., 2015; Garigliany et al., 
2014). Infections or transmission have not been described in suids for DENV/YFV (CFSPH, 
2009, 2013; Hubalek et al., 2014), while LIV/TBEV/WNV/USUV may cause asymptomatic 
infections and were present in Europe before/during 2013 (Ziegler et al., 2015). Extensive 
Belgian domestic/wild bird WNV-surveillance (serological/virological: n=9,444/3,404) proved 
negative in the period 2010-15 (FASFC, 2011, 2012, 2013, 2014b, 2015a, b; OIE-WAHID, 
2014).  
Though few IgM-positives are expected in sentinel populations, Klaus et al. (Klaus et al., 
2011) used the Immunozym FSME/TBE All-species IgM-kit, modified by Müller (Müller, 1997) 
using veterinary Units/L and without IgG-blocking step, to determine total immunoglobuline 
(IgG+M) in several species, with apparently more accuracy vs. SNT (Klaus et al., 2011).  
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However, since we experienced insufficient precision or accuracy with this protocol on the 
bovine sera (unpublished data Chapter IV) and due to low wild boar serum volumes, we opted 
not to use this protocol for this study.  
Using the manufacturer’s instructions, the IgG All-species ELISA showed low agreement 
with gold standard SNT, with low DSe and reasonable DSp. The threshold could be lowered to 
increase DSe for screening purpose, but lowering DSp. Ideally, we would have used more 
positive samples to evaluate the DSe, however, in this low prevalence setting, only n=10 reactors 
were available. The DSe estimates are therefore only tentative, also indicated by the very wide 
confidence intervals, while we can be more confident about the actual DSp, based on n=228 
negatives. DSe remains to be further evaluated when more positive samples become available, 
perhaps in an international effort to validate veterinary TBEV-ELISA’s. 
A first attempt to detect TBEV by qRT-PCR in veterinary samples returned negative results. 
Besides an obvious shortage of available samples (n=13), literature indicates that we should not 
expect to find TBEV easily. Viraemia lasts only few days in humans (ECDC, 2012; Holzmann, 
2003) and mammals (Jaenson et al., 2012; Klaus et al., 2012). Wild boar and pigs are assumed to 
only develop low-short flaviviral (e.g. WNV) viraemia (Boadella et al., 2012; Chambers and 
Diamond, 2003; Mandl, 2005; Pripuzova et al., 2013), but in analogy with blood and CSF the 
virus is probably cleared from lymph nodes by the time humoral response is detectable 
(Holzmann, 2003; Ruzek et al., 2013).  
 WILD BOAR AS TBEV-SENTINELSV.5.2
Though domestic animals are easier to sample than wildlife, the TBEV-seroprevalence in
sympatric wild boar is in some cases higher, making TBEV-presence easier to detect (Cisak et 
al., 2012; Gómez-Martínez, 2014). Wild boar feature frequent contacts with rodents and ticks as 
these species share the same preferential habitats and they provide relatively large serum 
quantities and cost-effective sampling opportunities (hunting or farming), making them valuable 
for retrospective surveys and flavivirus/TBEV monitoring (Boadella et al., 2012).  
Moreover, for unregulated/growing populations a positive temporal association may exist 
between human TBE-incidence and numbers of culled boar as this species may be partially 
driving spread of TBE from woods into suburbs (Kriz et al., 2014).  
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The 10 TBEV-reactors presented in a male/female ratio of 3/4 (+3 unknown) and their 
weights (35-98kg) and age ranges (4m-4y) indicated that at least some animals were subadults, 
capable of dispersal (Dzieciolowski et al., 1990; Markina et al., 2004). We assume that most 
Flemish wild boar are fairly sedentary, based on average home ranges (≤7km2), expansion 
velocity (≤4km/year) and subadult dispersal (≤10km) in Belgium and abroad (Cargnelutti et al., 
1992; Gaston et al., 2008; Morelle et al., 2015; Podgórski et al., 2013; Prévot and Licoppe, 2013; 
Truvé et al., 2004).  
However, subadults occasionally disperse quite far (≤40km) across highways and national 
borders (Prévot and Licoppe, 2013; Prévot and Morelle, 2012). Such longer movements may 
constitute an introduction pathway from TBEV-foci abroad given that adult female I. ricinus 
attach to hosts up to 14 days (Borcic et al., 1990; Kriz et al., 2014). GPS-tracking to define 
movement patterns of the surveyed population is ongoing (Casaer, pers. comm., 2015). However, 
given the current information and average Flemish municipality surface (±50km2), we are 
confident that in general the Flemish wild boar population is quite suitable to perform local 
TBEV-surveillance at the community level. 
Population size (abundance) is another valuable parameter to assess spread/presence/absence 
of TBEV within/from foci through epidemiological studies (Prévot and Licoppe, 2013). 
However, current population estimation methods are biased (Acevedo et al., 2007; Engeman et 
al., 2013), hence we resorted to expert estimates in our calculations.  
 GUIDANCE FOR FUTURE RESEARCH AND SURVEILLANCE V.5.3
To date, no local human TBE-cases have been confirmed in Belgium. However, this 
emerging vector-borne zoonotic infection has a complicated eco-epidemiology in which human 
infections only represent the tip of the iceberg (Randolph and Sumilo, 2007). In the light of the 
observed TBEV-seropositivity in multiple animal species in Belgium, a continued awareness and 
passive surveillance is indicated to monitor for human cases in general and referral hospitals.  
Furthermore, we cannot exclude a degree of underreporting as generally two thirds of human 
TBE-cases do not feature neurological disease (Süss, 2011). Furthermore, in Belgium general 
practitioners as well as neurologists are not familiar with TBE (Dr. P. Roelandt, MD, and Dr. M. 
Goethals, MD Neurologist, pers. comms.).  
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In such circumstances, veterinary surveillance components add valuable information to 
existing medical surveillance (ECDC, 2012; Klaus et al., 2011; Klaus et al., 2010a; Süss, 2008b, 
2011). For further focus localization and characterization, continued active serological 
surveillance in several host species is advisable. To attempt virus detection and detection of 
endemic foci, active surveillance would be recommended in the highlighted areas, by using 
targeted tick and particularly reservoir sampling and RT-QPCR testing. Indeed, the TBE-virus 
can be detected for longer periods in several organs of persistently infected wild reservoir rodents 
(Achazi et al., 2011; Kim et al., 2008; Knap et al., 2012; Pinter et al., 2014) and may be 
detectable in ticks collected off local hosts, including humans (Bormane et al., 2004; Süss et al., 
2006; Süss et al., 2004).  
 CONCLUSIONV.6
In a cross-sectional serological screening of Flemish wild boar, a positive TBEV-
seroprevalence of 2.90-4.20% was found. The seropositive/borderline reactors were clustered in a 
few municipalities. Three reactors presented with very high and specific anti-TBEV SNT-titers 
(>1/125) supporting a classification as true positives. Specificity of the SNT was also assessed 
using a panel of cross-reactivity tests, which ruled out other flaviviral infections for 9 out of 10 
TBEV-reactor samples. TBE-virus was not found in qRT-PCR testing of 13 available wild boar 
tonsils. A commercial TBEV-ELISA was evaluated for its screening accuracy. A fairly low 
agreement, diagnostic sensitivity and overall accuracy (AUC) were found for the IgG-protocol 
and the cut-off could be lowered to increase this sensitivity. Diagnostic specificity was found to 
be adequate For future research, adapted protocols for total immunoglobulin determination may 
be considered and more positive reference samples need to be collected to further assess DSe. 
In conclusion, wild boar can effectively be used for local TBEV-sentinel surveillance in low-
prevalence areas. The finding of TBEV-seropositive wild boar in Flanders warrants further 
follow-up through veterinary and public health surveillance and through targeted direct testing in 
rodents and/or ticks collected off hosts 
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 INTRODUCTIONVI.1
 PURPOSE OF MAPPING AND MODELLING TBEVI.1.1
Mapping and predictive modelling are risk-based methods that have been used particularly in
vector-borne diseases to identify the areas and time periods in which surveillance is more likely 
to successfully detect emerging health threats at an early stage (Rodriguez-Prieto et al., 2014). 
Such techniques greatly benefit governments and public health agencies:  
(1) by describing (maps) or analyzing (models) the situation in the field;
(2) by forecasting potential cases and by extrapolation of human risk to areas where no
epidemiological data have been collected yet; 
(3) by stimulating prevention and mitigation of vector-borne disease, through public
campaigns for personal protective actions; 
(4) by allowing allocation of limited resources to targeted control, such as vaccination,
communication, chemical tick control or habitat modifications (Daniel et al., 1998; Eisen and 
Eisen, 2011; Kalluri et al., 2007).  
Such integrated studies should be performed in interdisciplinary collaboration and are of 
particular importance especially for those areas where local economies rely on tourism and 
recreational activities, as the vital “healthy and safe” public image of these areas environment 
would be damaged by emerging zoonoses (Rizzoli et al., 2009).  
 MAPPING EXAMPLESVI.1.2
Mapping of clinical cases is a very useful tool to spatially allocate TBE surveillance and
interventions. It has therefore been used regularly in many countries (Labuda and Randolph, 
1999; Rinaldi et al., 2006; Stefanoff et al., 2011; Zeman, 1997). Endemic, risk and high risk areas 
may be defined based on clinical cases or on seroprevalence and series of risk maps may 
document the progressive addition of new risk areas, (RKI, 1998, 1999, 2001 2002, 2003, 2004, 
2005, 2006, 2007, 2009, 2010, 2011, 2012, 2013, 2014, 2015), including some close to the 
Belgian borders between 2006 and 2012: see Figure VI-1 (ISW-TBE and Baxter, 2006, 2009, 
2011a, b, 2013). 
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Figure VI-1: TBE/FSME in Europe: Established endemic areas in 2008 vs. 2013. 
Adapted from TBE/FSME in Europe: Established risk areas (Baxter/Hölzel Verlag, 2008/2013). 
 Maps based on documented cases of TBE as reported by WHO and national health institutions; Red dots in 
2008 and grey dots in 2013: large cities; Yellow areas in 2008 and red areas in 2013: TBEV endemic areas 
 
Case maps should also take into account sentinel animal sampling and seroprevalence and the 
prevalence in the tick population (ECDC, 2012; Rendi-Wagner, 2004; Süss, 2003): see Figure 
VI-2 and VI-3.  
 
Figure VI-2: Cattle sampling map.  
Origin of serum and milk samples (1997-2004) from southwestern Germany;  
nK=nE=nD=100; nR=206 (Leutloff et al., 2006) 
2008 2013 
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Figure VI-3: Fox seroprevalence map.  
Origin districts of the tested fox sera (first number - light and dark grey);  
districts with Western-blot positives (number between brackets - dark grey)  
Additionally, the important known epidemiological drivers/risk factors of vector-borne 
diseases can be visualized descriptively and comparatively (Braks et al., 2014). This may include 
habitat/landscape features and management actions, as well as tick/host distributions and 
abundance (Li et al., 2012b): Li et al., 2012b): see Figures VI-4 and VI-5 as examples from 
Sweden and Belgium. 
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Figure VI-4: Swedish records of Ixodes ricinus ticks (a: left)  
and estimated distribution versus vegetation zones (b: right). 
Dots: tick records 1980s to early 1990s; small dots: individual records; larger dots - 10 and 50 records ; vegetation 
data (1961–1990): the northern limit of the southern boreal zone (solid line) and the northern limit of the boreo-
nemoral zone (dashed line). Adapted from (Jaenson et al., 2009; Jaenson et al., 1994) 
 
 
Figure VI-5: Map of Belgium and location of sampling sites in 2009 and 2010. 
From (Li et al., 2012b) 
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 MODELLING EXAMPLES VI.1.3
Predictive models can produce TBE risk maps based on remote sensing data of the important 
environmental and meterological/climatic drivers, e.g. Figure VI-6 (Randolph, 2000).  
 
Figure VI-6: Predictive and Spatial Modelling for TBE(V). 
Satellite-derived predicted distributionof Tick-borne encephalitis in Western and Central Europe (red, 2000) 
compared with established foci (yellow, mapped 1997) (From Randolph and Rogers 2000 and Randolph 2001, with 
permission)  
Such predictive modelling assess the risk for vector-borne diseases, by combining different 
layers of sources related to the drivers/risk factors with field data/observations (recorded cases, 
tick bites, positive ticks, or seroprevalences). Spatial and predictive modelling are continuously 
evolving techniques with the goal to reveal the most important risk drivers, and where the 
explanatory variables (drivers) are often modelled with dependent variables obtained from field 
data, such as numbers of recorded cases or seroprevalences.  
Many different risk factors are known to drive TBE epidemiology (see Table I-1 – Annex VI-
4) and in Belgian and European modelling and mapping studies on Ixodid tick abundance, 
human-tick contacts (tick bites) or rodent-borne zoonotic pathogen prevalence in humans (e.g. 
Hantavirus, Lyme, TBE), there have been dozens of positively associated and significantly 
predictive variables (alone or in interactions) and there have been contradictions between the 
studies. These many correlated variables can be categorized in 7 major groups: 
meteorological/climatological; landscape structure/cover; landscape configuration; 
geological/geographical; wildlife; vegetation; socio-economic.  
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Often the models used are correlational pattern-matching regression models (e.g. negative 
binomial, linear, poisson, logistic, multilevel, mixed) or discriminant analysis (e.g. principal 
component analysis, boosted regression trees). Alternatively, mechanistic and machine learning 
simulation models may also be used (see Figure VI-7) (Eisen and Eisen, 2011; Hartemink et al., 
2014; Kalluri et al., 2007; Lambin et al., 2010; Randolph et al., 2000; Randolph and Sumilo, 
2007; Reisen, 2010; Zeimes et al., 2014). 
Though correlational statistical modelling may suffer from lack of causality and collinearity 
of the predictors (Hartemink et al., 2014), predictive landscape and meteorological factors are 
currently easier and cheaper to document spatially for large areas than the many mechanistic 
causative factors leading to human risk, i.e. abundance of transmission/reservoir hosts 
(rodents/birds) and the disease burden in ticks feeding on those hosts (James et al., 2013). The 
mechanistic models require complete quantification and elucidation of the causal relationships in 
the epidemiological triangle (vector-host-pathogen-environment) and of the (a)biotic factors 
influencing these (Randolph and Green, 1999; Randolph, 2000; Randolph and Rogers, 2000; 
Randolph and Sumilo, 2007).  
Predictive and spatial modelling has been performed in Belgium, for Lyme disease (Li et al., 
2012a; Linard et al., 2007), tick bites (De Keukeleire et al., 2015), Hantavirus (Linard et al., 
2007) and I. ricinus dynamics (Li et al., 2012b), but not yet for TBEV.  
 
Figure VI-7: Mechanistic model for Lyme disease in I. ricinus ticks 
solid box: a population stated in the model;  solid arrow: development of tick population; dashed lines show 
attachment relations; white box: questing or feeding stage; larvae feed on small-sized animals, adults feed 
on large-sized animals, and nymphs feed on both. From (Li et al., 2012a).  
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 APPLICATION TO BELGIUM AND TBEVVI.2
 SAMPLE AND CASE MAPS VI.2.1
Since Belgium currently has no confirmed autochtonous human TBE cases, we have mapped
the sampling (Figure VI-8) and seropositive sample results (Figure VI-9) from the three 
veterinary sentinel studies conducted as described in chapters III, IV and V (Roelandt et al., 
2011; Roelandt et al., 2014; Roelandt et al., 2016) 
Besides the seropositive samples obtained in this thesis, 9 human patients with inconclusive 
results were also added. These cases showed neurological symptoms indicative of 
neuroborreliosis (Lyme disease) and reacted negative in the neuroborreliosis tests, but positive in 
the TBEV SNT-test. However, these samples tested negative in TBEV IgM ELISA and could not 
be conclusively diagnosed as acute TBE cases. Since these medical data were obtained from the 
referral Lyme laboratory (Cliniques Saint Luc - UCL Brussels – Dr. B. Kabamba, MD), this 
mainly involves a catchment area around Brussels. Furthermore, the vaccination and 
mobility/exposure history of these patients is unfortunately unknown (n=9/113; Source data: 
WIV-ISP; 2009-2013).  
Figure VI-8: PhD Data: Sampled Belgian communities and hosts.  
Canine data (Roelandt et al., 2011; Chapter III), Bovine data (Roelandt et al., 2014; Chapter IV), Wild boar data: 
Roelandt et al., submitted; Chapter VI; Human data (source WIV-ISP; 2009-2013); WGS 84 projection. 
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Figure VI-9. PhD Results: TBEV SNT-reactors in sampled Belgian communities.  
Canine data (Roelandt et al., 2011; Chapter III), Bovine data (Roelandt et al., 2014; Chapter IV), Wild boar data: 
Roelandt et al., submitted; Chapter VI; Human data (source WIV-ISP 2009-2013)  
 
 RISK FACTOR MAPPING   VI.2.2
In the absence of sufficient data to model TBE risk for Belgium (See under VI.2.3), we 
decided to proceed by describing and qualitatively evaluating some documented major TBEV-
drivers for Belgium. The resulting maps in Figures VI-9-10 were based on the World Borders 
Dataset (Sandvik, 2009).  
From the very abundant literature on TBE risk factors (see Table I-1, Chapter I, and Annex 
VI.4), eight frequently mentioned risk factors were selected, without any subjectivity on relative 
importance other than “being mentioned frequently”. This means other layers may be used by 
other studies. Additionally, only those risk factors were selected for which Belgian spatial raster 
data or predictive model outputs at 1 km2 pixel resolution was available and easily accessible for 
the authors during Autumn 2015.  
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VI.2.2.1 Selected Layers for Risk Factor Mapping
Roe deer and wild boar are the most important wildlife hosts for I. ricinus and TBEV. For
these species, the modelled probability of presence in every 1 km2 pixel can be used to describe 
the likely geographical distribution of the species, based on incomplete available data from some 
pixels. The modeled output of these layers was based on the EMMA (Avia-GIS, 2012), GBIF 
(GBIF, 2015a, b) and IUCN red list (IUCN, 2012) databases, as well as (sub)national hunting bag 
data and species-specific GlobCover 2009 (Arino et al., 2012) habitat preferences  (Alexander et 
al., 2015; Alexander et al., 2014).  
Cattle and small ruminants are additional important domestic hosts and sentinels. Spatial 
ruminant distribution data were obtained during the Gloworm FP7 Project 
(http://www.gloworm.eu/;2012-14) and modeled during the EDENext Project 
(http://www.edenext.eu/; 2011-14). The final output layer represents the actual abundance per 1 
km2 for each population.  
An I. ricinus tick distribution layer was obtained from the VBORNET project (Wint and 
Alexander, 2013). Currently, abundance data on rodents or other species was not freely available 
to the authors.The presence or absence of mixed and/or broadleaved forests, which are important 
to support hosts and vectors, was mapped in 1 km2 pixels based on the Corine Land Cover raster 
data 2006, version 13 (CLC, 2006). This type of layer represents vegetation and is usually 
correlated to relative humidity indices, which promote tick stage development.  
Distance weighted human population proximity indices to forests (“human exposure”) were 
used, reflecting the actual exposure of urban human populations to local forested areas within 30 
km Euclidean distance. This layer describes the population which may be likely to visit specific 
less populated areas, e.g. forests which may  receive high urban visitor numbers (Alexander and 
Wint, 2013; EDENext, 2012). 
The monthly cooling rate during Autumn (August to December) is an important factor 
influencing occurrence of synchronised nymphal-larval co-feeding in Spring. temporal Fourier 
analysis was used (Randolph et al., 2000) on the longterm Belgian monthly maximum 
temperature data between 1980-2000 (more recent data were not available). These data were used 
to calculate the Autumn slopes of Land Surface Temperature with temporal Fourier analysis 
(Randolph et al., 2000; Rogers et al., 1996; WorldClim, 2015).  
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Fourier analysis is the study of the way general complicated functions may be represented or 
approximated by sums of simpler trigonometric functions (Wikipedia, 2016).  It yields the mean 
seasonal cycles of the variable of interest, including the amplitude, the phase i.e. timing of peak 
values, and the shape of the mean seasonal profile (Randolph et al., 2000). 
VI.2.2.2 Risk Factor Map Construction  
In step one, each of the described spatial layers represents one risk factor for TBE, for which 
we do not yet know the relative importance (regression coefficients) for Belgium at present. 
Hence, they were first depicted separately so that one can appreciate factor by factor (Figure VI-
11, left).  
Since there are no publications on qualitative TBE risk factor maps or on Belgian TBE risk 
factors, the risk was defined by defining a cut-off using the distribution of most of the different 
layers. We selected the most extreme 20% quantiles for each layer as the epidemiologically 
relevant, except for the forests. For the forest layer a binary classifier was used: simple 
presence/absence of broadleaved or mixed forests.  
The selection of the most extreme quantiles means the upper (80-100%) quantiles for the host 
distributions and for the human proximity index as these have a positive association with TBE-
risk, or the lower (0-20%) quantiles for Autumn T°slope as here a negative slope (drop in 
temperature) is associated with increasing TBE-risk. Each selection of 20% represents the more 
extreme cases at the higher end of the TBE risk scale (risk present~highest). All other quantiles 
were considered to be not at risk or at very low risk (absent~lowest) (Figure VI-11, right). With 
this cut-off, we intended to be sensitive enough for each risk factor (include 20%) but also 
specific enough (not assign TBE risk too easily). 
In a third step, the number of risk factors per 1 km2 was calculated by summing (GIS ‘or’ 
operation) the number of risk factors present per pixel. The resulting qualitative TBE risk factor 
presence map with color code (Range: 0-6) is shown in Figure VI-12, including the serologically 
positive municipalities, which can be observed in this thesis in a vector layer (red transparant 
polygon overlay). 
Finally, the average number of TBEV risk factors (Range: 0-6: see Figure VI-12) for tested 
infected municipality was calculated and compared to the average number in the tested free 
municipalities by the one-sided Mann-Whitney-U test (significant p<0.05). 
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VI.2.2.3 Results 
The Belgian monthly maximum temperatures (Tmax: 17-19°C) and negative slopes (between 
3.65- 4.79°C per month) in Figure VI-10a are below Prof. Randolph’s TBE risk zone in Figure 
VI-10b: Tmax: >24°C and T° slope: 8-9°C per month (Randolph et al., 2000). Also, there seems 
to be no difference between Belgian communities with and without TBEV seropositivity. 
 
 
Figure VI-10. Fourier analysis to calculate the Autumn slopes of Land Surface Temperature (LST) 
a. Belgian seasonal LST cycles (1980-2000): same slopes for TBEV seropositive and – negative communities 
2016; b. Seasonal LST cycles for four European sites (1970’s-‘80s); black symbols: TBEV present and steaper 
slopes – white symbols: TBEV absent and gradual slopes (Randolph, 2000) 
Tmax: 17-19°C 
Tmax: >24°C 
Slope / month  
3.65- 4.79°C  
Slope/month 
>8-9°C 
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                                        Original layer (Step1) = Selected layer (Step 2)  
 
 
 
 
Figure VI-11. Descriptive TBE risk factors / drivers present in Belgium (step 1, left) and at risk pixels (white) 
versus not at risk pixels (black) per risk factor (step 2, right). 
Step1: Hosts, vectors, landscape and meteorological factors; Full scale between 0-100% probability or min.-
max.density/km2. Step 2: Selected pixels at risk (grey) are at or above the 80th percentile (hosts, ticks and landscape 
factors) or at or below the 20th percentile (negative Autumn T° slope) of the distribution; WGS 84 projection 
 
Original layer (Step 1) Selected layer (Step 2)
Vegetation layer 
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Figure VI-11 (Continued). Descriptive TBE risk factors / drivers present in Belgium (step 1, left) and at risk 
pixels (white) versus not at risk pixels (black) per risk factor (step 2, right). 
Step1: Hosts, vectors, landscape and meteorological factors; Full scale between 0-100% probability or min.-
max.density/km2. Step 2: Selected pixels at risk (grey) are at or above the 80th percentile (hosts, ticks and landscape 
factors) or at or below the 20th percentile (Autumn T° slope) of the distribution; WGS 84 projection. 
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Figure VI-11. (continued) Descriptive TBE risk factors / drivers present in Belgium (step 1, left) and at risk  
 pixels (white) versus not at risk pixels (black) per risk factor (step 2, right).  
Step1: Hosts, vectors, landscape and meteorological factors; Full scale between 0-100% probability or min.-
max.density/km2. Step 2: Selected pixels at risk (grey) are at or above the 80th percentile (hosts, ticks and landscape 
factors) or at or below the 20th percentile (Autumn T° slope) of the distribution; WGS 84 projection 
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Figure VI-12. Map of TBE risk factors with serolopositive communities (Step 3). 
Number of TBE risk factors present in Belgium for 1km2 pixels (color code 0-6) and Belgian communities with 
TBEV-seropositive reactions in vector overlay; (veterinary: red polygons; medical: blue polygons). 
Figure VI-13. Map of TBE positive roe deer in Flanders, adapted from Tavernier et al. (2015). 
Orange circles: these zones were sampled (n=11); Red circles: the TBEV-seropositive zones were no. 2 (n=1/4) , 
no.7 (2/24) , no.9 (1/11) and no.10 (1/47). 
TBE Risk Factors versus seropositive communities 
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The cattle cases in southern Belgium do overlap with the roe deer cases in Liège and 
Luxembourg (data not shown; Dr. Linden A., pers.comm.). Comparing the Figures VI-9, VI-12 
and VI-13, there are also matching case patterns i.e. overlaps in Limburg for cattle (Roelandt et 
al., 2014), roe deer (areas no. 9-10) (Tavernier et al., 2015) and wild boar (Roelandt et al., 2016). 
There is a further overlap between roe deer (area no.7) and humans in Antwerp province. These 
overlaps are some further substantiation of true TBEV endemic foci in these areas.  
The human inconclusive seropositives around Brussels may indicate a potential relationship 
with the Sonian forest that contains well-known recreational areas full of suitable TBEV hosts, 
vectors and habitat. So far this has not been matched with positive dogs (Roelandt et al., 2011), 
but one roe deer was TBEV-seropositive in Flemish Brabant (Tavernier et al., 2015); the other 
species were not yet sampled in this area. Furthermore, the medical data need to be interpreted 
with great care, since the suspected patients mainly came from the same hospital (Cliniques St. 
Luc, ULC, brussels): there is some selection bias. And since the patients’ flaviral vaccination 
histories were unknown, these results may still indicate a population vaccinated against e.g. 
TBEV or YFV and traveling internationally.   
Statistically, the p-value for the one-sided Mann-Whitney-U test for all species together 
(NISpos=26 vs NISneg=268) was not significant (p=0.9342). The one sided p-value for cattle + 
wild boar (NISpos=15 versus NISneg=30) was statistically significant (p<0.01), indicating that 
veterinary (cattle+boar) seropositive communities are associated with a higher number of TBE 
risk factors, but not so for dog and human seropositives. 
 DISCUSSIONVI.3
 RISK FACTOR MAPPING METHODSVI.3.1
We considered many potential data layers, but many were not available at short notice and in
a raster format. Despite the plethora of potential risk factor variables to choose from (Table I-1 
and Annex VI.4), the current selection covers the three main categories (bold) of TBE risk 
factors (Lambin et al., 2010):  
(1) Life cycles and population dynamics of pathogens, hosts and vectors;
(2) Landscape structure and composition, configuration and connectivity;
(3) Human behaviour and land use.
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For this first qualitative TBE risk mapping at the scale of 1 km2 Belgian pixels, the counting 
of quite broadly defined “presence/absence” risk factors was used, as opposed to fully 
quantitative modelling of the continuous raster data (Belgium = 30,528 x 1km² pixels). Quantiles 
can be applied to such continuous distributions, providing a way to allow rank statistics of these 
variables, such as Mann-Whitney-U test (syn. Wilcoxon rank-sum test).  
In our approach, we arbitrarily defined the risk factor’s presence or absence (ranks) based on 
the more extreme quantiles of the observed continuous distributions (20% upper or lower values). 
This might not be totally realistic, but with the real Belgian risk factor regression coefficients 
missing and with insufficient case data, this dichotomization per risk factor was the only 
approach feasible at this time; the 20% cut-off is meant to be sufficiently sensitive/specific.  
The dichotomous cut-offs and the summing of risk factors with the same weigth/coefficient 
(=1) are in fact a simplification of logistic regression treatment of predictive variables, to obtain 
ordinal colour ranks according to the number of risk factors present. Together with overlay of the 
seropositive communities (available case data in vector format) was the only mapping/regression 
approach feasible with the available data at this time.  
The original cattle and wild boar studies were risk-based at the province selection level, 
based on the risk of TBEV introduction from Germany. However, at the community level, all the 
available serum samples were used, independent of animal densities or other TBEV risk factors, 
allowing for random selection at this level and comparison of risk factors at the community level 
within those selected regions. However, as was concluded after each of the serology studies, the 
local/regional TBEV seroprevalence should not be extrapolated to the whole Belgian territory 
without further surveillance and verification. 
Despite these limitations, the observed seropositive Belgian communities in all species do 
seem to fall within the arbitrarily defined “at risk” zones that are associated with a qualitatively 
higher number of risk factors (orange-red zones: 4-6 risk factors). For the cattle and wild boar 
data, there was a statistically significant association in the MWU-test.  
Additionally, we also included human, roe deer, sheep risk, vegetation and meteorological 
factors. The output thus allows us to hypothesize that cattle and wild boar exposure is to be 
expected where more of these other factors are present. Provided that a much larger number of 
confirmed Belgian cases/infections can be obtained for the whole territory, these risk factors 
could be confirmed or refuted, as has been done in other countries. 
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 Predictive and spatial modelling would provide a much more detailed and precise insight 
(real regression coefficients) on the spatial distribution of Belgian TBE risk, and of the relative 
importance of the different risk factors, much as done in other Europan TBEV, Lyme and tick 
modelling studies (see VI.1.3. and Annex VI.4).  
 PREDICTION VERSUS REALITY VI.3.2
In Figure VI-6 and in the accompanying models of Randolph et al. (Randolph, 2000; 
Randolph et al., 2000; Randolph and Rogers, 2000), using remote sensing data of well known 
TBEV climatic risk factors, it was predicted that TBEV would not spread so far westwards. 
Belgium should never contain TBEV endemic areas, although the scenario was not completely 
excluded. The biological/epidemiological basis for this prediction was the predicted absence of 
co-feeding of nymphs and larvae due to some climatic requirements (temperature slopes) (Prof. 
Dr. Randolph, pers. comm., 2009).  
Currently, sixteen years after these models and predictions, five Belgian sentinel serology 
studies point towards TBEV presence in Belgium, against all expectations. A “co-presence” of 
overwintered nymphs with new larvae has been observed in Belgium during late Spring (May-
June) in diverse vegetation types (Tack et al., 2012). It would still need to be confirmed whether 
these nymphs and larvae actually “co-feed” on hosts during this period. 
Our calculations on The Belgian monthly maximum temperatures (Tmax: 17-19°C; data not 
shown) and negative Autumn slopes (between 3.65-4.79°C per month) are indeed objectively 
below the previously defined risk zone for co-feeding: Tmax: >24°C – Autumn slope: 8-9°C per 
month (Randolph et al., 2000). This would seem to exclude TBE zones in Belgium, however, our 
temperature data were based on the years 1980-2000.  
In the mean time, climate change (hotter/longer summers, warmer winters, increased annual 
rainfalls) may indirectly have played a role in the increase of the number of Belgian Lyme 
disease cases (n1991 = 137 → n2000 = 1,442) by favouring vector development (Clement and Van 
Ranst, 2002 ; Hoyaux et al., 2011) and could potentially lead to introduction of diseases such as 
TBE into new places (BELSPO-VGT10; Hoyaux et al., 2011). 
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Since we defined risk as the 20% most extreme of the Belgian temperature slope ranges, a 
large part of Belgium remained in the defined risk zone for this study. Perhaps the temperature 
dichotomization might have been a little more strict (5-10% most extremes as risk zone), to 
exclude more of the Belgian territory, although there is no objective reason for or against this, 
until the potential for co-feeding and more recent temperature (slope) data are re-assessed for 
Belgium.  
Additionally, very recently (June 2016), a Dutch-Belgian research team has detected the first 
ELISA- and SNT-positive Dutch roe deer in sera collected during 2010. Importantly, TBE viral 
RNA was also detected in two questing ticks from the same location in 2015 (Jahfari et al., 
[submitted]), demonstrating the presence of TBEV in the Low Countries (60km from the Dutch-
German border), where it was not predicted. 
 ANNEX RISK FACTORS*VI.4
*Significant risk factors found in EU and USA mapping 
and predictive modelling studies on TBE – Lyme –Ticks – Reservoir/Host 
 METEOROLOGICAL AND CLIMATOLOGICALVI.4.1
High daily maximum temperature, low daily wind speed, low daily relative humidity and high daily vapour
pressure deficit (BE) (Li et al., 2012a); high number of days with max. temp 24°C, high precipitation in the last two 
months (BE)(De Keukeleire et al., 2015); land surface temperature (EU; Randolph, 2000); low 
humidity/precipitation (UK) (James et al., 2013); mean summer temperature above 12°C (SW) (Palo, 2014); 
autumnal cooling rate (IT)(Rizzoli et al., 2007); amount of precipitation (snow) in December (SW)(Haemig et al., 
2011); temperate climate with high relative humidity and seasons (USA) (Falco et al., 1999); increase in winter 
temperatures rainfall (USA) (Estrada-Pena, 2002b);  8°C annual isotherm and mean rainfall 800mm (EU)(Labuda et 
al., 1997a; Labuda et al., 1997b; Labuda and Randolph, 1999); maximum, minimum, and mean temperatures and 
vapor pressure (USA) (Brownstein et al., 2003); no effect fast spring warming (D)(Kiffner et al., 2010); effect fast 
spring warming (EU) (Randolph and Sumilo, 2007); mild winter and high summer temperatures, and low seasonal 
amplitude of temperatures (EU) (EEA, 2012); higher temperature promotes tick + higher humidity promotes virus 
replication in ticks (EU)(Sonenshine  and Mather, 1994); dry and hot spring may disrupt cofeeding (CH)(Burri et al., 
2011); February to May the temperature rises rapidly >10°C (larvae) and >7°C (nymps) at 60cm above soil 
(Randolph, 2004) and simultaneous dry weather(Randolph and Storey, 1999); mild winter followed by hot/dry spring 
decreases nymphs (CH)(Burri et al., 2011); higher rate of autumnal cooling (mean monthly LST august – October ) 
(Randolph, 2001); milder winters less days of < -7°C and extended spring/autumn with >5-8°C (SW)(Lindgren and 
Gustafson, 2001; Randolph and Rogers, 2000); >85% relative humidity =  broadleaved litter layer; (Randolph, 
2000);  
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NDVI annual amplitude, amplitude/phase of LST, middle infrared radiation , ground temperature (Randolph, 
2000). 
 LANDSCAPE STRUCTURE  VI.4.2
 High proportion of broadleaved forest (BE) (Li et al., 2012a); high proportions of forest and broadleaved forest, 
agriculture, artificial/urban, peri-urban; low proportion of arable land or water and high proportion of artificial land 
of semi-natural habitats bordering forest (BE) (De Keukeleire et al., 2015); high proportion of forest, low proportion 
of agricultural land, smaller villages with smaller less aggregated human populations (HU)(Racz et al., 2006); high 
proportion of forests and high proportion spatially dispersed larger houses (BE) (Linard et al., 2007); 
environment/land cover is suitable for tick and tick-host populations (LT; Wanwambeke et al., 2010); highly 
fragmented woodlands, low proportion of adjacent grasslands (BE; Li et al., 2012b); diverse broadleaved or mixed 
forest with water bodies, holiday houses and open areas/clear-cuts (SW: Zeimes et al., 2014); green vegetation or 
proportion of woods, less developed/urbanised region (USA) (Glass et al., 1995); more greenness (relative measures 
of vegetation structure and moisture) and wetness (vegetation abundance) (USA) (Dister et al., 1997); high risk in 
mixed and deciduous woods with shrubs versus low risk in coniferous woods (CZ) (Daniel et al., 1998); land cover 
(USA) (Bunnell et al., 2003); proportions of broad-leafed, mixed and coniferous forest cover (D) (Kiffner et al., 
2010); protective effects agricultural land, low residential housing, flat land, inside of forest versus risk at forest edge 
(USA) (Das et al., 2002); higher vegetation indices in the May-June period (EU) (EEA, 2012); broadleaved forest >> 
coniferous/non-wooded (Randolph, 2000). 
 LANDSCAPE CONFIGURATION  VI.4.3
High forest edge density, high area-weighted mean forest shape index, high forest patch fractal dimension, low 
Euclidean mean nearest-neighbour distance between forest patches (BE)(Li et al., 2012a); high proportion edge 
forest-artificial land, low proportion edge forest-water, high edge density, low distance to nearest forest patch (BE) 
(De Keukeleire et al., 2015); mixed landscapes in peri-urban areas (Lyme) versus remote forest areas with low 
urbanization (hanta) (BE)(Linard et al., 2007); density, shape and aggregation level of woodland patches (BE) (Li et 
al., 2012b); well-connected forest with complex shape (SW) (Zeimes et al., 2014); residential properties close to 
wooded areas (USA) (Glass et al., 1995); deciduous forests with leaf litter or grass lands with shrubs and tall grasses 
(USA) (Falco et al., 1999); increase in woodland in close proximity of human habitation (USA) (Wilson et al., 
1985); more in deciduous, dry to mesic forests and less in grasslands, conifer forests, wet to wet/mesic forests (USA) 
(Guerra et al., 2002); heterogeneity of inner wood structure (CZ)(Daniel et al., 1998); distance to water, distance to 
forest edge (USA) (Bunnell et al., 2003); larger and less isolated forest patches have higher human risk but smaller 
more isolated patches have more ticks and tick infection prevalence (USA)(Brownstein et al., 2005); forest 
fragmentation to small patches (D) (Kiffner et al., 2010);  and well-connected vegetation patches (EU) (EEA, 2012); 
fragmented forest, patchiness, <1-2ha (USA)(Allan et al., 2003); areas with high forest, high NDVI, and moisture 
next to housing, agriculture, recreation (Randolph, 2000). 
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 GEOLOGICAL - GEOGRAPHICAL VI.4.4
Proportion of clay soil (as opposed to gravel, sand, silt) (BE) (Li et al., 2012a); low altitude (UK) (James et al., 
2013); more on alfisol-type soils of sandy or loam-sand textures overlying sedimentary rock and less on acidic soils 
of low fertility, a clay soil texture and Precambrian bedrock (USA) (Guerra et al., 2002); elevation and soil type 
(USA) (Bunnell et al., 2003); increased risk on slopes (USA)(Das et al., 2002). 
 WILDLIFE POPULATIONS VI.4.5
Roe deer hunting bag (BE) (Li et al., 2012a); changes in wildlife management practices leading to increase in 
roe deer (IT)(Rizzoli et al., 2009); roe and red deer abundance (UK) (James et al., 2013); wild boar population 
density much better than roe deer density (CZ) (Kriz et al., 2014); roe deer abundance/density (BE) (Linard et al., 
2007);  local host spatial patterns and movement (BE) (Li et al., 2012b); female > male in moose/roe deer/wild boar ; 
male > female in fallow deer ; older age ; areas with low/absent roe deer population may not be free (SW) (Gómez-
Martínez, 2014); abundance of European hare and red fox best predictors (SW) (Palo, 2014); wildlife abundance of 
unstable populations (Knap and Avsic-Zupanc, 2013); high abundance of fox and 1ow abundance of mink (SW) 
Haemig (Haemig et al., 2011); high abundance of wild boar, red/fallow deer versus low abundance of roe deer 
(SW)(Zeimes et al., 2014); increase in deer (USA: white-tailed deer) (Wilson et al., 1985); Increase in rodents (USA: 
white-footed mouse) (Allan et al., 2003); roe deer density and abundance of large adult animals (D)(Kiffner et al., 
2012); positive effect hunting bag roe deer, no effect hunting bag red deer,  negative effect hunting bag red fox, all in 
the previous year (D) (Kiffner et al., 2010); increases in roe deer (EU) (Randolph, 2001). 
 VEGETATION STRUCTURE VI.4.6
Structure-rich oak/deciduous forests, shrub cover, number of deer beds (BE) (Tack et al., 2012); normalized 
difference vegetation index NDVI (EU) (Randolph, 2000); vegetation structure + suitability for small mammals 
(IT)(Rizzoli et al., 2009); deciduous woodland type, high ericaceous/grass/herb/moss ground vegetation (UK) (James 
et al., 2013); oak, birch and pine forests with tree hight variation of ≥5m (SW) (Zeimes et al., 2014); NDVI ~ 
vegetation vitality (Estrada-Pena, 2002b); moist mat of undergrowth, broadleaved forests (Randolph, 2001). 
 SOCIO-ECONOMIC  VI.4.7
High income, separated large houses (Lyme), low income (Hantavirus-rodents) (BE) (Linard et al., 2007), low 
income ? recreation (TBE);  population is likely to enter the forest on a regular base, accessibility and land 
ownership (Latvia)(Vanwambeke et al., 2010)); accessibility and land ownership (BE) (De Keukeleire et al., 2015); 
accessibility: roads, holiday houses, attractiveness of forest (SW)(Zeimes et al., 2014); decrease in hunting (USA); 
(Wilson et al., 1985); awareness (Randolph, 2001). 
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AIMS AND FINDINGS OF THE THESIS VII.1
 EVIDENCE FOR TBEV PRESENCE IN BELGIUM (PHD AIMS 1-2)VII.1.1
Serology is internationally accepted as sufficient evidence to diagnose clinical cases, and for
contributing complementary or sufficient evidence to document endemic areas, according to the 
internationally accepted definitions of “TBE case” and “endemic area” (Amato-Gauci and Zeller, 
2012; ECDC, 2012; Süss, 2011; Süss et al., 2010).   
In this thesis the evidence “pro” TBEV-presence is indirect: it was obtained through three 
veterinary serological studies (Chapters III, IV, V; Table VII-1). Due to the encountered 
problems such as cross-reactions and specific validation problems for implementing ELISA 
protocols for TBEV, a seroneutralisation test was used in all studies for detection and 
confirmation of TBEV-specific antibodies.  
This SNT test is internationally accepted both in the medical and veterinary communities as 
the current gold standard for TBE diagnosis and surveillance purposes. Furthermore, in Belgium 
the SNT is performed under specific accreditation and it has scored well in international 
proficiency tests (PT report, pers.comm, V. Suin, WIV-ISP). Although no test or laboratory is 
ever 100% perfect, discarding all positive samples from this thesis as false positives would mean 
that the gold standard is only 98.26% specific. In this case, the observed seropositives would all 
be falsely positive: 1 positive dog (1/880), 17-23 positive cattle (17-23/650), 7-10 wild boar (7-
10/238) and 7 deer (7/596). 
All the efforts undertaken in this thesis (Chapters III, IV and V) to disprove the positive SNT 
results i.e. to exclude false positive reactions represented important additional work. This 
consisted of batteries of cross-reaction tests for all studies and an animal infection experiment in 
the cattle study. Indeed, in many other studies positive ELISA results are often considered 
unquestionable proof of TBEV-endemicity/positivity (See Tables I-3 and I-4).  
In each serological survey conducted in this thesis, it was found that most TBEV-
seropositive animals were not clearly positive for any other pathogen. Additionally, several 
animals had very high antibody titers (>1/125) and the bovine antibodies were effectively 
neutralising and protecting mice against virulent TBEV in an in vivo challenge.  
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Aspecific reactions are very rare in SNT, and since we have no reason to assume 
travel/dispersal-related infections in the cattle and wild boar, we may conclude that at least some 
of these animals were really exposed to TBEV in Belgium or very close to its borders.  
Based on Chapters III, IV and V (Roelandt et al., 2011; Roelandt et al., 2014; Roelandt et al., 
2016) and the additional knowledge from two other Belgian sentinel studies (Linden et al., 2012; 
Tavernier et al., 2015), TBEV has been present in Belgium from at least 2010 onwards. The 
current absence of a characterized TBEV-strain and of confirmed human/veterinary clinical cases 
is likely due to a lack of surveillance effort and sensitivity, and a lack of additional investigation 
or follow-up in focal areas where TBEV-specific antibodies were detected.   
 
Available evidence for TBEV presence in Belgium, anno 2016. 
Species Seroprevalence Sample  Reference 
SNT+ SNT +/- ELISA+ 
Dogs 0.11% 0.00% 1.13% n=880 Roelandt et al., 2011 
Cattle 2.61% 0.92% 3.85% n=650 Roelandt et al., 2014 
Wild Boar 2.91% 1.26% 5.46% n=238 Roelandt et al., 2016 
Roe Deer 0.4% 0.00% 12.4% n=498 Linden et al., 2012  
5.1% 0.00% / n=98 Tavernier et al., 2015 
Table VII-1: Available TBE Sentinel Data in Belgium anno 2015.  
SNT: seroneutralisation test; (+: positive result; +/- doubtful);  
ELISA: enzyme-linked immunosorbent assay; n: sample size 
 
In addition, the risk map as produced in Chapter VI, has demonstrated in a qualitative way 
that the overlayed seropositives match with a higher number of risk factors. For the cattle and 
wild boar data, there was a statistically significant association. Additionally, there exist 
geographical overlaps between areas with seropositive Flemish cattle, roe deer and wild boar 
(Figures VI-9, VI-12 and VI-13), and between Wallonian cattle and roe deer (data not shown). 
Furthermore, the very recently discovered ELISA/SNT-seropositive deer in the Netherlands  
were also sampled in 2010 and the Dutch TBEV-positive ticks from 2015 were found at ~60 km 
of the Dutch-German border (Jahfari et al., [submitted]), hence also in an area in a country very 
similar to Belgium where emergence was not really foreseen (Gould et al., 2004; Randolph and 
Green, 1999; Randolph, 2000; Randolph et al., 2000; Randolph et al., 1999; Randolph and 
Rogers, 2000).  
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All these results suggest that the 16 year old paradigm of co-feeding - where co-feeding 
transmission alone determines the persistence or absence of TBEV endemic foci - may not be 
applicable in the Low Countries and should be re-investigated. Alternatively, perhaps co-feeding 
currently does occur in this evolving climatical and ecological setting, as nymphs and larvae have 
been co-present in Spring (Tack et al., 2012). This geographical region of Europe at the edge of 
the TBEV distribution has a more coastal climate than the TBE core zones in Central Europe, but 
climatic and other parameters still fall within TBEV’s and I. ricinus’ broad requirements 
(Hoyaux et al., 2011; Roelandt et al., 2010; Tack et al., 2012). 
 EVALUATION OF VETERINARY TESTS (PHD AIM 3) VII.1.2
VII.1.2.1 TBEV-ELISA for Screening
The IgG protocol of the commercial ELISA Immunozym FSME IgG All Species (Progen,
Biotechnik, Heidelberg, Germany) has been used by most veterinary researchers in several 
species (see Tables I-3-4): dogs, horses, goats, foxes, wild boar, cattle, ruminant milk, deer, 
monkeys, rodents and moose.  
In the studies presented in this thesis (Chapters III, IV, V), the same Progen ELISA kit was 
used to detect TBEV-specific IgG antibodies in the collected animal sera. This non-competitive 
indirect assay uses horseradish peroxidase – Protein G conjugate to detect any IgG against whole 
TBE-virus and can theoretically be used for TBEV testing in all species. In humans, this ELISA 
was shown to have a diagnostic sensitivity of 97% and analytical specificity of 99% for IgG 
(Progen, 2006).  
Despite the claim of being an “All-Species” ELISA, and despite the IgG-protocol being often 
used internationally, we experienced problems in obtaining accurate test results from all three 
selected species with the IgG kit, when compared to the gold standard serological TBE 
seroneutralisation test (Chapters III, IV, V; Table VII-2). We obtained less than satisfactory 
results, certainly for cattle, where even the measures of precision were suboptimal 
(repeatability/reproducibility coefficients of variation >20).  
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Since in validation studies the DSe is usually determined in a larger positive population, i.e.  
with higher prevalence, our DSe may be overly pessimistic due to the small number of positives 
obtained in the studies. However, it is clear that the Immunozym FSME IgG All Species kit will 
miss true positives in a population where the prevalence is moderate to low. As such, the IgG 
protocol may need considerable adjustments before being suitable as a sufficiently sensitive first-
line and large-scale screening test. 
Diagnostic Test Accuracy of the All-species IgG-ELISA.  
Species Parameter Results Sample 
Size 
Reference 
Dog DSe 1.00 (1/1 pos)  
 
n=1 Roelandt et al. (2011)  
n=880; Chapter III 
Negatives not confirmed  DSp 0.98 (9 false positives ) n=879 
Cattle DSe Min: 0.13 (0.00 - 0.27) 
Max: 0.17 (0.00 - 0.21) 
n=18-23 Roelandt et al.  
(2014 - unpublished)  
n=650; Chapter IV DSp Min: 0.89 (0.87 - 0.92) 
Max: 0.97 (0.96-0.98) 
n=627  
Wild 
Boar 
DSe Min: 0.40 (0.12 - 0.74) 
Max: 0.57 (0.18 - 0.90) 
n=7-10 Roelandt et al. (2015)  
n=238; Chapter V  
DSp Min: 0.91 (0.86 - 0.94) 
Max: 0.92 (0.88 - 0.95) 
n=228 
 Table VII-2: Diagnostic Test Accuracy of the All-species IgG-ELISA.  
As compared to TBE-SNT as gold standard. DSe/DSp: Diagnostic Sensitivity or Specificity; Min: with borderline 
SNT as true positives – Max: with borderline SNT as true negatives 
 
Klaus et al. (Klaus et al., 2011) used the Immunozym All-species FSME IgM kit in an 
adapted version (Müller, 1997) due to the claimed higher sensitivity of the IgG+IgM protocol, 
since it should additionally detect early infections. This protocol was indeed tested with a small  
number of available cattle SNT-positives, but this did not seem to result in improved sensitivity, 
thereby supporting our initial hypothesis that IgG-testing for previous exposure is potentially 
more likely to have a higher overall sensitivity in field studies, at the inevitable cost of some false 
positives. 
In addition, researchers will never know when the small window of opportunity of IgM 
detection (3-6 weeks post-infection) is exploitable in any field population (see Figure I-8). Most 
likely none of our cattle were experiencing an acute infection with IgM production (since all 
samples were collected during the winter months), and somehow the SNT-positives became 
falsely negative in the IgG+IgM protocol, making it even less sensitive compared to IgG-ELISA 
and SNT.  
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The Testline® EIA TBEV Ig® veterinary ELISA kit has been used once in a cattle, sheep and 
horse field study (Sîkutova et al., 2009). The Enzygnost® kit has been used in dog studies twice 
(Csángó et al., 2004; Lindhe et al., 2009). As far as we are aware, none of the veterinary ELISA-
tests in Table I-2, except the Progen® kit, were validated in veterinary species. No publications 
from the companies were found, therefore, it is difficult to say if any of the ELISA’s has superior 
accuracy. A veterinary penside test may be handy in the future, but the Reagena® ReaScan TBE 
IgM (rapid test) was not intended and has not been evaluated for use in animals (Table I-2; 
Reagena, pers. comm., 2015).  
Another WNV study has showed that with IDVET’s ID screen West Nile competition ELISA 
kit, 67 horses were seropositive and all (100%) were in fact strong true TBEV SNT-positives, as 
confirmed in TBE-SNT (Rushton et al., 2013). Only 9 reactor horses showed a low grade 
reaction in the WNV- and USUV- SNT’s (Rushton et al., 2013). This means that researchers 
studying WNV, USUV or LIV by ELISA in any animal species in Europe, should always check 
for TBEV in their differential of seropositive ELISA results.  
In the future, more accurate TBEV-ELISA kits may be developed based on subviral particles 
(recombinant viral proteins) produced in mammalian cell cultures. Obara developed an in-house 
medical IgM/IgG ELISA based on FE-TBEV subviral particles, which showed higher sensitivity 
(94.1-98.8%) and specificity (100%: no cross-reactions with JEV) than a commercial medical test 
based on whole virions, when compared to SNT with a panel of human sera (Obara et al., 2006).  
Ikawa-Yoshida developed a similar ELISA with subviral particles for rodent sera, and 
equally found increased accuracy (91.4% sensitivity and 100% specificity) opposed to one with 
recombinant E-proteins (77.1% sensitivity and 80.0% specificity), both compared to SNT 
(Ikawa-Yoshida et al., 2011).   
VII.1.2.2 Confirmation Tests to rule out Cross-Reactions 
Aspecific or false positive SNT-reactions cannot be 100% excluded in TBEV-negative 
samples 100%, especially at low dilution titers. Nonetheless, this remains a rare event and mostly 
in IgG kits (Klaus et al., 2014; Niedrig et al., 2007a; Niedrig et al., 2007b). Klaus et al. (2014) 
very recently reported rare cross-reaction in TBEV-SNT with homologous LIV in sheep. This is 
fairly unsurprising given the close phylogenetic and antigenic relationships between the viruses. 
Importantly, such cross-reactions were not found in other species infected with a variety of other 
flaviviruses at diverse dilutions/titers (Klaus et al., 2014).  
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Our studies equally documented some of the expected flaviviral cross-reactions, as one of 
the dogs reacted more strongly to LIV-HIT than to TBEV-SNT, and some of the wild boar 
showed a reaction in LIV-HIT and/or USUV/WNV-SNT. In flaviviral research, cross-reactions in 
ELISA kits are so common that we might hypothesize that almost “any” veterinary flaviviral 
ELISA kit could potentially be used as a screening test for TBEV-exposure.  
Ultimately, these cross-reactions are only a real concern for laboratories in regions where 
multiple viruses could co-circulate (Klaus et al., 2014). This is currently highly unlikely in 
Belgium, where the presence of other flaviviruses has not been reported in any species during the 
studies performed and presented in this thesis (Beck et al., 2013; FASFC, 2011, 2012, 2013, 
2014c, 2015a, b; Hubalek et al., 2014; OIE-WAHID, 2014), besides 2 single dead birds with 
USUV (Garigliany et al., 2014). 
Despite being an absolute necessity, SNT confirmation testing against other possibly cross-
reacting flaviviruses was not always straightforward. The selected SNT for a combination of 
species and flavivirus was not always readily available in Belgium/Europe (e.g. LIV/ USUV) or 
not validated for the species under study so that quality of the assays could not be guaranteed 
(e.g. WNV in wild boar). For the confirmation testing we preferably selected genetically related 
(LIV) and geographically relevant viruses (USUV, WNV, LIV: see Figure VII-1)(Beck et al., 
2013). However, our sample panels came from non-target species for each respective test, e.g. 
wild boar, dog and cattle versus birds, horses, or small ruminants. Hence, control sera of the 
correct species-flavivirus combinations were often not available. 
 
 
Figure VII-1:  Flaviviruses geographically relevant to Belgium (present in neighboring countries). 
WNV: West Nile virus; USUV: Usutu virus; LIV: Louping ill virus;                                                              
Selected from Beck et al., 2013. 
 
General Discussion 
138 
Moreover, the SNT is a delicate test and poor quality samples necessitated kaolin sample 
treatments for the wild boar and cattle sera besides the usual pre-heating and treatment of stable 
cell cultures with antibiotics. Occasionally, we had to opt for “second choice” confirmation tests 
such as ELISA, HIT or IFAT. Nonetheless, despite the potential cross-reactions, in medical 
diagnosis HIT and IFAT are generally known as reasonably sensitive tests (Storch, 2007), that 
may also be specific in skilled hands through repetition and titer comparisons (Duscher et al., 
2015b), and that may agree well with SNT (Litzba et al., 2014).   
In the wild boar study, we tested the Euroimmun flaviviral IFAT-biochips 
(www.euroimmun.ch) for medical diagnostics (TBEV/WNV/JEV/YFV/DENV)(Litzba et al., 
2014), after recalibration with specific primary/secondary conjugates and with porcine TBEV 
control samples obtained from the Friedrich Loeffler Institute (FLI). This IFAT confirmed only 
the three strongly SNT-positive/ELISA-positive wild boar and thus currently seems to be a less 
sensitive test than TBEV-SNT in wild boar.  
VII.1.2.3 Test Validation
Due to the low accuracy characteristics of the veterinary TBEV-ELISA, it is recommended to
validate these methods for each species tested. This can be done using standardized, highly 
positive as well as diluted control samples and ROC-analysis to adjust IgG cut-offs to obtain the 
DSe and DSp envisaged for specific surveillance purposes (rule-in or rule-out screening).  
The few available veterinary commercial veterinary screening tests have most likely still 
been insufficiently validated and quality controlled by the manufacturers: there are no 
publications by the companies. In our studies, several positive samples were clearly missed by 
the IgG-ELISA and several false positives were equally observed in each species.  
It is thus vital that at least during the first time that a test-protocol combination is used in 
TBEV-surveillance in a new species, attempts should be made to properly validate it before 
estimating seroprevalence or claiming freedom from infection. Some efforts have been done in 
domestic animals by Klaus and colleagues at FLI (Klaus et al., 2011; Klaus et al., 2010c) and in 
the present thesis, as described in Chapters III, IV, and V. However, TBEV remains a second 
priority pathogen in European veterinary and wildlife test validation projects (EWDA, 2015; 
Wildtech, 2010). 
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Another recurring issue in veterinary TBEV-ELISA testing is not excluding false negatives 
and/or positives. Many authors do not test all ELISA-positives in SNT, and most do not test any 
ELISA-negatives in SNT. However, at least 2 of the studies reported in the present thesis (cattle 
and boar: Chapters IV and V) have shown that the investment in confirmation testing of a 
considerable number of negatives must be made at least once per species, in order to evaluate the 
true DSe and DSp of the ELISA test protocol in the populations and species under study. This 
will allow adjustment of seroprevalence estimates for the imperfection of the screening test. 
Consequently, if we had retested all the ELISA-negatives in our dog study in SNT (Chapter III), 
perhaps more than one true positive dog would have been detected, and the canine population 
seroprevalence estimate may have been higher than 0.11%.  
Lack of diagnostic TBEV test validation remains to our knowledge a large gap in current 
veterinary flaviviral diagnostics, which needs to be resolved at an international scale, through 
cooperation of veterinary (reference) laboratories with the ELISA producers, if veterinary 
sentinel surveillance is to be adopted to complement medical TBEV-surveillance in a 
standardized and quality-controlled way. International and standardized serum panels of diverse 
species-flavirus-combinations for veterinary proficiency testing are needed. The tests in use may 
benefit from no-gold-standard statistical evaluation (Klaus et al., 2011).  
In any case, without robust confirmation, the current veterinary screening studies that are 
regularly published lose specificity and thus scientific value, as they actually may be saying more 
about “any apparent flavivirus prevalence” as opposed to the “true TBEV prevalence” in the 
population.  
VII.1.2.4 Test Selection and Use 
In general, it is known that measures of accuracy are not fixed indicators of a test 
performance (Šimundić, 2008) and that test accuracy in the field may be influenced by many 
factors, including population characteristics, genetic variation in the infectious agent, the 
sampling, storage and test methodologies and the population prevalence (Banoo et al.; Leeflang 
et al., 2009). With the ELISA accuracy results obtained during this thesis, it seems ill advised to 
start using any ELISA as a TBEV screening test in a low prevalence area at the fringe of the 
TBEV geographic distribution, at least not before some further international validation of these 
tests in multiple species.  
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The main reason for this is that Belgium and other low prevalence countries first have to be 
able to accurately map their endemic risk areas, as opposed to just estimating a true prevalence 
from an apparent ELISA-prevalence, to follow relative trends. For this risk assessment purpose, 
an unknown proportion of ELISA-false negatives may constitute a major problem. Clearly, this 
has never been an issue in the core areas of TBE(V) endemicity where the ELISA-tests were 
developed, as there the seroprevalence is usually quite high in one or more species, and clinical 
cases are much more common. 
Therefore, the IFA and SNT are currently the most accurate veterinary serological tests for 
the Belgian situation, for either surveillance or diagnostic settings. Even when testing all sera 
with SNT/IFA tests is not sustainable in field screening, it should currently be best practice to test 
all ELISA-positives and -doubtfuls in SNT/IFA, together with a randomly selected sample of the 
ELISA-negatives. In the mean time, research projects should focus on continued (re-)validation 
and improvement of current ELISA’s (e.g. sub-viral particles, study matrix and species effects on 
analytical and diagnostic sensitivity/specificity, sample preparation protocols, etc). The goal 
would be to obtain a more accurate and better characterized screening tool applicable to low 
prevalence settings for surveillance, risk assessment and trend watching purposes.  
 EVALUATION OF VETERINARY SENTINELS (PHD AIM 4) VII.1.3
VII.1.3.1 The ideal TBE(V)-sentinel Species
The ideal species for TBEV sentinel surveillance should have an adequately limited home
range in comparison to TBE focus size, which is often a few 0.5 - 1 km2 (Dobler et al., 2011; 
Imhoff et al., 2015), should be available in large numbers, should be well dispersed in the 
surveillance area, and should show a long-lasting response after natural infection (Dobler, 2010; 
Gerth et al., 1995; Kunze, 2015). Additionally, (sero)prevalence should show a good spatial 
correlation with human TBE incidence, and frequent tick exposure/infestation is an advantage 
(Imhoff et al., 2015).  
Considering the results in this thesis (Chapters III, IV, VI), a number of additional practical 
and epidemiological factors should equally be taken into account to set up an effective sentinel 
surveillance (Table VII-3), as these issues may severely limit certain aspects of the study, such as 
the diagnostic accuracy, the statistical power of the results, or the precision of any calculations 
(freedom/prevalence) and the potential to proceed with modelling or mapping exercises. 
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Table VII-3: Suitability criteria for TBEV sentinel surveillance. 
Expanded from Dobler (2010), Gerth et al (1995), Kunze (2015), Imhoff et al. (2015) 
 
VII.1.3.2 Experiences with and Suggestions for Dogs, Cattle and Wild Boar  
The provincially selected private sentinel laboratories in Belgium were good contact points to 
construct an active sentinel surveillance component based on a convenience sample (leftovers 
from previous tests). This can be fine tuned by adding some more laboratories to covering the 
whole Belgian territory. At present, it would take a considerably larger effort to organize a 
nationwide random surveillance in this species, since national companion animal databases are 
not easily accessible for research. ID-Chip databases could be a starting point to obtain a 
sampling frame (e.g. Dogs: https://www.dogid.be/nl/home; Cats: http://www.idchips.com/nl/; 
Horses: http://www.cbc-bcp.be/identificatie/).  
Aditionally, a very low exposure prevalence was found in the Belgian dogs tested (0.11%, 
n=880), which would seem to imply very large sample sizes needed to detect TBEV or to 
substantiate freedom (especially at a local level). On the other hand, some Belgian hotspots for 
ticks and Lyme disease such as Limburg and Luxembourg (Ducoffre, 2008b; WIV-ISP, 2011) 
were not covered in our dog study, which may have biased our results towards a low prevalence. 
Finally, we did experience difficulty in locating the actual exposure site for the SNT-seropositive 
animal, even with the detailed anamnesis that was obtained, e.g. travel history, tick bites and 
prevention and (flavivirus) vaccination status.  
Table VII-3 Suitability criteria for TBEV sentinel surveillance 
Clinical  
Characteristics 
- Clinical cases, viraemia and/or lasting antibody response 
- No flaviviral vaccination or exposure to other flaviviruses than TBEV 
- Tick exposure, good tick host and lack of preventive actions 
Correlation with   
spatial human risk 
- Useful proxy for human risk behaviour,  mobility and travel 
- Spatial presence at national (NUTS 1), regional (NUTS 2), local (NUTS 3/4)  
- Suitable home range (km²) and  representative - even distribution in the area 
Epidemiological      
Parameters 
- Knowledge of population size, density and sampling frame  
- Pre-existing surveillance for other pathogens: passive, active or targeted 
- Sample size sufficient for the surveillance purpose and design prevalence 
- Place on the iceberg: close to tip (clinical) or base (cycles) 
Practical       
Parameters 
- Organisations - Governments involved and available funding  
- Serum quality, volume and transport 
- Available flaviviral diagnostic tests for each species-virus combination 
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Therefore, dogs should currently preferably be involved in a passive surveillance 
component. Such a component would be easier to install, with the cooperation of the two 
university veterinary clinics in Belgium (in Liège and Gent). Severe neurological veterinary cases 
in dogs and horses are most likely to be seen by these referral centers, and they may already 
dispose of stored sera/CSF of interesting, undiagnosed aseptic meningitis cases (Dr. Cornelis I., , 
pers. comm., 2015).  
In Belgium, domestic cattle are easy to sample as part of pre-existing veterinary surveillance 
programs (FASFC, 2014a). Since cattle and their movements are well-documented in the Belgian 
Sanitel Database (Ensoy et al., 2014; FASFC, 2016), serological reactions in cattle serum or milk 
should be the result of a verifiable and traceable exposure locality. Surveillance based on large 
scale existing national surveillance for cattle pathogens (FASFC, 2014a) would deliver steady 
and good quality cross-sectional and longitudinal sentinel data.  
Random sampling is feasible and the resulting data are routinely registered by the Veterinary 
Authorities (FASFC) and readily accessible to government researchers. Despite the detectable 
prevalence in a similarly low range as the wild boar, the cattle titers were generally lower than 
the wildlife titers. The reason for this is currently unknown (e.g. lower tick exposure, test 
characteristics, low infection susceptibility). 
Wild boar have been sampled in both Belgian regions before, to survey Aujeszky’s disease 
(Czaplicki et al., 2006; Linden, 2005; Verpoest et al., 2014; Vervaeke, 2012), brucellosis 
(Gregoire et al., 2012; Linden, 2005; Vervaeke, 2012), classical swine fever (Linden, 2005; 
Mintiens et al., 2005; Vervaeke, 2012), bovine tuberculosis (Linden, 2005), and hepatitis E virus 
(Thiry et al., 2015).  Despite the fact that wild boar are not distributed homogeneously throughout 
the whole Flemish territory (see Figure VII-2a), the results were still representative at the local 
level, as discussed in Chapter V (Roelandt et al., 2016).  
The TBEV screening study in wild boar was easily attached to the existing yearly wildlife 
disease surveillance scheme in the Flemish communities. The field work and sample flow were 
pre-existing and well organised, however, background data on these wild animals is somewhat 
harder to obtain and was often incomplete.  This also remains a convenience sample as opposed 
to the preferable first stage random sampling of spatial units (NIS/UTM), followed by a second 
stage hunter sampling of predefined sample sizes per demographic category (age – sex). 
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VII.1.3.3 Alternative Sentinels 
In recent studies, dogs and cats have turned out to be cost-effective proxies/sentinels to 
target for human tick-borne disease risk assessments in (peri-)urban areas (Chomel, 2013; 
Jongejan and Uilenberg, 2013; Pfeffer and Dobler, 2013). Pets have certainly contributed to tick 
surveillance and identification of new pathogens and tick foci on a local scale (Beck et al., 2014; 
Claerebout et al., 2013; Eichenberger et al., 2015; Schreiber et al., 2014). Horses have been good 
sentinels and suitable for risk mapping in other countries (Imhoff et al., 2015; Janitza-Futterer, 
2003; Klaus et al., 2013). They are worth considering for active (serological) and passive 
(clinical) sentinel surveillance folowing similar principles and remarks as for dogs.  
In Wallonia and Flanders (2005-2015), cervid samples have been collected for 
paratuberculosis and tuberculosis surveillance (Linden, 2005), for surveys on Bluetongue virus, 
Schmallenberg virus and Hepatitis E virus (Linden et al., 2010; Linden et al., 2008; Thiry et al., 
2015), and for serological screening for several ruminant pathogens (De Bosschere et al., 2006; 
De Craeye, 2012; Tavernier et al., 2015).  
TBEV seropositivity was found in Wallonia (Linden et al., 2012) and in Flanders (Tavernier 
et al., 2015). Roe deer should be a priority for TBEV sentinel surveillance in Belgium, as they are 
key I. ricinus and TBEV hosts. They can serve for a randomized veterinary serosurveillance in 
forests to complement cattle surveillance in meadows. Most researchers have had good 
experiences with this species (see Tables I-3 and Chapter I). Furthermore, roe deer are more 
homogeneously spread throughout the whole Belgian territory: see Figure VII-2b 
(www.waarnemingen.be). A randomized sampling procedure would once again be preferable 
over risk-based or convenience sampling, to highlight as many risk areas as possible.  
Despite the availability of existing surveillance networks for other (smaller) mammal and 
bird sentinel species, they should not be considered as a priority for TBEV sentinel surveillance. 
They may have too many drawbacks for TBEV surveillance such at large scale, such as small 
blood volumes for the necessary assays, suboptimal risk-correlation, less homogeneous spatial 
distribution or less sampling opportunities and large mortality.  
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Figure VII-2a/b:  Wild species sightings by the general public in Belgium (26/05/15 – 26/05/16).  
a: Wild boar sightings (n=1235 animals in 262 UTM’s); b: Roe deer sightings (n=2804 animals in 865 
UTM’s); UTM: universal transversal Mercator square unit (5 km), www. http://waarnemingen.be/                                          
 CURRENT KNOWLEDGE GAPS AND PRIORITY ACTIONS         VII.2
(PHD AIM 5) 
   PRIORITY 1: MEDICAL SURVEILLANCE AND AWARENESS VII.2.1
Belgium has always simply been assumed to be TBEV-free, though this was based on very 
little scientific evidence (Haglund et al., 2003). In 2016, despite five veterinary sentinel 
publications between 2010-2016, and despite multiple unexplained/inconclusive seropositive 
human cases, the medical world still considers TBEV as a non-endemic virus and of little  
importance to Belgium (Callens, 2016).  
However, despite improvements in the diagnosis of viral encephalitis since the use of PCR on 
CSF to try and detect the more common viruses (Debiasi and Tyler, 2004; Jarrin et al., 2016; 
Parisi et al., 2016), the aetiology of up to 75% of aseptic/viral encephalitis and meningitis cases 
remains unknown around the world, even in 2016 (Donoso Mantke et al., 2008b; Frantzidou et 
al., 2008; Glaser et al., 2003; Harrell and Hammes, 2012; Jarrin et al., 2016).  
Since 2010, there has been a TBEV National Reference Laboratory for Belgium, which is 
currently hosted by the Institute of Tropical Medicine (Antwerp). None of the Belgian samples 
submitted to the ITM between 2014-16 were positive in serology (n=40) or PCR (n=25), while  
occasional imported travel related cases (1 per year) continue to be diagnosed (Dr. M Van 
Esbroek, ITM, pers. comm., 2016). 
This is more or less the expected number, considering ECDC and other data sources reported 
a total of only 38 travel-related cases for 2012 (Rendi-Wagner, 2004; Steffen, 2016). 
a: wild boar b: roe deer 
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Nonetheless, if 70% of TBE cases are symptomatic, the EU and Belgium should at least count 
n=127 and n=7 travel-related infections respectively. Considering the TBE-risk of 1 /10,000 for 
an unvaccinated tourist staying in highly endemic areas in Austria and applying this to total 
numbers of summer tourist overnight stays one should expect 60 clinical TBE case leaving 
Austria per year (Rendi-Wagner, 2004).  There is still a significant amount of underdiagnosis and 
underreporting.  
Moreover, TBEV does not feature in the regular diagnostic panel for locally acquired 
medical encephalitis (unless very clear anamnestic indications)(Jarrin et al., 2016; Parisi et al., 
2016; Solomon et al., 2007) and medical surveillance has been very passive and limited (1 
laboratory). The professional awareness in regards with prevention of travel related TBE cases is 
only beginning to rise now (ITM, pers.comm., 2016).  For the clinician, it is important to try to 
establish an etiologic diagnosis in all cases of encephalitis/meningitis, even if there are no 
specific effective treatments. The identification of a specific etiological agent, such as TBEV, 
may still be important for the individual prognosis and counseling of patients and family 
members (Tunkel et al., 2008). 
The Belgian veterinary sentinel studies (Linden et al., 2012; Roelandt et al., 2011; Roelandt 
et al., 2014; Roelandt et al., 2016; Tavernier et al., 2015), the Dutch ones (Jahfari et al., 
[submitted]; van der Poel et al., 2005) and the recent discovery of a new TBE-virus in the 
Netherlands on tick samples from September 2015 (Jahfari et al., [submitted]), should now 
prompt Belgian scientists and clinicians to reconsider this situation. The studies described and the 
evidence presented lead us now to reject the old hypothesis that TBEV is not present in Belgium 
and that only very few travel related cases are to be expected. It is internationally accepted now 
that even authochtonous human cases are merely the tip of the iceberg, and that TBEV shows an 
emerging character in several European countries (see Chapter I).  
The Netherlands equally do not seem to have autochthonous TBE cases, but TBEV-infected 
questing ticks and seropositive sentinels are present within the Dutch territory. Clearly, enhanced 
medical surveillance and increased awareness among medical professionals are now absolute 
priorities for the Low Countries, necessary to minimize and assess any potential TBE risk to 
humans from this uncharacterised strain of TBEV and to guide prophylaxis and public health 
decisions and measures.  
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Additionally, medical surveillance may lead to explanations for the apparent mismatch 
between the veterinary findings and the lack of medical cases. Potential hypotheses to be 
explored may include: suboptimal diagnostic test quality, timing of (paired) sampling, 
insufficient testing by clinicians, lack of awareness, a large proportion of asymptomatic or 
clinically mild exposures, and presence of an atypical low-virulent TBEV virus.  
TBE could be made notifiable, as in other European member states (ECDC, 2012, 2014). 
Next to the enhanced passive components it should include an active component, to increase 
detection sensitivity of the surveillance system (Hadorn and Stärk, 2008; Rodriguez-Prieto et al., 
2014) and to improve usefulness, value and cost-effectiveness of the data (Thurmond, 2003). As 
suggested for veterinary surveillance, existing medical surveillance schemes and available 
ticks/sera/datasets should be exploited.  
Since Lyme disease and TBE share a large part of their epidemiologic triad, vector, risk 
factors and cycle, there are obvious benefits of combining TBE surveillance/awareness 
campaigns with the newly developed Belgian Lyme Disease Surveillance and Awareness 
Strategy. This medical program (Lernout, 2016) also follows a pyramid/iceberg approach, as 
proposed by Braks et al (2014): see Figure VII-3. It will include data collection and awareness 
creation on tick bites and Lyme (https://tekennet.wiv-isp.be/)(Lernout, 2016).  
This multi-component program will document tick bite GP consultations, include a large 
seroprevalence study in the general Belgian population (n=3,215 from 2013-14) and analysis of 
longitudinal seropositivity trends (sentinel laboratories). Finally, a project will assess the health 
burden and cost of Lyme disease (Lernout, 2016), which currently causes a median of 1,132.5 
hospitalized cases per year in Belgium (2003-2012) (Bleyenheuft et al., 2015).  
Figure VII-3: Belgian Medical Surveillance Strategy for Lyme Disease.  
As example for TBE medical surveillance (Braks et al., 2014; Lernout, 2016) 
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   PRIORITY 2: VIROLOGICAL RESEARCH  VII.2.2
The probability to detect TBEV via direct methods such as isolation and PCR, in ticks, 
humans or animals, is low given the currently available methods and low prevalence setting (see 
Chapter I). Due to this low detection probability and the considerable resources needed to collect 
sufficient ticks/samples to obtain confident results, scientists are often not activated to conduct 
such surveillance activities in low prevalence areas (Stefanoff et al., 2013). Such practical and 
financial objections have until now hampered efforts towards direct testing in Belgium, but also 
in other EU member states.  
TBEV does not often cause epidemics with high case loads, as might be the case with other 
vector-borne emerging diseases (e.g. Bluetongue virus or Chikungunya). Occasionally, one may 
be confronted with a food-borne outbreak with a few dozen cases, e.g. Košice, Slovakia, May-
June 2016 (KICM, 2016). This flavivirus remains mostly submerged in its tick-host cycles within 
largely unaffected populations of diverse wild/domestic species (Figure I-1, I-2). It causes only 
short viremia and the majority of infections are asymptomatic (Figure I-7).  
This makes it very difficult to catch the virus “in action” and the international scientific 
community still rarely succeeds in isolating TBEV-strains from known human/veterinary cases, 
or from hosts even in known highly endemic areas. Well characterized and fully sequenced 
TBEV isolates are scarce throughout the entire Eurasian endemic zone (Belikov et al., 2014; 
Bertrand et al., 2012; Formanova et al., 2015). Some of the characterized TBEV strains were 
isolated from ticks or rodents, and rarely from a human case (Fajs et al., 2012; Golovljova et al., 
2004; Leonova et al., 2013; Süss, 2011; Wallner et al., 1996). 
TBEV is capable of evolution, mutation and recombination when passaged in the lab through 
different hosts (Bertrand et al., 2012; Kaluzova et al., 1994; Romanova et al., 2007), in the field 
throughout the Eurasian continent (Pogodina et al., 2007; Zanotto et al., 1995), and also at the 
biogeographic edges of its distribution, where it is subjected to a number of ecological constraints 
(Carpi et al., 2009; Hubalek et al., 1995). At the edges of the European distribution, the related 
louping ill virus (LIV), Spanish sheep encephalitis virus (SSEV), Greek goat encephalitis 
(GGEV) virus and Turkish sheep encephalitis virus (TSEV) (Hubalek and Rudolf, 2012; Hubalek 
et al., 2014), and the in 2015 characterised Spanish goat encephalitis virus (SGEV) virus are 
present (Mansfield et al., 2015). 
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Very recently (June 2016), a Dutch-Belgian research team successfully detected TBEV-viral 
RNA from an unknown TBEV strain (Jahfari et al., [submitted]). This was in two ticks collected 
in September 2015, obtained in a forested area where 6 roe deer sera from 2010 were found 
seropositive. The Dutch isolates were found to cluster within the TBEV species complex, but not 
within the three established TBEV subtypes (W-S-FE) nor within the LIV cluster, implying that 
it concerns a novel subtype (Jahfari et al., [submitted]). 
So far, the TBE-virus has not been amplified or isolated yet in Belgium. The study on 13 
wild boar tonsils (all negative) was the first published attempt (Roelandt et al., 2016). Secondly, 
during 2014-2015, the WIV-ISP has executed a field study in rodents in some of the communities 
where the Belgian TBEV-seropositive cattle were found (Roelandt et al., 2014). Several authors 
have indeed advocated rodents (serum, brain, spleen) for attempts to find TBEV, and capturing 
them in areas highlighted by veterinary serosurveillance is current good practice.  
Nonetheless, so far the Belgian rodents have been SNT-negative (n=0/173) and PCR-
negative (n=0/308) (Dr. Brochier B., pers. comm., 2016). This could be due to a number of 
factors, such as large rodent turnover so they remain only seropositive for a short time, low 
TBEV tick-prevalence and non-viremic transmission, or just bad luck with the location of the 
sites, as endemic foci can be quite small. The sentinel and tick research should continue at least 
until a Belgian TBEV strain is characterized, as this strain may very well be an  atypical strain as 
the one found in the Netherlands.  
   PRIORITY 3: RISK ASSESSMENT BASED ON ONE HEALTH SURVEILLANCE VII.2.3
VII.2.3.1 One Health Surveillance
In a globalized world with increasing numbers of emerging diseases, an interdisciplinary so-
called ”one health” approach is indispensable for the prevention and control of vector-borne 
zoonoses, such as TBE (Braks et al., 2014). This approach leads to better preparedness and 
contingency planning, more effective surveillance and control systems, increased health equity 
and improved sharing of logistics and costs (Leach and Scoones, 2013; Obsomer et al., 2013). In 
addition, knowing the precise location of infection risk can lead to better targeted prevention and 
control measures, control (Obsomer et al., 2013). 
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Medical surveillance and awareness should now be a critical part the Belgian TBE(V) 
surveillance program, given the potential clinical zoonotic importance of this pathogen, even if 
afterwards it turns out to be non- or low- pathogenic for humans. On the other hand, veterinarians 
also have a role to play, since sentinel species help the scientific community to explore the bulk 
part of TBE epidemiology, to perform risk assessment, to define risk areas and to guide 
researchers to the TBE-virus itself.  
In general, Belgium should still first focus on the randomized national (regional) 
surveillance components, certainly in humans but still in animals, as currently the general picture 
is still very incomplete. Many communities and some Belgian provinces have not been 
sufficiently covered. This can include both active as passive surveillance components, involving 
serological, clinical syndromic and virological follow-up, which can be organized through the 
existing networks.  
Humans, cattle and roe deer are the most suitable species for a national active component.  A 
randomized survey design is to be preferred in all species if serology data are to be used for 
prevalence estimation, risk mapping and modeling afterwards. Any clinical cases detected in 
enhanced national passive surveillance in sentinel hospitals and practices should be fully traced 
and a very detailed exposure and vaccination anamnesis should be obtained.  
Each time that a national/regional surveillance component has been analysed for a certain 
area (province, community), the competent governments can move their attention to highlighted 
areas for risk-based local surveillance. This includes trying to find TBEV in viremic reservoir 
rodents or infected ticks as well as continued serology in humans and sentinel animals in specific, 
highlighted areas. This is a second phase surveillance in a low prevalence situation, as it will 
generally require much more resources to obtain results: a virus isolate, RNA or (a)symptomatic 
cases. The endemic cycle of TBEV may be very localized with low tick prevalence. Therefore, it 
is advised to implement this research at the local level (community, NIS, postal code) or in a 
natural landscape unit (e.g. UTM square, forest, park, field, garden) with known seropositive 
animals or to collect ticks directly off hosts.  
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VII.2.3.2 Modelling and Mapping 
Up till now, real case maps or spatial predictive risk modelling were considered unfeasible 
for TBEV in Belgium, in particular because of lack of human case/exposure data, randomised 
serological sentinel data or tick TBEV-prevalence data covering the whole country. There are no 
autochthonous clinical human/animal cases yet, and the recording of numbers of tick bites per 
municipality has only started at a national level in 2015: see Figure VII-3 (Lernout, 2016). Until 
now, there are no published studies on TBEV-prevalence in Belgian ticks. The case data obtained 
in this thesis was based on sentinel studies that were differently designed for species playing 
different epidemiological roles. As such, the obtained data are not necessarily representative for 
the whole Belgian territory or for other species. Indeed, the cattle and wild boar data (bottom 
iceberg) cannot easily be combined with human and canine seroprevalence data (tip iceberg).   
The combined cattle and wild boar seroprevalence data alone (Animalstested=888 with 
Animalspos=33=3.72%; Cattle herdssampled=41 with herdspos=10; NISsampled=45 with NISpos=15; 
NIS: National Institute of Statistics code for Community/Municipality) are not sufficient to serve 
as case data in a multivariate Poisson model with continuous/categorical predictor variables. 
Firstly, the positive NIS, herd and animal sample sizes are insufficient, leading to a potential lack 
of power (type II errors) (Dohoo et al., 2009a), biased estimates and variance inflation (Dohoo et 
al., 2009d).  
Equally, we would risk false positive regression coefficients (type I errors) by multiple 
comparison errors (Dohoo et al., 2009c). A Poisson or negative binomial distribution may 
approximate our data (Figure VII-4), however, due to likely overdispersion (s2>??) and excess 
zeroes (nzero=30/45=66% of the NIS, the zero-inflated model may be the best candidate, as zero 
counts can then be generated both in infected as non-infected communities or herds (Dohoo et al., 
2009e).  
However, the sample size of positive and negative NIS/herds should ideally still be at least 
10*(k+1) (k=3-6: the no. of estimated predictors in the final model), in order to avoid the issues 
listed above and lack-of-fit or non-convergence of the model (Dohoo et al., 2009d; SAS, 2008), 
implying a much larger study containing at least 40-70 positive NIS (Belgian communities) or 
herds, which is currently not available (Figure VII-4). 
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Figure VII-4: Number of TBE reactors per sampled NIS. 
Bar plot of 0-6 reactors per NIS. NIS: National Institute of Statistics code for Community/Municipality. 
 
As discussed in Chapter VI and listed in Annex VI.4, there are a multitude of potential TBEV 
risk factors to choose from to perform a modelling or mapping exercise. They are not always 
consistently significant throughout studies. In Chapter VI, we selected data that were available in 
Belgium on the most mentioned TBE risk factors: large hosts, Ixodes ticks, human proximity, 
forests, and temperature. This covered the 3 main areas of risk as well as meteorology. 
Many other layers can of course be selected depending on data availability and the search for 
suitable Belgian datasets at sufficient spatial resolution continues. However, the final model/map 
should not contain too many predictive variables, for the same epidemiological reasons as 
mentioned above for the case data: statistical power, model convergence, false positive effects. 
So, if many datasets on the potentially confounding and interacting risk factors become available, 
variable selection methods (e.g. forward/backward selection; regression tree pruning; sensitivity 
analysis) should be used to select the best subset of TBEV risk predictors for the Belgian 
situation.  
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 European Meta-AnalysisVII.2.3.3
Researchers may consider a renewed TBE-meta-analysis for the whole of Europe, in the
spirit of Randolph and Green (1999) and Randolph and Rogers (2000). Currently, some of the 
national/regional modelling papers still contradict each other on the relative importance of certain 
landscape, host or climatic risk factors. A quantitative (Bayesian) meta-analysis could examine 
the heterogeneity and publication biases in the existing studies and may provide the scientific 
community with more precise, powerful, valid and consistent estimates of effects and interactions 
than any single study could do (Lean et al., 2009; Sargeant et al., 2014; WHO, 2015).  
This would involve (re-)analyzing existing datasets from known endemic and free areas in 
Belgium and from neighboring EU countries in multi-level models. Through a pooling of 
international clinical and serological case data from humans, domestic/wild animals or tick data 
collected at the community level (NUTS4) or at least regional level (NUTS3), generalized 
regression coefficients for local factors and interactions with higher level variables (climate) 
could be determined.  
However, this approach would have to involve a multi-year international project with data 
exchange between research groups and the final results may still not be completely tailored to the 
local situation (i.e. extrapolated) or the results may only be delivered after the first Belgian TBE 
case(s). Therefore, this should be a second choice approach from the Belgian point of view: it 
remains preferential to collect sufficient Belgian medical and virological data to enable risk 
assessment together with the available risk factor data. 
CONCLUSIONSVII.3
In this doctoral work, serological evidence was obtained in favour of TBEV-presence in 
Belgium. Serological surveys were performed in three relevant veterinary species: dogs (Chapter 
III), cattle (Chapter IV) and wild boar (Chapter V). These studies have confirmed the exposure of 
Belgian animals to TBEV, based on the use of the serological gold standard test (SNT). Exposure 
may have occurred in Belgium (cattle, wild boar, dog?) or abroad (wild boar, dog?). The indirect 
serological evidence was strong, with high SNT titers in some animals. In addition, sera from 
positive cattle showed protection in a mouse bioassay (TBE challenge experiment).   
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An extensive literature search (Chapter I) confirmed that indirect serological evidence is in 
most cases the only suitable and practical evidence for TBEV presence/absence substantiation, 
especially in a low prevalence and national surveillance setting. 
A first attempt was conducted to map the geographical distribution of the TBEV seropositive 
communities against the known spatial data on known TBE(V) risk factors in Belgium (Chapter 
VI). This simplified exercise showed qualitatively and statistically that combined seropositivity 
of cattle and wild boar corresponds to the areas with a higher number of risk factors. In the 
future, more data should be collected on a national or regional scale to enable true predictive 
modelling and spatial mapping.  
In order to evaluate the current serological diagnosis of TBE in veterinary species (Chapter 
VII), a commercial ELISA screening test (Progen) was evaluated in the selected sentinel species 
(Chapters III, IV, V). Cross-reactivity testing and test validation in general need additional 
research attention in the future. As long as veterinary ELISA’s are internationally not well 
validated and accuracy improved in cooperation with the producers, SNT and IFA are 
recommended for TBEV diagnosis and surveillance in low prevalence situations.   
The selected sentinel species from the previous chapters were evaluated based on criteria 
from the literature and on our survey experiences. This was done with a view to determine their 
suitability for ongoing TBEV-sentinel surveillance (Chapter VII). The three evaluated sentinel 
species were each found to be useful for at least one specific purpose, e.g. for local, regional, or 
national surveillance; for passive or active surveillance; for risk-based or random surveillance; 
for clinical, serological or virological surveillance.  
With the knowledge that TBEV is present in Belgium, medical surveillance should be 
enhanced to minimize risk and to explain the apparent mismatch between veterinary sentinel 
studies and the lack of medical cases in the Low Countries. The TBE-virus needs to be found in 
ticks, clinical cases or viremic hosts and fully characterized. Finally, a broad one health 
surveillance approach was suggested to allow TBE risk modelling/mapping and/or a European 
TBE meta-analysis in the future (Chapter VII). 
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 INTRODUCTION – AIMSVIII.1
The Western subtype Tick-borne encephalitis virus (TBEV) is the most important, highly 
pathogenic, neurotropic arthropod-borne flavivirus in Europe, and is carried by Ixodes ricinus. 
Tick-borne encephalitis (TBE) has become a considerable public health risk in many European 
countries with currently on average 3,000 hospitalized cases per year, and with long-term 
sequelae and disability in many patients.  
Recent increases and fluctuations in human incidence in Central and Eastern European 
countries and the emergence of the disease in Scandinavia and France, have sparked international 
concern and research. TBE is also emerging in Europe’s canine and equine population, and the 
numbers of clinical cases are expected to increase, as travelling and veterinary awareness 
increase. 
The literature review in the introduction aims to highlight important features of TBE(V) 
epidemiology, the clinical course, the diagnostics and the surveillance possibilities for this tick-
borne flavivirus. There are no confirmed autochthonous Belgian TBE cases. However, there are 
strong suspicions in the medical community (pers. comms.) and favorable environmental and 
(a)biotic conditions are present. Hence, it was discussed why Belgium is at risk for TBE(V)
emergence and why active and national veterinary surveillance should be of benefit to public
health in addition to the existing medical surveillance.
The aims of this PhD were multiple:  
1. To establish veterinary serological evidence pro or contra TBEV presence in Belgium,
based on studies in key species relevant for TBEV epidemiology and surveillance 
2. To map the geographical distribution of the samples and seropositive cases versus a
number of known TBE risk factors  
3. To evaluate an ELISA first-line test for veterinary screening based on the gold standard
seroneutralisation test 
4. To evaluate the selected sentinel species (domestic and wild) regarding their suitability for
ongoing veterinary TBEV surveillance based on experiences and literature 
5. To identify remaining knowledge gaps and suggest priority actions for the future
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 CANINE SEROLOGY STUDY VIII.2
Tick-borne encephalitis virus (TBEV) is an emerging tick-borne viral infection of dogs in 
Europe. Therefore, a commercial enzyme-linked immunosorbent assay (Progen® ELISA) was 
adapted for the detection of TBEV-specific IgG-antibodies in canine sera. In 2008, serum 
samples of Belgian dogs were obtained from three diagnostic laboratories located in Northern 
(n=688) and Southern Belgium (n=192), and their distribution was mapped.  
ELISA-positive (n=2), (near-)borderline (n=8) and some negative (n=10) samples were 
subjected to the gold standard seroneutralisation test (SNT), based on the TBEV rapid fluorescent 
focus inhibition test protocol (RFFIT). One dog was confirmed TBEV seropositive in TBEV-
SNT. Nine samples giving a borderline or positive TBEV ELISA result (including the SNT-
positive sample) and two of the negative samples were further screened for West Nile virus 
(WNV) and were found negative. Five samples from which sufficient serum remained, were then 
additionally tested by LIV HIT: one borderline sample tested LIV antibody positive (titer 1:160), 
which may have been an LIV- or a TBEV-reaction. 
We remarked that the cut-off for the Progen® ELISA IgG protocol could possibly be 
decreased to to increase the sensitivity of the test for canine sera. It was concluded that it would 
be prudent to further validate and standardize this ELISA test for estimating prevalence of 
infection or exposure to TBEV in several species, including dogs. 
The clinical history of the seropositive dog could not explain beyond doubt where and when 
TBEV infection was acquired (in Belgium or abroad – recently or 7-8 years before testing). 
Further surveillance was found necessary to determine whether this dog represented a single 
travel-related case or whether it represented an early warning of a possible future emergence of 
TBEV. 
 BOVINE SEROLOGY STUDY VIII.3
The risk of TBEV-introduction into Belgium remains high and domestic animals can serve as 
excellent sentinels for TBEV-surveillance, in order to install an early warning surveillance 
component for this emerging zoonotic disease of public health importance. In a targeted, risk-
based and cross-sectional sampling design, serological screening was performed on Belgian cattle 
(n=650), selected from the 2010 Belgian national cattle surveillance serum bank.  
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All samples were subjected to a commercial ELISA (Progen®) and to the gold standard 
TBEV seroneutralisation test (SNT), based on the rapid fluorescent focus inhibition test protocol 
(RFFIT). Seventeen bovines were seropositive (titer >1/15) and six had borderline results (1/10 < 
titer < 1/15). The accuracy of the SNT was confirmed with cross-reactivity WNV and Rabies 
virus SNT, ELISA-tests and in a mouse inoculation experiment/test.  
The IgG protocol of the Progen ELISA® seemed to have an extremely low relative DSe in 
cattle, combined with a fairly reasonable relative DSp. The precision, predictive values, Cohen’s 
kappa and Youden index, also followed the same trends, indicating an overall low capacity of this 
test/protocol to distinguish and correctly classify TBEV seropositive and negative cattle. When 
inspecting the cattle ROC curves (AUC=54%), we felt that no big improvement could be made to 
this particular protocol by changing the cut-off in this species. A generally used formula for a 
calculated cut-off value (c = μneg + 2*SDneg) would still have led to a large amount of miss-
classification. 
The overall bovine TBEV-seroprevalence in the targeted area was estimated between 2.61 
and 4.29% based on the SNT results. This confirmed the presence of infected foci in the Eastern 
parts of Belgium for the first time. Further surveillance in cattle, other sentinels, ticks and 
humans at risk was recommended to further determine the location and size of endemic foci and 
the risk for public health.  
 WILD BOAR SEROLOGY STUDYVIII.4
In the frame of a Flemish wildlife surveillance in 2013, a serological screening was 
performed on sera from Flemish wild boar (Sus scrofa; n=238) in order to detect TBEV-specific 
antibodies. These sera were taken throughout the whole Flemish wild boar population range. All 
samples were subjected to gold standard TBEV seroneutralisation (SNT). Seven wild boars were 
seropositive and showed moderate to high SNT-titers - three had borderline results. 
Seroprevalence was estimated around 4.20% (95%CI: 1.65-6.75%). Other Flaviviridae (Classical 
Swine Fever, West Nile Fever, Louping Ill viruses) were excluded and thirteen available tonsils 
tested negative in TBEV RT-PCR. 
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The test characteristics of The Progen® TBEV-ELISA were assessed against the gold 
standard results. The IgG protocol showed low diagnostic sensitivity and good diagnostic 
specificity (DSe: 40-57% and DSp: 91-92%). ELISA agreement with the SNT was judged “slight 
to fair”. ROC-analysis showed that for early detection screening purposes the ELISA cut-off 
might be placed as low as 35 Vienna-units: this would result in improved DSe (70-71%) at the 
cost of DSp (64.04-69.74%).  
This study showed the presence of TBEV-specific antibodies in wild boar and potential 
TBEV-foci in Flanders (both in Limburg and West Flanders). Ongoing wild boar surveillance 
could serve as a local or regional sentinel warning system for public or human health prevention. 
Additional active surveillance and direct testing are now recommended to attempt virus detection 
and to further determine the characteristics of endemic foci, while continued passive medical and 
veterinary surveillance is indicated to monitor the potential risk for Belgian public health. 
 MAPPING AND MODELLING BELGIAN TBE DATA VIII.5
There are several types of maps and models used in TBE research: prevalence and sampling 
maps, predictive risk maps, spatial and predictive models. Since Belgium currently has no 
confirmed human TBE cases, we descriptively mapped the sampling datasets and the seropositive 
sample results from the three veterinary sentinel studies performed in this PhD. Besides the 
veterinary results obtained, nine inconclusive but suspected human patients were added, that 
reacted negative in tests for neuroborreliosis (Lyme disease), positive in TBEV-SNT and 
negative in IgM TBEV-ELISA. 
Using several host, vector, landscape and meteorological spatial distribution layers, it was 
attempted to map TBE(V) risk factors for Belgium. Due to the current lack of sufficient case data 
for predictive modelling, a first and simple approach was used, by selecting the “extreme 20%” 
quantiles for each of the TBE risk factors and by summing the risk factors per Belgian surface 
pixel with equal weights. Despite the simple and crude approach, this indicated in a qualitative 
way, that the seropositive animals and humans are found in the as such defined TBE “at risk” 
zones. The co-feeding paradigm and LST slopes/cycles should be re-investigated in the Low 
Countries. 
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 DISCUSSION  VIII.6
 AIMS AND FINDINGS VIII.6.1
The findings of this PhD were discussed following the PhD Aims:   
PhD Aim 1: TBEV has been present in Belgium since at least 2010. The current evidence is 
indirect (5 veterinary sentinel studies Belgium), but internationally acceptable; 
PhD Aim 2: the samples and results were mapped and a risk factor map was constructed 
based on known TBEV risk factor layers. The overlay of the seropositive cattle/wild boar 
matched with pixels with qualitatively more factors; 
PhD Aim 3: It was discussed what would be needed for better validation and selection of 
TBEV diagnostic tests. International cooperation with ELISA producers and collection of more 
reference samples for multiple species would be beneficial here. For now, SNT and IFA are the 
most accurate tests for veterinary use in Belgium; 
PhD Aim 4: The selected sentinel species were evaluated for suitability criteria and were 
found suitable for specific purposes. Other sentinels were suggested, cervids are to be a priority.  
PhD Aim 5: Identifying knowledge gaps and suggesting priority actions (see VIII.6.2.). 
 GAPS AND ACTIONS  VIII.6.2
Medical surveillance is now an absolute priority, to elucidate the apparent discrepancy 
between the veterinary findings and a lack of medical cases. The amount of aseptic meningitis 
encephalitis cases with etiological diagnosis needs to increase by including TBEV in the 
diagnostic panel. Exposure and infection prevalence should be assessed in a national serosurvey. 
The necessary TBE surveillance components (active and passive) could easily be attached to the 
Belgian Lyme disease and tick bite surveillance and awareness strategy components.  
Direct evidence of an atypical TBE-virus was recently discovered in the Netherlands (Jahfari 
et al., [submitted]). Despite unsuccessful attempts in Belgium so far (wild boar tonsils - rodents), 
this search must continue in clinical cases, ticks and hosts especially in areas highlighted through 
randomized national surveillance. The Belgian TBEV-strain needs to be fully characterized and 
its virulence assessed. 
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161 
An interdisciplinary One Health approach to TBE will be indispensable to assess and map the 
risk of this emerging pathogen. Surveillance should include national randomized and local risk-
based studies on different target species. The data from these studies will allow detection of the 
virus and spatial predictive (risk/factor) modelling, which is still unfeasible at this time. A 
renewed European meta-analysis for TBE may be indicated. 
 CONCLUSIONS VIII.7
TBEV seems to have been present in Belgian veterinary sentinel species from 2010 onwards. 
The commercial ELISA test was evaluated for screening but the SNT and IFA have superior 
accuracy. Simultaneous extensive test validation for different species and flaviviruses remains a 
challenging and urgent task. The three selected sentinel species (dogs, cattle and wild boar) were 
found suitable for different types of complementary veterinary TBE surveillance. The medical 
community should now increase TBE surveillance to assess the risk. The virus strain needs to be 
found and assessed. For this purpose ticks, cervids (roe deer) and rodents need to be investigated. 
One health interdisciplinary TBE(V) surveillance should lead to sufficient data collection for 
predictive modelling and true risk mapping in future studies.  
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